Processing 00000000.tx.1: Upregulation of Glucose Metabolism During Intimal Lesion Formation Is Coupled to the Inhibition of Vascular Smooth Muscle Cell Apoptosis Role of GSK3 Jennifer L. 

Phrase: "Upregulation of Glucose Metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041904:Up-Regulation [Cell Function,Molecular Function]
   770   C0162493:Up-Regulation [Genetic Function]

Phrase: "During Intimal Lesion Formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "Is"

Phrase: "Coupled to the Inhibition of Vascular Smooth Muscle Cell Apoptosis Role"
Meta Candidates (Total=29; Excluded=2; Pruned=0; Remaining=27)
   831   C2612495:inhibition of smooth muscle cell apoptosis [Cell Function]
   797   C2612492:smooth muscle cell apoptosis [Cell Function]
   775   C0026844:Muscle, Smooth, Vascular [Tissue]
   775   C1135918:Smooth muscle cell [Cell]
   775   C2611952:muscle cell apoptosis [Cell Function]
   772   C1512772:Inhibition of Apoptosis [Cell Function]
           Apoptosis Inhibition
   756   C0596981:Muscle cell [Cell]
   756   C1267092:Muscle, Smooth [Tissue]
   738   C0005847:vascular [Body Part, Organ, or Organ Component]
   738   C0007634:Cell [Cell]
   738   C0021467:Inhibition [Mental Process]
   738   C0021469:Inhibition [Molecular Function]
   738   C0026845:Muscle [Tissue]
   738   C0035820:Role [Social Behavior]
   738   C0162638:Apoptosis [Cell Function]
   738   C0205357:Smooth [Qualitative Concept]
   738   C1269647:Cell [Cell]
   738   C1558950:VASCULAR [Finding]
   738   C1628982:% inhibition [Quantitative Concept]
   738   C1704653:Cell [Medical Device]
   738   C1705810:Role [Conceptual Entity]
   738   C1801960:Vascular [Qualitative Concept]
   738   C1948027:Coupled [Functional Concept]
   738   C1948049:Cell [Spatial Concept]
   738   C3463820:Inhibition [Activity]
   712   C2328697:Hemal cell [Cell]
   704 E C0005773:Blood cell [Cell]
   704 E C0010222:couple [Family Group]

Phrase: "of GSK3 Jennifer L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.2: Hall1, John C. 

Phrase: "Hall1,"

Phrase: "John C."
Processing 00000000.tx.3: Chatham2, Hagit Eldar-Finkelman3, and Gary H. 

Phrase: "Chatham2,"

Phrase: "Hagit Eldar-Finkelman3,"

Phrase: "and"

Phrase: "Gary H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: Gibbons1 1 Division of Cardiovascular Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts 2 Department of Radiology, Division of MR Research, Johns Hopkins University School of Medicine, Baltimore, Maryland 3 Department of Human Genetics, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  The purpose of this study was to define the role of metabolic regulatory genes in the pathogenesis of vascular lesions. 

Phrase: "Gibbons1 1 Division of Cardiovascular Medicine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1293097:Division [Therapeutic or Preventive Procedure]
   753   C2919030:Division [Organization]
   753   C2919031:Division [Activity]

Phrase: "Brigham"

Phrase: "and"

Phrase: "Womens Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "Massachusetts 2 Department of Radiology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587500:Radiology department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "Division of MR Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1293097:Division [Therapeutic or Preventive Procedure]
   770   C2919030:Division [Organization]
   770   C2919031:Division [Activity]

Phrase: "Johns Hopkins University School of Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0036375:School [Manufactured Object,Organization]
   753   C0041740:University [Manufactured Object,Organization]

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "Maryland 3 Department of Human Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0587466:Genetics department [Health Care Related Organization]
   753   C1704729:Department [Organization]

Phrase: "Sackler Faculty of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015535:Faculty [Professional or Occupational Group]

Phrase: "Tel-Aviv University,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041740:University [Manufactured Object,Organization]
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: "Tel-Aviv,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0796520:TEL [Gene or Genome]
   861   C3272379:TEL [Intellectual Product]

Phrase: "Israel  ABSTRACT TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0035171:Research Design [Research Activity]
   795   C0035168:research [Research Activity]
   795   C0242481:Research [Research Activity]
   795   C1707689:Design [Activity]
   795   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The purpose of this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0681832:purpose of study [Research Activity]
   760   C1285529:Purpose [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the role of metabolic regulatory genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of vascular lesions."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1402315:Vascular lesions [Disease or Syndrome]
   861   C0221198:lesions [Finding]
   827 E C1546698:Lesion [Intellectual Product]
Processing 00000000.tx.5: The glucose transporter isoform, GLUT1, was significantly increased in the neointima after balloon injury. 

Phrase: "The glucose transporter isoform,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597298:Isoform [Amino Acid, Peptide, or Protein]
   734   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "GLUT1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "significantly"

Phrase: "increased in the neointima"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C2936380:Neointima [Acquired Abnormality]

Phrase: "after balloon injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.6: To define the role of GLUT1 in vascular biology, we established cultured vascular smooth muscle cells (VSMCs) with constitutive upregulation of GLUT1, which led to a threefold increase in glucose uptake as well as significant increases in both nonoxidative and oxidative glucose metabolism as assessed by 13Cnuclear magnetic resonance spectroscopy. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the role of GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in vascular biology,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "we"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "cultured vascular smooth muscle cells (VSMCs) with constitutive upregulation of GLUT1,"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   770   C0026844:Muscle, Smooth, Vascular [Tissue]
   770   C1135918:Smooth Muscle Cells [Cell]
   753   C0596981:Muscle Cells [Cell]
   753   C1267092:Muscle, Smooth [Tissue]
   751   C0007600:cultured cells [Cell]
   751   C0007635:Cultured Cells [Cell]
   751   C3282338:Cells, Cultured [Cell]
   736   C0005847:vascular [Body Part, Organ, or Organ Component]
   736   C0007634:Cells [Cell]
   736   C0026845:Muscle [Tissue]
   736   C0205357:Smooth [Qualitative Concept]
   736   C1558950:VASCULAR [Finding]
   736   C1801960:Vascular [Qualitative Concept]
   736   C3282337:Cells [Cell]
   703 E C1269647:Cell [Cell]
   703 E C1704653:Cell [Medical Device]
   703 E C1948049:Cell [Spatial Concept]
   701   C0005773:Blood Cells [Cell]
   701   C0005802:Blood Glucose [Carbohydrate]

Phrase: "which"

Phrase: "led to a threefold increase"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   760   C0442805:Increase [Functional Concept]
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159527:glucose uptake [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "as well as"

Phrase: "significant increases in both nonoxidative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:increases [Functional Concept]

Phrase: "and"

Phrase: "oxidative glucose metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0282636:oxidative metabolism [Cell Function]
   901   C0596620:glucose metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "as"

Phrase: "assessed by 13Cnuclear magnetic resonance spectroscopy."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0024487:Magnetic Resonance Spectroscopy [Diagnostic Procedure]
   790   C0028580:Magnetic Resonance [Natural Phenomenon or Process]
   790   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   790   C1551403:Magnetic resonance [Laboratory Procedure]
   753   C0024488:Magnetic [Occupation or Discipline]
   753   C0037812:spectroscopy [Laboratory Procedure]
   753   C0231881:Resonance [Finding]
   753   C0459800:resonance [Natural Phenomenon or Process]
   753   C0563532:magnetic [Natural Phenomenon or Process]
   753   C0684213:Resonance [Qualitative Concept]
   753   C1516048:Assessed [Activity]
   753   C2713504:Spectroscopy [Occupation or Discipline]
   753   C2984732:SPECTROSCOPY [Functional Concept]
Processing 00000000.tx.7: We hypothesized that the differential enhancement of glucose metabolism in the neointima contributed to formation of lesions by increasing the resistance of VSMCs to apoptosis. 

Phrase: "We"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "the differential enhancement of glucose metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]

Phrase: "in the neointima"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2936380:Neointima [Acquired Abnormality]

Phrase: "contributed to formation of lesions"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0220781:formation [Biologic Function]
   760   C0221198:lesions [Finding]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
   726 E C1546698:Lesion [Intellectual Product]
   726   C1880177:Contribute [Activity]

Phrase: "by increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the resistance of VSMCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0042380:Vascular resistance [Physiologic Function]
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]

Phrase: "to apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.8: Indeed, upregulation of GLUT1 significantly inhibited apoptosis induced by serum withdrawal (control 20  1% vs. GLUT1 11  1%, P < 0.0005) as well as Fas-ligand (control 12  1% vs. GLUT1 6  1.0%, P < 0.0005). 

Phrase: "Indeed,"

Phrase: "upregulation of GLUT1 significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induced by serum withdrawal"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205263:Induced [Functional Concept]
   770   C0229671:Serum [Body Substance]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]
   770   C2349954:Withdrawal [Activity]
   770   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "(control 20  1%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "vs. GLUT1 11  1%,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   888   C1422501:GLUCOSE TRANSPORTER 11 [Gene or Genome]
   884   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   840   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "P < 0.0005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "as well as"

Phrase: "Fas-ligand"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0253023:Fas Ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1515370:Fas Ligand [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0023688:Ligand [Chemical]

Phrase: "(control 12  1%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "vs. GLUT1 6  1.0%,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   827   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   799   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "P < 0.0005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.9: Provocatively, the enhanced glucose metabolism in GLUT1 overexpressing VSMC as well as neointimal tissue correlated with the inactivation of the proapoptotic kinase, glycogen synthase kinase 3 (GSK3). 

Phrase: "Provocatively,"

Phrase: "the enhanced glucose metabolism in GLUT1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0596620:glucose metabolism [Molecular Function]
   744   C0025519:Metabolism [Organism Function]
   744   C0025520:metabolism [Functional Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "VSMC"
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth muscle cell [Cell]
   861   C0596981:Muscle cell [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   861   C2328697:Hemal cell [Cell]
   852 E C0005773:Blood cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cell [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1269647:Cell [Cell]
   812   C1558950:VASCULAR [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1801960:Vascular [Qualitative Concept]
   812   C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "as well as"

Phrase: "neointimal tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "correlated with the inactivation of the proapoptotic kinase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0544461:Inactivation [Cell or Molecular Dysfunction]
   744   C1707520:Correlated [Qualitative Concept]

Phrase: "glycogen synthase kinase 3 (GSK3)."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.10: Transient overexpression of GSK3 was sufficient to induce apoptosis (control 7  1% vs. GSK3 28  2%, P < 0.0001). 

Phrase: "Transient overexpression of GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1514559:Overexpression [Genetic Function]

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(control 7  1%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "vs. GSK3 28  2%,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   904   C1415378:GLYCOGEN SYNTHASE 2 [Gene or Genome]
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "P < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.11: GSK3-induced apoptosis was significantly attenuated by GLUT1 overexpression (GSK3 29  3% vs. GLUT1 + GSK3 6  1%, n = 12, P < 0.001), suggesting that the antiapoptotic effect of enhanced glucose metabolism is linked to the inactivation of GSK3. 

Phrase: "GSK3-induced apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0162638:Apoptosis [Cell Function]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   727 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "attenuated by GLUT1 overexpression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   790   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0332161:Attenuated [Qualitative Concept]
   753   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0599946:Attenuated [Activity]
   753   C1514559:Overexpression [Genetic Function]

Phrase: "(GSK3 29  3%"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "vs. GLUT1 + GSK3 6  1%,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   871   C1420173:GLUCOSE TRANSPORTER 3 [Gene or Genome]
   849   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   807   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   807   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   791   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   791   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 12,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the antiapoptotic effect of enhanced glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1158774:glucose effect [Genetic Function]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "linked to the inactivation of GSK3."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   818   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0544461:Inactivation [Cell or Molecular Dysfunction]
   708   C1517892:Link [Intellectual Product]
   708   C1704666:Link [Intellectual Product]
Processing 00000000.tx.12: Taken together, upregulation of glucose metabolism during intimal lesion formation promotes an antiapoptotic signaling pathway that is linked to the inactivation of GSK3.  

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "upregulation of glucose metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041904:Up-Regulation [Cell Function,Molecular Function]
   770   C0162493:Up-Regulation [Genetic Function]

Phrase: "during intimal lesion formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "an antiapoptotic signaling pathway"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0037083:signaling pathway [Cell Function]
   901   C0086982:Signaling Pathway [Molecular Function]
   884 E C0037080:Signal Pathway [Molecular Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "that"

Phrase: "is"

Phrase: "linked to the inactivation of GSK3."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   818   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0544461:Inactivation [Cell or Molecular Dysfunction]
   708   C1517892:Link [Intellectual Product]
   708   C1704666:Link [Intellectual Product]
Processing 00000000.tx.13: INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  The risk of restenosis and atherosclerosis after balloon angioplasty is significantly elevated in individuals with diabetes (123). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The risk of restenosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "atherosclerosis after balloon angioplasty"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004153:Atherosclerosis [Disease or Syndrome]

Phrase: "is"

Phrase: "significantly"

Phrase: "elevated in individuals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205250:Elevated [Qualitative Concept]
   790   C3163633:Elevated [Qualitative Concept]
   756   C0027361:Individual [Population Group]
   756   C0237401:Individual [Human]

Phrase: "with diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(123"

Phrase: ")."
Processing 00000000.tx.14: This suggests a potential link between vascular smooth muscle cell (VSMC) glucose metabolism and the progression of lesion formation. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a potential link between vascular smooth muscle cell (VSMC) glucose metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1517892:Link [Intellectual Product]
   739   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "the progression of lesion formation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0242656:progression [Pathologic Function]
   760   C0449258:Progression [Functional Concept]
Processing 00000000.tx.15: However, the contributing role of glucose metabolism to the process of vascular lesion formation in the nondiabetic population has not been defined. 

Phrase: "However,"

Phrase: "the contributing role of glucose metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "to the process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "of vascular lesion formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "in the nondiabetic population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.16: Recent in vivo studies from our laboratory and others indicate that intimal VSMCs seem to have an intrinsic resistance to apoptosis (456). 

Phrase: "Recent in vivo studies from our laboratory"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   797   C0681829:in vivo study [Research Activity]
           studies vivo
   774   C0681827:Laboratory studies [Laboratory Procedure]
   748   C0947630:studies [Laboratory Procedure]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "indicate"

Phrase: "that intimal VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "seem"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "an intrinsic resistance to apoptosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332325:Resistant to [Functional Concept]
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]

Phrase: "(456"

Phrase: ")."
Processing 00000000.tx.17: We hypothesized that a component of the intrinsic property of intimal VSMCs to survive was related to a significant alteration in metabolic regulatory pathways. 

Phrase: "We"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "a component of the intrinsic property of intimal VSMCs to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   735   C0449432:Component [Manufactured Object]
   735   C1705248:Component [Conceptual Entity]
   732   C0243092:Cell component [Cell Component]
   732   C1178969:Cell Component [Cell Component]

Phrase: "survive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0310255:SURVIVE [Pharmacologic Substance]

Phrase: "was"

Phrase: "related to a significant alteration"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0237881:significant [Quantitative Concept]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C0750502:Significant [Idea or Concept]
   760   C1515926:Alteration [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "in metabolic regulatory pathways."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1291081:Metabolic Pathways [Functional Concept]
   884   C1514829:Regulatory Pathway [Functional Concept]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.18: VSMCs exhibit unusually high rates of glucose utilization and lactate production under normal, well-oxygenated conditions (7,8). 

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "unusually high rates of glucose utilization"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0860803:glucose high [Finding]
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C2700149:HIGH [Intellectual Product]
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "lactate production under normal, well-oxygenated conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]

Phrase: "(7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.19: Glucose metabolism seems to be an important determinant of vascular reactivity (9). 

Phrase: "Glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an important determinant of vascular reactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521761:Determinant [Functional Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.20: Moreover, recent work from our laboratory has demonstrated that hyperglycemia inhibits medial VSMC apoptosis in the murine carotid artery in response to a reduction in blood flow (10). 

Phrase: "Moreover,"

Phrase: "recent work from our laboratory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0043227:Work [Occupational Activity]

Phrase: "has"

Phrase: "demonstrated"

Phrase: "that hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "medial VSMC apoptosis in the murine carotid artery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2612492:smooth muscle cell apoptosis [Cell Function]
   775   C2611952:muscle cell apoptosis [Cell Function]
   738   C0162638:Apoptosis [Cell Function]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to a reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in blood flow"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0232338:Blood flow [Organism Function]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0806140:Flow [Natural Phenomenon or Process]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.21: Thus, we postulated that adaptive alterations in glucose regulatory pathways and metabolism contributed to the antiapoptotic phenotype of neointimal VSMCs. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "postulated"

Phrase: "that adaptive alterations in glucose regulatory pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "contributed to the antiapoptotic phenotype of neointimal VSMCs."
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   775   C0026844:Muscle, Smooth, Vascular [Tissue]
   775   C1135918:Smooth Muscle Cells [Cell]
   756   C0596981:Muscle Cells [Cell]
   756   C1267092:Muscle, Smooth [Tissue]
   738   C0005847:vascular [Body Part, Organ, or Organ Component]
   738   C0007634:Cells [Cell]
   738   C0026845:Muscle [Tissue]
   738   C0031437:Phenotype [Organism Attribute]
   738   C0205357:Smooth [Qualitative Concept]
   738   C1285572:Phenotype [Laboratory Procedure]
   738   C1558950:VASCULAR [Finding]
   738   C1801960:Vascular [Qualitative Concept]
   738   C2986514:antiapoptotic [Chemical Viewed Functionally]
   738   C3282337:Cells [Cell]
   737   C0427385:Cell phenotype [Laboratory Procedure]
   737   C1318444:Cell phenotype [Organism Attribute]
   704   C0005773:Blood Cells [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704   C1880177:Contribute [Activity]
   704 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.22: Glucose transport is the rate-limiting step in glucose metabolism and is controlled through a family of glucose transporter proteins (GLUT1GLUT7) with GLUT1 being the predominant isoform in VSMCs (11,12). 

Phrase: "Glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "is"

Phrase: "the rate-limiting step in glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0596620:glucose metabolism [Molecular Function]
   799   C0025519:Metabolism [Organism Function]
   799   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "controlled through a family of glucose transporter proteins"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   770   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   750   C0726398:GLUCOSE CONTROL [Indicator, Reagent, or Diagnostic Aid]
   750   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   744   C0015576:Family [Family Group]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1704727:Family [Conceptual Entity]
   744   C2587213:Controlled [Functional Concept]
   711 E C0243148:control [Qualitative Concept]
   711 E C1550141:Control [Substance]
   711 E C1882979:Control [Conceptual Entity]
   711 E C3274648:Control [Qualitative Concept]

Phrase: "(GLUT1GLUT7"

Phrase: ")"

Phrase: "with GLUT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "being"

Phrase: "the predominant isoform in VSMCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597298:Isoform [Amino Acid, Peptide, or Protein]

Phrase: "(11,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.23: The regulation of GLUT1 in VSMCs during the formation of vascular lesions remains to be defined. 

Phrase: "The regulation of GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "in VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "during the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of vascular lesions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1402315:Vascular lesions [Disease or Syndrome]
   861   C0221198:lesions [Finding]
   827 E C1546698:Lesion [Intellectual Product]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.24: Accordingly, the first aim of this study was to determine whether VSMC glucose metabolism and gene expression were altered with the progression of lesion formation. 

Phrase: "Accordingly,"

Phrase: "the first aim of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1947946:Aim [Idea or Concept]
   753   C2948600:Aim [Pharmacologic Substance]
   753   C3540471:AIM [Gene or Genome]
   753   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "VSMC glucose metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0596984:muscle metabolism [Organ or Tissue Function]
   827   C0596620:glucose metabolism [Molecular Function]
   799   C0025519:Metabolism [Organism Function]
   799   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "altered with the progression of lesion formation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0220781:formation [Biologic Function]
   748   C0221198:Lesion [Finding]
   748   C0242656:progression [Pathologic Function]
   748   C0392747:Altered [Functional Concept]
   748   C0439634:formation [Spatial Concept]
   748   C0449258:Progression [Functional Concept]
   748   C1522492:Formation [Functional Concept]
   748   C1546698:Lesion [Intellectual Product]
Processing 00000000.tx.25: Previous studies simulating the perturbations of glucose metabolism observed in diabetes have suggested that abnormal glucose metabolism influences vascular biology (13). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "simulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284447:simulating [Biomedical or Dental Material]

Phrase: "the perturbations of glucose metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0332453:perturbation [Functional Concept]

Phrase: "observed in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C1441672:Observed [Functional Concept]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that abnormal glucose metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0596620:glucose metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0580546:Abnormal glucose [Finding]

Phrase: "influences"

Phrase: "vascular biology"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.26: Exposure to high extracellular concentrations of glucose is associated with growth of VSMCs in vitro and in vivo (13). 

Phrase: "Exposure to high extracellular concentrations of glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332157:Exposure to [Clinical Attribute]
           Exposure
   748   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "is"

Phrase: "associated with growth of VSMCs"
Meta Candidates (Total=27; Excluded=6; Pruned=0; Remaining=21)
   800   C0026844:Muscle, Smooth, Vascular [Tissue]
   800   C1135918:Smooth Muscle Cells [Cell]
   782   C0007595:growth of cell [Cell Function]
           cells growth
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0596981:Muscle Cells [Cell]
   770   C1267092:Muscle, Smooth [Tissue]
   750   C0699040:cell associated [Cell Component]
   744   C0005847:vascular [Body Part, Organ, or Organ Component]
   744   C0007634:Cells [Cell]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0026845:Muscle [Tissue]
   744   C0205357:Smooth [Qualitative Concept]
   744   C0220844:growth [Physiologic Function]
   744   C1558950:VASCULAR [Finding]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1801960:Vascular [Qualitative Concept]
   744   C2911660:Growth [Activity]
   744   C3282337:Cells [Cell]
   717   C0005773:Blood Cells [Cell]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1706221:Associate [Professional or Occupational Group]
   711 E C1948049:Cell [Spatial Concept]
   709 E C2328697:Hemal cell [Cell]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.27: However, the influence of alterations in glucose transporter expression on VSMC glucose metabolism and cell biology is unclear. 

Phrase: "However,"

Phrase: "the influence of alterations"

Phrase: "in glucose transporter expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "on VSMC glucose metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0596984:muscle metabolism [Organ or Tissue Function]
   827   C0596620:glucose metabolism [Molecular Function]
   799   C0025519:Metabolism [Organism Function]
   799   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "cell biology"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.28: The present study uses nuclear magnetic resonance (NMR) spectroscopy to clarify the influence of glucose transport on VSMC metabolism in the context of normal extracellular concentrations of glucose. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "uses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "nuclear magnetic resonance (NMR) spectroscopy to"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   937   C0877853:Spectroscopy, Nuclear Magnetic Resonance [Diagnostic Procedure]
   884   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   884   C0024487:Magnetic Resonance Spectroscopy [Diagnostic Procedure]
   884   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   884   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   840   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   840   C1551403:Magnetic resonance [Laboratory Procedure]
   804   C0024488:Magnetic [Occupation or Discipline]
   804   C0037812:spectroscopy [Laboratory Procedure]
   804   C0231881:Resonance [Finding]
   804   C0459800:resonance [Natural Phenomenon or Process]
   804   C0521447:Nuclear [Spatial Concept]
   804   C0563532:magnetic [Natural Phenomenon or Process]
   804   C0684213:Resonance [Qualitative Concept]
   804   C2713504:Spectroscopy [Occupation or Discipline]
   804   C2984732:SPECTROSCOPY [Functional Concept]
   733 E C0024483:Magnet [Manufactured Object]
   733 E C0577554:Resonant [Qualitative Concept]
   733 E C0885556:magnets [Pharmacologic Substance]
   733 E C1706318:Magnet [Manufactured Object]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the influence of glucose transport"

Phrase: "on VSMC metabolism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0596984:muscle metabolism [Organ or Tissue Function]
   804   C0025519:Metabolism [Organism Function]
   804   C0025520:metabolism [Functional Concept]
   717   C0026844:Muscle, Smooth, Vascular [Tissue]
   717   C1135918:Smooth muscle cell [Cell]

Phrase: "in the context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of normal extracellular concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   896   C1277200:Normal concentration [Finding]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.29: The cellular signaling pathways by which changes in glucose metabolism modulate VSMC biology are poorly understood. 

Phrase: "The cellular signaling pathways by which"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   783   C0037080:pathways signaling [Molecular Function]
   773 E C0037083:signaling pathway [Cell Function]
   773 E C0086982:Signaling Pathway [Molecular Function]
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]

Phrase: "changes in glucose metabolism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0596620:glucose metabolism [Molecular Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "VSMC biology"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   840   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   804   C0005532:Biology [Biomedical Occupation or Discipline]
   733 E C0205460:Biologic [Qualitative Concept]
   733 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]
   717   C0026844:Muscle, Smooth, Vascular [Tissue]
   717   C1135918:Smooth muscle cell [Cell]

Phrase: "are"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "understood."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]
Processing 00000000.tx.30: There is evidence to suggest that the induction of growth factors as well as mediators such as protein kinase C may play a role (131415). 

Phrase: "There"

Phrase: "is"

Phrase: "evidence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the induction of growth factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "as well as"

Phrase: "mediators such as protein kinase C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   719 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "(131415"

Phrase: ")."
Processing 00000000.tx.31: Recent work has also suggested that glucose regulates the serine-threonine kinase, GSK3 (16). 

Phrase: "Recent work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "has"

Phrase: "also"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "regulates"

Phrase: "the serine-threonine kinase,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0072402:Serine-Threonine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
           Serine Kinase
           Threonine Kinase
  1000   C1414387:serine/threonine kinase [Gene or Genome]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.32: GSK3 was originally identified as one of many enzymes involved in the complex regulation of glycogen metabolism (17,18). 

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "originally"

Phrase: "identified as one of many enzymes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0014442:Enzymes [Enzyme,Organic Chemical]
   753   C0014445:enzymes [Functional Concept]
   753   C0205396:Identified [Qualitative Concept]
   753   C0205447:One [Quantitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: "involved in the complex regulation of glycogen metabolism"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C2753952:regulation of glycogen metabolism [Molecular Function]
   793   C1159402:regulation of metabolism [Organism Function]
           metabolism regulation
   770   C0599784:glycogen metabolism [Molecular Function]
   744   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   744   C0025519:Metabolism [Organism Function]
   744   C0025520:metabolism [Functional Concept]
   744   C0439855:Complex [Qualitative Concept]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1314939:Involved [Functional Concept]
   744   C1327622:Regulation [Biologic Function]
   744   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.33: However, GSK3 is now known to also play a critical role in protein synthesis (19), cell fate determinations (20,21), and dorsoventral axis formation in Xenopus (22,23). 

Phrase: "However,"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a critical role in protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(19"

Phrase: ")"

Phrase: ","

Phrase: "cell fate determinations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   988   C1160037:cell fate determination [Cell Function]
   827   C0680730:determinations [Governmental or Regulatory Activity]
   793 E C1148554:determination [Laboratory Procedure]
   734   C1540661:cell fate [Cell Function]

Phrase: "(20,"

Phrase: "21"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "dorsoventral axis formation in Xenopus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C2984245:Dorso-ventral axis formation [Functional Concept]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "(22,"

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.34: Activation of GSK3 has been shown to be proapopoptic (21). 

Phrase: "Activation of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1879547:Activation [Activity]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "proapopoptic"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.35: Antiapoptotic factors, including insulin, fibroblast growth factor, and epidermal growth factor, have been shown to inactivate GSK3 through phosphorylation of a serine residue at position 9 (19,24,25). 

Phrase: "Antiapoptotic factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "fibroblast growth factor,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0016026:Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0016030:Fibroblast [Cell]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "epidermal growth factor,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inactivate"

Phrase: "GSK3 through phosphorylation of a serine residue"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0033640:Glycogen synthase a kinase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C1417673:glycogen synthase A kinase [Gene or Genome]
   795   C3537353:Glycogen Synthase A Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0072402:Serine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "at position 9"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "(19,"

Phrase: "24,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.36: Considering the multifactorial nature of GSK3, we hypothesized that regulation of GSK3 may be a critical component linking metabolism to cell fate in the vasculature. 

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "the multifactorial nature of GSK3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0349590:Nature [Idea or Concept]
   744   C1262865:Nature [Functional Concept]

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that regulation of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "may"

Phrase: "be"

Phrase: "a critical component linking metabolism to cell fate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0025519:Metabolism [Organism Function]
   744   C0025520:metabolism [Functional Concept]

Phrase: "in the vasculature."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005839:vasculature [Body Part, Organ, or Organ Component]
Processing 00000000.tx.37: This is the first study to demonstrate that glucose transport and metabolism are differentially upregulated in the progression of lesion formation. 

Phrase: "This"

Phrase: "is"

Phrase: "the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "that glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "are"

Phrase: "differentially"

Phrase: "upregulated in the progression of lesion formation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0220781:formation [Biologic Function]
   748   C0221198:Lesion [Finding]
   748   C0242656:progression [Pathologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C0449258:Progression [Functional Concept]
   748   C1522492:Formation [Functional Concept]
   748   C1546698:Lesion [Intellectual Product]
Processing 00000000.tx.38: Furthermore, this shift in glucose metabolism seems to be coupled to the regulation of antiapoptotic signaling pathways, in part through the inactivation of GSK3. 

Phrase: "Furthermore,"

Phrase: "this shift in glucose metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0333051:Shift [Functional Concept]
   760   C2347509:Shift [Phenomenon or Process]

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "coupled to the regulation of antiapoptotic signaling pathways,"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   811   C3158094:regulation of signaling pathway [Molecular Function]
   793   C2756011:regulation of signaling [Biologic Function]
   767   C0037080:pathways signaling [Molecular Function]
   754 E C0037083:signaling pathway [Cell Function]
           Signaling
   754 E C0086982:Signaling Pathway [Molecular Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   744   C1704259:Pathways [Molecular Function]
   744   C1705987:Pathways [Conceptual Entity]
   744   C1948027:Coupled [Functional Concept]
   744   C2986514:antiapoptotic [Chemical Viewed Functionally]
   744   C3537152:signaling [Biologic Function]
   711 E C0010222:couple [Family Group]
   711 E C1710082:Signal [Phenomenon or Process]

Phrase: "in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "through the inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "of GSK3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.39: The notion that cellular glucose transport and metabolism are involved in orchestrating VSMC fate in the nondiabetic context is a novel concept and may have important implications for the contributing role of metabolism in vascular disease.  

Phrase: "The notion"

Phrase: "that cellular glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0178666:glucose transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "are"

Phrase: "involved in orchestrating VSMC fate"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   800   C0026844:Muscle, Smooth, Vascular [Tissue]
   800   C1135918:Smooth muscle cell [Cell]
   770   C0596981:Muscle cell [Cell]
   770   C1267092:Muscle, Smooth [Tissue]
   770   C1540661:cell fate [Cell Function]
   767   C0449621:Muscle involved [Functional Concept]
   744   C0005847:vascular [Body Part, Organ, or Organ Component]
   744   C0007634:Cell [Cell]
   744   C0026845:Muscle [Tissue]
   744   C0205357:Smooth [Qualitative Concept]
   744   C1269647:Cell [Cell]
   744   C1314939:Involved [Functional Concept]
   744   C1539479:FATE [Gene or Genome]
   744   C1558950:VASCULAR [Finding]
   744   C1704653:Cell [Medical Device]
   744   C1801960:Vascular [Qualitative Concept]
   744   C1948049:Cell [Spatial Concept]
   725   C2328697:Hemal cell [Cell]
   717 E C0005773:Blood cell [Cell]

Phrase: "in the nondiabetic context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449255:Context [Finding]
   861   C0542559:Context [Functional Concept]

Phrase: "is"

Phrase: "a novel concept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0178566:concept [Idea or Concept]

Phrase: "and"

Phrase: "may"

Phrase: "have"

Phrase: "important implications for the contributing role of metabolism"

Phrase: "in vascular disease."
Meta Candidates (Total=17; Excluded=12; Pruned=0; Remaining=5)
  1000   C0042373:Vascular disease [Disease or Syndrome]
   950 E C0018939:Blood disease NOS [Disease or Syndrome]
   950 E C1533163:Blood disease [Disease or Syndrome]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0012634:Disease [Disease or Syndrome]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   745 E C0333275:Bloody [Qualitative Concept]
Processing 00000000.tx.40: RESEARCH DESIGN AND METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Balloon-distention injury. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0086912:methods research [Research Activity]
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Balloon-distention injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.41: Male New Zealand White rabbits (2.54 kg) and male Sprague-Dawley rats (300 g) were used for all experiments in accordance with protocols approved by the Standing Committee on Animals at Harvard Medical School. 

Phrase: "Male New Zealand White rabbits"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C0324547:New Zealand White Rabbits [Mammal]
           New Zealand Rabbits
           New Zealand White
   840   C0027978:New Zealand [Geographic Area]
   804   C0007457:White [Population Group]
   804   C0034493:Rabbit [Mammal]
   804   C0043157:White [Population Group]
   804   C0205314:New [Temporal Concept]
   804   C0220938:White [Qualitative Concept]

Phrase: "(2.54 kg)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022718:KG [Geographic Area]
   827   C0439209:kg [Quantitative Concept]

Phrase: "and"

Phrase: "male Sprague-Dawley rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0034715:Rats, Sprague-Dawley [Mammal]
   861   C2699239:Sprague-Dawley [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "(300 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "used for all experiments"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]

Phrase: "in accordance with protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442711:Protocols [Intellectual Product]
   966 E C1507394:Protocol [Intellectual Product]
   966 E C1522729:Protocol [Intellectual Product]
   966 E C2348563:Protocol [Intellectual Product]

Phrase: "approved by the Standing Committee"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205540:Approved [Qualitative Concept]
   760   C0231472:Standing [Physiologic Function]
   760   C2699414:Committee [Group]

Phrase: "on Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "at Harvard Medical School."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]
Processing 00000000.tx.42: Animals were anesthetized with an intramuscular injection of xylazine and ketamine hydrochloride. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "anesthetized with an intramuscular injection of xylazine"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0021492:Intramuscular injection [Functional Concept]
           INTRAMUSCULAR
   748   C0021485:injection [Therapeutic or Preventive Procedure]
   748   C0043366:Xylazin [Organic Chemical,Pharmacologic Substance]
   748   C0442117:Intramuscular [Spatial Concept]
   748   C1272883:Injection [Biomedical or Dental Material]
   748   C1533685:Injection [Therapeutic or Preventive Procedure]
   748   C1720436:Anesthetized [Finding]
   748   C1828121:Injection [Functional Concept]

Phrase: "and"

Phrase: "ketamine hydrochloride."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0700541:Ketamine Hydrochloride [Organic Chemical,Pharmacologic Substance]
   944 E C0022613:Ketalar [Organic Chemical,Pharmacologic Substance]
   861   C0022614:Ketamine [Organic Chemical,Pharmacologic Substance]
   861   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.43: The left common carotid artery was exposed via a 6-cm midline cervical incision. 

Phrase: "The left common carotid artery"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0226087:Left common carotid artery [Body Part, Organ, or Organ Component]
   923   C0162859:Common carotid artery [Body Part, Organ, or Organ Component]
           Carotid artery
   861   C0007272:Carotid artery [Body Part, Organ, or Organ Component]
   812   C0003842:Artery [Body Part, Organ, or Organ Component]
   812   C0205091:Left [Spatial Concept]
   812   C0205214:Common [Quantitative Concept]
   812   C0226004:artery [Body System]
   812   C0741968:Carotid [Body Part, Organ, or Organ Component]
   812   C1522138:Common [Functional Concept]
   812   C1552822:left [Functional Concept]
   812   C3245511:common [Intellectual Product]
   741 E C0221464:Arterial [Spatial Concept]

Phrase: "was"

Phrase: "exposed via a 6-cm midline cervical incision."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0442944:Cervical incision [Therapeutic or Preventive Procedure]
   767   C0456276:Midline incision [Therapeutic or Preventive Procedure]
   744   C0027530:Cervical [Body Location or Region]
   744   C0184898:Incision [Therapeutic or Preventive Procedure]
   744   C0205064:Cervical [Spatial Concept]
   744   C0332157:Exposed [Clinical Attribute]
   744   C0549183:Midline [Spatial Concept]
   744   C1660780:midline [Cell Component]
   744   C2338258:Incision [Body Location or Region]
   744   C2939193:Midline [Spatial Concept]
Processing 00000000.tx.44: A 2-Fr Fogarty embolectomy balloon catheter was inserted retrograde through the internal carotid artery, inflated, and withdrawn to the carotid artery bifurcation as described previously (5). 

Phrase: "A 2-Fr Fogarty embolectomy balloon catheter"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   858   C0179757:Fogarty catheter [Medical Device]
   839   C0995127:CATHETER, EMBOLECTOMY [Medical Device]
   827   C0441127:Balloon catheter [Medical Device]
   799   C0085590:Catheter [Medical Device]
   799   C0336867:Balloon [Manufactured Object]
   799   C0441144:balloon [Medical Device]
   799   C1704454:Catheter [Medical Device]

Phrase: "was"

Phrase: "inserted"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441587:Inserted [Health Care Activity]
   966 E C1743766:Insert [Medical Device]
   966 E C1883719:Insert [Functional Concept]

Phrase: "retrograde through the internal carotid artery,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439784:Retrograde [Spatial Concept]
   753   C0589500:Retrograde [Spatial Concept]

Phrase: "inflated"

Phrase: ","

Phrase: "and"

Phrase: "withdrawn to the carotid artery bifurcation"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0007272:Carotid artery [Body Part, Organ, or Organ Component]
   790   C0162859:Carotid artery [Body Part, Organ, or Organ Component]
   783   C0226088:Carotid bifurcation [Body Location or Region]
   753   C0003842:Artery [Body Part, Organ, or Organ Component]
   753   C0184906:Bifurcation [Therapeutic or Preventive Procedure]
   753   C0226004:artery [Body System]
   753   C0424092:Withdrawn [Finding]
   753   C0741968:Carotid [Body Part, Organ, or Organ Component]
   753   C2349954:Withdrawn [Activity]
   753   C2825032:Withdrawn [Mental or Behavioral Dysfunction]
   753   C3146289:Bifurcation [Body Space or Junction]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.45: After a 4-week period to allow formation of a neointima, animals were killed by intravenous overdose of pentobarbital and both carotid arteries were rapidly excised. 

Phrase: "After a 4-week period to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0439531:/period [Temporal Concept]
   812   C1948053:Period [Temporal Concept]
   741 E C0332182:Periodic [Temporal Concept]
   741 E C1706381:PERIODIC [Intellectual Product]
   712 E C0031084:Periodicities [Temporal Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "formation of a neointima,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C2936381:Neointima Formation [Pathologic Function]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "killed by intravenous overdose of pentobarbital"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0029944:Overdose [Injury or Poisoning]
   753   C0030883:Pentobarbital [Organic Chemical,Pharmacologic Substance]
   753   C0162388:killed [Social Behavior]
   753   C0348016:Intravenous [Spatial Concept]
   753   C1546941:Overdose [Idea or Concept]
   719 E C0681205:Kill [Idea or Concept]
   719 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "both carotid arteries"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0007272:Carotid Arteries [Body Part, Organ, or Organ Component]
   966 E C0162859:Carotid artery [Body Part, Organ, or Organ Component]
   861   C0003842:Arteries [Body Part, Organ, or Organ Component]
   861   C0226004:arteries [Body System]
   861   C0741968:Carotid [Body Part, Organ, or Organ Component]
   777 E C0221464:Arterial [Spatial Concept]

Phrase: "were"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "excised."
Processing 00000000.tx.46: Both injured and uninjured vessels were opened en face, and the endothelial lining was gently removed before snap-freezing. 

Phrase: "Both injured"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332664:Injured [Functional Concept]

Phrase: "and"

Phrase: "uninjured vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827 E C1511228:Vessel [Tissue]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "opened"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175566:Opened [Spatial Concept]

Phrase: "en face,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0015450:Face [Body Location or Region]
   861   C1281591:Face [Body Part, Organ, or Organ Component]
   861   C1417861:eN [Gene or Genome]
   861   C2987294:EN [Qualitative Concept]

Phrase: "and"

Phrase: "the endothelial lining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205132:lining [Spatial Concept]

Phrase: "was"

Phrase: "gently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1638411:Gently [Qualitative Concept]

Phrase: "removed before snap-freezing."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0016701:Freezing [Natural Phenomenon or Process]
   770   C0849355:Removed [Qualitative Concept]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]
Processing 00000000.tx.47: In the injured vessel, the neointimal layer was gently dissected from the medial lining under a dissecting microscope and rapidly snap-frozen. 

Phrase: "In the injured vessel,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0005847:Vessel [Body Part, Organ, or Organ Component]
   861   C1511228:Vessel [Tissue]
   805 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "the neointimal layer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0934502:Layer [Body Part, Organ, or Organ Component]
   861   C1522408:Layer [Qualitative Concept]
   861   C1561599:Layer [Intellectual Product]

Phrase: "was"

Phrase: "gently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1638411:Gently [Qualitative Concept]

Phrase: "dissected from the medial lining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205098:Medial [Spatial Concept]
   760   C0205132:lining [Spatial Concept]
   760   C0205239:dissected [Functional Concept]

Phrase: "under a dissecting microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0181839:Microscope [Medical Device]
   861   C1706379:Microscope [Medical Device]

Phrase: "and"

Phrase: "rapidly snap-"

Phrase: "frozen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016701:Frozen [Natural Phenomenon or Process]
  1000   C0677542:Frozen [Functional Concept]
Processing 00000000.tx.48: Cell culture. 

Phrase: "Cell culture."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.49: The clonal A7r5 rat aortic VSMCs were purchased from ATCC (Rockville, MD) and subcultured in Dulbeccos modified Eagles medium (DMEM) with 10% fetal bovine serum (FBS; Gibco Life Technologies, Grand Island, NY) plus 1% penicillin/streptomycin (Gibco Life Technologies). 

Phrase: "The clonal A7r5 rat aortic VSMCs"
Meta Candidates (Total=20; Excluded=7; Pruned=0; Remaining=13)
   856   C0009013:Clone Cells [Cell]
   835   C0026844:Muscle, Smooth, Vascular [Tissue]
   835   C1135918:Smooth Muscle Cells [Cell]
   812   C0596981:Muscle Cells [Cell]
   812   C1267092:Muscle, Smooth [Tissue]
   793   C0005847:vascular [Body Part, Organ, or Organ Component]
   793   C0007634:Cells [Cell]
   793   C0026845:Muscle [Tissue]
   793   C0205357:Smooth [Qualitative Concept]
   793   C1558950:VASCULAR [Finding]
   793   C1801960:Vascular [Qualitative Concept]
   793   C3282337:Cells [Cell]
   786   C0005773:Blood Cells [Cell]
   778 E C2328697:Hemal cell [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]
   737 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   737 E C1511228:VESSEL, BLOOD [Tissue]
   721 E C0442025:Muscular [Spatial Concept]

Phrase: "were"

Phrase: "purchased from ATCC (Rockville,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0598079:ATCC [Intellectual Product]
   770   C0869011:purchased [Activity]

Phrase: "MD)"

Phrase: "and"

Phrase: "subcultured in Dulbeccos modified Eagles medium (DMEM)"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagles [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719   C0200940:Subculture [Laboratory Procedure]
   719   C0699799:subculture [Population Group]
   719 E C1551720:Eagle [Population Group]

Phrase: "with 10% fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "(FBS"

Phrase: "; Gibco Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039421:technologies [Occupation or Discipline]

Phrase: "Grand Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022130:Island [Geographic Area]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "plus 1% penicillin/streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "(Gibco Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039421:technologies [Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.50: VSMCs were plated on 6-well Nunc plates in DMEM + 10% FBS for 48 h, at which time cells were near-confluent. 

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "plated on 6-well Nunc plates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205170:Well [Qualitative Concept]
   753   C1139930:plates [Medical Device]
           plate
   753   C3146287:Well [Manufactured Object]
   719   C0005971:Plate [Medical Device]
   719   C3537155:Plate [Manufactured Object]

Phrase: "in DMEM + 10% FBS"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   795   C0009458:Medium [Intellectual Product]
   795   C0150312:In [Quantitative Concept]
   795   C0325564:Eagles [Bird]
   795   C0332285:In [Spatial Concept]
   795   C0392747:Modified [Functional Concept]
   795   C0439536:Medium [Quantitative Concept]
   795   C1705217:Medium [Substance]
   795   C3244283:medium [Intellectual Product]
   762 E C1551720:Eagle [Population Group]

Phrase: "for 48 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at which time cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "near-confluent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205200:Confluent [Qualitative Concept]
Processing 00000000.tx.51: Apoptosis was induced by serum withdrawal or treatment with Fas-ligand (100 ng/ml) (recombinant human Fas-ligand; Upstate Biotechnology, Lake Placid, NY) in the presence of 2% FBS and a mouse IgG Fas-ligand enhancer protein (Upstate Biotechnology). 

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "induced by serum withdrawal"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205263:Induced [Functional Concept]
   770   C0229671:Serum [Body Substance]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]
   770   C2349954:Withdrawal [Activity]
   770   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "or"

Phrase: "treatment with Fas-ligand"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "(100 ng/ml) (recombinant human Fas-ligand"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   852   C1515370:Recombinant Fas Ligand [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Fas Ligand
   818   C0253023:Fas Ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0023688:Ligand [Chemical]

Phrase: "; Upstate Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Lake Placid, NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027976:NY [Geographic Area]
   827   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 2% FBS"

Phrase: "and"

Phrase: "a mouse IgG Fas-ligand enhancer protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   898   C1454643:Fas protein, mouse [Amino Acid, Peptide, or Protein,Receptor]
   895   C1334805:Mouse Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867   C0253023:Fas Ligand Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Upstate Biotechnology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.52: Transfection strategies Transient transfection. 

Phrase: "Transfection strategies Transient transfection."
Processing 00000000.tx.53: A7r5 VSMCs were transiently cotransfected using Lipofectamine PLUS (Gibco Life Technologies) according to the manufacturers directions with a transfection efficiency of 1520%. 

Phrase: "A7r5 VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "transiently"

Phrase: "cotransfected"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Lipofectamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "PLUS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332287:Plus [Qualitative Concept]

Phrase: "(Gibco Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039421:technologies [Occupation or Discipline]

Phrase: ")"

Phrase: "according to the manufacturers directions"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0439755:Directions [Spatial Concept]
   827 E C0449738:Direction [Spatial Concept]
   755 E C1707761:Directionality [Functional Concept]
   755 E C3274524:Directionality [Functional Concept]

Phrase: "with a transfection efficiency"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013682:Efficiency [Quantitative Concept]
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "of 1520%."
Processing 00000000.tx.54: Cells were transfected with an expression vector containing the full-length GLUT1 cDNA (M. Mueckler, Washington University, St. Louis, MO) or an empty control vector, pcDNA3.1, along with the reporter gene, green fluorescent protein (GFP; Gibco Life Technologies). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with an expression vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0442335:Vector [Spatial Concept]
   760   C1705099:Vector [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the full-length GLUT1 cDNA (M. Mueckler,"

Phrase: "Washington University,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041740:University [Manufactured Object,Organization]
   861   C0043038:Washington [Geographic Area]

Phrase: "St. Louis,"

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "or"

Phrase: "an empty control vector,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0031249:control vector [Occupational Activity]
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "pcDNA3.1,"

Phrase: "along with the reporter gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206414:Reporter Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "green fluorescent protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "(GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "; Gibco Life Technologies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039421:technologies [Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.55: A subset of studies involved the transfection of an expression vector containing the full-length wild-type GSK3 cDNA (18). 

Phrase: "A subset of studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515021:Subset [Classification]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "the transfection of an expression vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C0872089:transfection/expression vector [Genetic Function]
   783   C0017397:transfection vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the full-length wild-type GSK3 cDNA (18"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   840   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   835   C0441731:Type 3 [Classification]
   821   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1883559:Wild Type [Organism Attribute]
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   790   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0332307:Type [Qualitative Concept]
   790   C0443225:Full [Qualitative Concept]
   790   C0445392:Wild [Intellectual Product]
   790   C1444754:Length [Quantitative Concept]
   790   C1547052:*Type [Quantitative Concept]
   790   C1706316:LENGTH [Research Activity]
   718 E C0205166:Long [Qualitative Concept]
   718 E C1522425:Longest [Qualitative Concept]
   718 E C1706317:Long [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.56: Transient expression of this vector results in a significant increase in GSK3 activity (18). 

Phrase: "Transient expression of this vector"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "results in a significant increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0237881:significant [Quantitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   760   C2825142:Result [Finding]

Phrase: "in GSK3 activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1150570:glycogen synthase kinase 3 activity [Molecular Function]
   933   C2261482:glycogen synthase kinase activity [Molecular Function]
   911   C1152133:glycogen synthase activity [Molecular Function]
   853   C1150423:kinase activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.57: All expression vectors were driven by cytomegalovirus promoters. 

Phrase: "All expression vectors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vectors [Spatial Concept]
   827 E C1705099:Vector [Idea or Concept]

Phrase: "were"

Phrase: "driven by cytomegalovirus promoters."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010825:Cytomegalovirus [Virus]
   770   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   737   C0013126:Drive [Mental Process]
Processing 00000000.tx.58: Stable transfection. 

Phrase: "Stable transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.59: Stable VSMC lines overexpressing GLUT1 were constructed using a retroviral transfection technique. 

Phrase: "Stable VSMC lines"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   887   C0598091:stable cell line [Cell]
   859   C0700221:Vascular line [Medical Device]
   827   C0007600:Cell lines [Cell]
   799   C0205132:lines [Spatial Concept]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "GLUT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a retroviral transfection technique."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0449851:Technique [Functional Concept]
   743 E C0025664:techniques [Intellectual Product]
Processing 00000000.tx.60: A retroviral expression plasmid (pDOJ-GT1) containing the rat GLUT1 cDNA encoding the entire coding region as well as 17 and 97 bp of 5'- and 3'-nontranslated sequences (M. Birnbaum, University of Pennsylvania, Philadelphia, PA) was transiently transfected into the 293T-cell-derived Phoenix packaging cell line (G. Nolan, Stanford University, Stanford, CA) by calcium phosphate according to the manufacturers directions (Promega, Madison, WI). 

Phrase: "A retroviral expression plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(pDOJ-GT1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412719:GT1 [Gene or Genome]
   861   C1417549:GT1 [Gene or Genome]
   861   C3537450:GT1 [Gene or Genome]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the rat GLUT1 cDNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   717   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   708   C1514732:Rat-1 [Cell]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the entire coding region"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0079941:Coding Region [Gene or Genome]
   827   C0009219:Coding [Occupational Activity]
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   793 E C0805701:Code [Intellectual Product]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "as well as"

Phrase: "17"

Phrase: "and"

Phrase: "97 bp of 5'-"

Phrase: "and"

Phrase: "3'-nontranslated sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "(M. Birnbaum,"

Phrase: "University of Pennsylvania,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030853:Pennsylvania [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "PA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: "was"

Phrase: "transiently"

Phrase: "transfected into the 293T-cell-derived Phoenix packaging cell line"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   757   C0007600:Cell Line [Cell]
   739   C0007634:Cell [Cell]
   739   C0013194:Packaging [Medical Device]
   739   C0030176:Packaging [Human-caused Phenomenon or Process]
   739   C0205132:Line [Spatial Concept]
   739   C0331993:Phoenix [Health Care Related Organization]
   739   C1080696:Phoenix [Plant]
   739   C1269647:Cell [Cell]
   739   C1441547:Derived [Qualitative Concept]
   739   C1550648:Line [Substance]
   739   C1552960:Line [Quantitative Concept]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
   739   C2828395:Packaging [Activity]
   739   C3245521:derived [Idea or Concept]
   706 E C2700580:Package [Manufactured Object]

Phrase: "(G. Nolan,"

Phrase: "Stanford University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Stanford,"

Phrase: "CA) by calcium phosphate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   819   C0006675:Ca - Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "according to the manufacturers directions"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0439755:Directions [Spatial Concept]
   827 E C0449738:Direction [Spatial Concept]
   755 E C1707761:Directionality [Functional Concept]
   755 E C3274524:Directionality [Functional Concept]

Phrase: "(Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.61: A retroviral expression plasmid, pLEIN, encoding the reporter gene GFP (Clonetech, Palo Alto, CA), was similarly transfected into 293T-cells to create control transfected VSMC lines. 

Phrase: "A retroviral expression plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "pLEIN,"

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the reporter gene GFP (Clonetech,"

Phrase: "Palo Alto,"

Phrase: "CA),"

Phrase: "was"

Phrase: "similarly"

Phrase: "transfected into 293T-cells to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "create"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706214:Create [Activity]
  1000   C3244320:create [Functional Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "transfected"

Phrase: "VSMC lines."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   881   C0700221:Vascular line [Medical Device]
   840   C0007600:Cell lines [Cell]
   804   C0205132:lines [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]
   717   C0026844:Muscle, Smooth, Vascular [Tissue]
   717   C1135918:Smooth muscle cell [Cell]
Processing 00000000.tx.62: Viral supernatant was harvested 2472 h posttransfection, passed through a 2-m filter, and directly applied to A7r5 VSMCs, after which G418 (500 g/ml) was added. 

Phrase: "Viral supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "2472 h posttransfection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "passed through a 2-m filter,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0180860:Filter [Manufactured Object]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0581406:Filter [Medical Device]
   753   C1522664:Filter [Intellectual Product]
   753   C1704449:Filter [Conceptual Entity]
   753   C1704684:Filter [Medical Device]
   753   C1875155:FILTER [Medical Device]
   753   C2828386:Passed [Finding]

Phrase: "and"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "applied to A7r5 VSMCs,"
Meta Candidates (Total=19; Excluded=6; Pruned=0; Remaining=13)
   814   C0026844:Muscle, Smooth, Vascular [Tissue]
   814   C1135918:Smooth Muscle Cells [Cell]
   778   C0596981:Muscle Cells [Cell]
   778   C1267092:Muscle, Smooth [Tissue]
   748   C0005847:vascular [Body Part, Organ, or Organ Component]
   748   C0007634:Cells [Cell]
   748   C0026845:Muscle [Tissue]
   748   C0185125:Applied [Health Care Activity]
   748   C0205357:Smooth [Qualitative Concept]
   748   C1558950:VASCULAR [Finding]
   748   C1801960:Vascular [Qualitative Concept]
   748   C3282337:Cells [Cell]
   724   C0005773:Blood Cells [Cell]
   716 E C2328697:Hemal cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1632850:Apply [Functional Concept]
   714 E C1704653:Cell [Medical Device]
   714 E C1879355:Apply [Functional Concept]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "after"

Phrase: "which G418"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0052009:G418 [Antibiotic,Organic Chemical]

Phrase: "(500 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "added."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]
Processing 00000000.tx.63: Upregulation of GLUT1 was confirmed by Western blotting, whereas GFP expression was tracked in living cells by fluorescent microscopy. 

Phrase: "Upregulation of GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041904:Up-Regulation [Cell Function,Molecular Function]
   760   C0162493:Up-Regulation [Genetic Function]

Phrase: "was"

Phrase: "confirmed by Western blotting,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1705493:Western [Spatial Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "whereas"

Phrase: "GFP expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "tracked in living cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0376558:Living [Idea or Concept]
   770   C3282337:Cells [Cell]
   737   C0040594:Track [Manufactured Object]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "by fluorescent microscopy."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0026022:FLUORESCENT MICROSCOPY [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   789 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.64: Western blotting. 

Phrase: "Western blotting."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]
Processing 00000000.tx.65: Equal amounts of protein were loaded and run on 12% polyacrylamide gels as described previously (10). 

Phrase: "Equal amounts of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "loaded"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]

Phrase: "and"

Phrase: "run on 12% polyacrylamide gels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   804   C0017243:Gels [Biomedical or Dental Material]
   804   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   771 E C1382104:Gel [Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.66: Membranes were probed with various primary antibodies for the GLUT1 (L. Goodyear, Chemicon International, Temecula, CA), GLUT4 (IF8 clone; Biogenesis, Kingston, NH), total GSK3 (Quality Controlled Biochemicals, Hopkinton, MA), and ser9 phosphorylated GSK3 (Quality Controlled Biochemicals), followed by exposure to respective secondary horseradish peroxidaselinked antibodies (goat anti-rabbit, Transduction Labs, Lexington, KY; sheep anti-mouse, Amersham, Arlington Heights, IL). 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "probed with various primary antibodies"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]

Phrase: "for the GLUT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(L. Goodyear,"

Phrase: "Chemicon International, Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1555271:Temecula [Population Group]

Phrase: "CA),"

Phrase: "GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: "(IF8 clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: "; Biogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005495:Biogenesis [Natural Phenomenon or Process]
  1000   C0220781:Biogenesis [Biologic Function]

Phrase: "Kingston,"

Phrase: "NH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0268059:NH [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "total GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   884   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Quality Controlled Biochemicals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: "Hopkinton,"

Phrase: "MA"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "ser9"

Phrase: "phosphorylated"

Phrase: "GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Quality Controlled Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "followed by exposure"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "to respective secondary horseradish peroxidaselinked antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(goat anti-rabbit, Transduction Labs,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0587081:Labs [Finding]
   771 E C0022877:Lab [Manufactured Object,Organization]
   733 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "Lexington,"

Phrase: "KY"

Phrase: "; sheep anti-mouse, Amersham,"

Phrase: "Arlington Heights,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0489786:heights [Organism Attribute]
   777 E C0205250:High [Qualitative Concept]
   777 E C1299351:High [Qualitative Concept]
   777 E C1522410:Highest [Qualitative Concept]
   777 E C2700149:HIGH [Intellectual Product]

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.67: Membranes were treated with an enhanced chemiluminescent detection reagent and exposed to film. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "treated with an enhanced chemiluminescent detection reagent"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]
   748   C1522326:Treated [Functional Concept]
   748   C2349975:Enhanced [Activity]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "film."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086296:Film [Manufactured Object]
  1000   C1561571:film [Biomedical or Dental Material]
  1000   C1561572:film [Substance]
Processing 00000000.tx.68: India ink was used to verify equal protein loading and transfer on all membranes. 

Phrase: "India ink"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0123471:India ink [Indicator, Reagent, or Diagnostic Aid]
   861   C0021201:India [Geographic Area]
   861   C0021510:Ink [Manufactured Object]
   861   C2700456:India [Fish]
   861   C2740010:INK [Indicator, Reagent, or Diagnostic Aid]
   789 E C1524069:Indian [Population Group]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "equal protein loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708715:Loading [Activity]

Phrase: "and"

Phrase: "transfer on all membranes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040671:Transfer [Mental Process]
   770   C1705822:Transfer [Activity]
Processing 00000000.tx.69: Computer-assisted imaging analysis was performed using Scion Image (PC version of NIH Image, Frederick, MD). 

Phrase: "Computer-assisted imaging analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   988   C0009618:Image Analysis, Computer-Assisted [Machine Activity]
   902   C1516770:Computer Analysis [Machine Activity]
   844   C0200765:Image analysis [Laboratory Procedure]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   708   C0596446:computer imaging [Machine Activity]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Scion Image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1704254:Image [Intellectual Product]
   861   C1704922:Image [Entity]
   861   C3542466:Image [Intellectual Product]

Phrase: "(PC version of NIH Image,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0333052:Version [Functional Concept]
   760   C2607870:Version [Spatial Concept]

Phrase: "Frederick,"

Phrase: "MD)."
Processing 00000000.tx.70: Quantitation of apoptosis. 

Phrase: "Quantitation of apoptosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709793:Quantitation [Quantitative Concept]
Processing 00000000.tx.71: VSMC apoptosis was assessed by staining with the nuclear chromatin dye H33342 and quantitating the percentage of apoptotic nuclei in each sample (400 cells counted per sample) as described previously (10). 

Phrase: "VSMC apoptosis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   937   C2612492:smooth muscle cell apoptosis [Cell Function]
   884   C2611952:muscle cell apoptosis [Cell Function]
   804   C0162638:Apoptosis [Cell Function]
   733 E C1516044:Apoptotic [Qualitative Concept]
   717   C0026844:Muscle, Smooth, Vascular [Tissue]
   717   C1135918:Smooth muscle cell [Cell]

Phrase: "was"

Phrase: "assessed by staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0487602:Staining [Laboratory Procedure]
   790   C1516048:Assessed [Activity]
   790   C1704680:Staining [Finding]

Phrase: "with the nuclear chromatin dye H33342"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0062907:H33342 [Pharmacologic Substance]

Phrase: "and"

Phrase: "quantitating"

Phrase: "the percentage of apoptotic nuclei"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "in each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "(400 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "counted per sample"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0370003:Sample [Substance]
   790   C2347026:Sample [Conceptual Entity]
   756   C0750480:Count [Activity]
   756   C1705566:Count [Quantitative Concept]

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.72: Our laboratory has performed extensive validation of this assay in vivo and in vitro with many other techniques for assessing apoptotic cell death (5,6,10,26). 

Phrase: "Our laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]

Phrase: "has"

Phrase: "performed extensive validation of this assay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1519941:Validation [Research Activity]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro with many"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]

Phrase: "other techniques for assessing apoptotic cell death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025664:techniques [Intellectual Product]
   748   C0449851:Techniques [Functional Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6,"

Phrase: "10,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.73: The percentage of apoptotic nuclei in transiently transfected VSMC was assessed in the GFP-positive transfected subset of cells by staining with H33342 and identifying the percentage of apoptotic nuclei in the transfected population expressing GFP (75 GFP-positive cells counted per sample) as described previously (10,21). 

Phrase: "The percentage of apoptotic nuclei"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "in transiently"

Phrase: "transfected"

Phrase: "VSMC"
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth muscle cell [Cell]
   861   C0596981:Muscle cell [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   861   C2328697:Hemal cell [Cell]
   852 E C0005773:Blood cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cell [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1269647:Cell [Cell]
   812   C1558950:VASCULAR [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1801960:Vascular [Qualitative Concept]
   812   C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "was"

Phrase: "assessed in the GFP-positive transfected subset of cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   762   C0439178:% positive cells [Quantitative Concept]
           % Positive
   742   C0007634:Cells [Cell]
   742   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   742   C1446409:Positive [Qualitative Concept]
   742   C1514241:Positive [Finding]
   742   C1515021:Subset [Classification]
   742   C1516048:Assessed [Activity]
   742   C2825490:Positive [Qualitative Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "by staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "with H33342"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0062907:H33342 [Pharmacologic Substance]

Phrase: "and"

Phrase: "identifying"

Phrase: "the percentage of apoptotic nuclei"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "in the transfected population expressing GFP (75 GFP-positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0439178:% positive cells [Quantitative Concept]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "counted per sample"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0370003:Sample [Substance]
   790   C2347026:Sample [Conceptual Entity]
   756   C0750480:Count [Activity]
   756   C1705566:Count [Quantitative Concept]

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(10,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.74: Cell-cycle analysis. 

Phrase: "Cell-cycle analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]
Processing 00000000.tx.75: Cell-cycle analysis was assessed by fluorescence-activated cell sorter in transiently transfected GLUT1 or control transfected VSMC after a 24-h exposure to low serumcontaining media (1% FBS) followed by stimulation with 10% FBS for 24 h. 

Phrase: "Cell-cycle analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]

Phrase: "was"

Phrase: "assessed by fluorescence-activated cell sorter"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   882   C0598442:fluorescence activated cell sorter [Medical Device]
   790   C1140606:SORTER, CELL [Medical Device]
   753   C0007634:Cell [Cell]
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0879123:sorter [Medical Device]
   753   C1269647:Cell [Cell]
   753   C1516048:Assessed [Activity]
   753   C1704653:Cell [Medical Device]
   753   C1879547:Activated [Activity]
   753   C1948049:Cell [Spatial Concept]
   719 E C1515877:Activate [Functional Concept]

Phrase: "in transiently transfected GLUT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   840   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "control transfected VSMC after a 24-h exposure"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   775   C0026844:Muscle, Smooth, Vascular [Tissue]
   775   C1135918:Smooth muscle cell [Cell]
   756   C0596981:Muscle cell [Cell]
   756   C1267092:Muscle, Smooth [Tissue]
   738   C0005847:vascular [Body Part, Organ, or Organ Component]
   738   C0007634:Cell [Cell]
   738   C0026845:Muscle [Tissue]
   738   C0205357:Smooth [Qualitative Concept]
   738   C1269647:Cell [Cell]
   738   C1558950:VASCULAR [Finding]
   738   C1704653:Cell [Medical Device]
   738   C1801960:Vascular [Qualitative Concept]
   738   C1948049:Cell [Spatial Concept]
   712   C2328697:Hemal cell [Cell]
   704 E C0005773:Blood cell [Cell]

Phrase: "to low serumcontaining media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "(1% FBS)"

Phrase: "followed by stimulation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1948023:Stimulation [Natural Phenomenon or Process]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with 10% FBS"

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.76: Metabolic assays Glucose uptake. 

Phrase: "Metabolic assays Glucose uptake."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.77: Glucose uptake was quantitated with 2-[3H]-deoxy-D-glucose (Du PontNEN, Boston, MA) as described previously (27). 

Phrase: "Glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159527:glucose uptake [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "quantitated with 2-"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]-deoxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "D-"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(Du PontNEN,"

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA)"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.78: Briefly, cells in six-well plates were washed five times with phosphate-buffered solution (PBS), and incubated in PBS for 20 min before the addition of 1 Ci/ml radiolabeled deoxy-D-glucose. 

Phrase: "Briefly,"

Phrase: "cells in six-well"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   819   C2347578:Cells/well [Quantitative Concept]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "five times with phosphate-buffered solution (PBS),"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "incubated in PBS"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "before the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 1 Ci/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2348025:Ci/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "radiolabeled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527121:Radiolabeled [Qualitative Concept]
   966 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "deoxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "D-"

Phrase: "glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.79: Cytochalasin B was added to a subset of wells to determine specific carrier-mediated glucose uptake. 

Phrase: "Cytochalasin B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010737:Cytochalasin B [Biologically Active Substance,Pharmacologic Substance]
   861   C0010739:Cytochalasin [Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "added to a subset of wells to"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C1515021:Subset [Classification]
   748   C1524062:Added [Functional Concept]
   714   C0205170:Well [Qualitative Concept]
   714 E C1883712:Add [Functional Concept]
   714   C3146287:Well [Manufactured Object]

Phrase: "determine"

Phrase: "specific carrier-mediated glucose uptake."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1159527:glucose uptake [Cell Function]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0243144:Uptake [Physiologic Function]
   804   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.80: Uptake was linear between 2.5 and 10 min; 

Phrase: "Uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "linear between 2.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205132:Linear [Spatial Concept]

Phrase: "and"

Phrase: "10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.81: thus, subsequent measurements were taken at 5 min. 

Phrase: "thus,"

Phrase: "subsequent measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "taken at 5 min."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1883727:Taken [Conceptual Entity]
   737 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.82: Uptake was immediately stopped by rinsing five times with ice-cold PBS. 

Phrase: "Uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "stopped by rinsing five times"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   764   C1301703:Stop time [Qualitative Concept]
   760   C0040223:times [Temporal Concept]
   760   C0205451:Five [Quantitative Concept]
   760   C1272691:stopped [Qualitative Concept]
   760   C1632851:Times [Quantitative Concept]
   760   C1882955:Rinsing [Activity]
   726 E C1947925:Stop [Activity]
   726 E C2746065:Stop [Temporal Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "with ice-cold PBS."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   823   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C0037633:Solution [Substance]
   804   C0525069:Solution [Biomedical or Dental Material]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.83: Cells were air-dried, solubilized in 1N NaOH, and counted in a -counter. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "air-dried"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0001861:Air [Substance]
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]
   861   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   827 E C0011682:Dry [Natural Phenomenon or Process]
   827 E C0205222:Dry [Qualitative Concept]
   777 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ","

Phrase: "solubilized in 1N NaOH,"

Phrase: "and"

Phrase: "counted in a -counter."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0677601:Counter [Manufactured Object]
   770   C1705206:Counter [Medical Device]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.84: Data are expressed as glucose uptake in the absence of cytochalasin B minus uptake in the presence of cytochalasin B. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1159527:glucose uptake [Cell Function]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of cytochalasin B minus uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of cytochalasin B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010737:Cytochalasin B [Biologically Active Substance,Pharmacologic Substance]
   861   C0010739:Cytochalasin [Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.85: Glucose concentrations. 

Phrase: "Glucose concentrations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427743:Glucose concentration [Laboratory Procedure]
   983   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.86: Whole-tissue glucose concentrations in snap-frozen medial and neointimal specimens as well as in cell culture media (DMEM) were analyzed using an enzymatic spectrophotometric assay (HK-50; Sigma, St. Louis, MO). 

Phrase: "Whole-tissue glucose concentrations in snap-frozen medial"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0427743:concentrations glucose [Laboratory Procedure]
   767   C1287281:concentrations glucose [Laboratory or Test Result]
   744   C0086045:Concentrations [Mental Process]
   711 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "neointimal specimens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0370003:specimens [Substance]
   827 E C2347026:Specimen [Conceptual Entity]

Phrase: "as well as"

Phrase: "in cell culture media"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   923   C1139023:cell culture media [Indicator, Reagent, or Diagnostic Aid]
   861   C0007585:Cell Culture [Laboratory Procedure]
   861   C0010454:Culture Media [Indicator, Reagent, or Diagnostic Aid]
   812   C0009458:Media [Intellectual Product]
   812   C0010453:Culture [Idea or Concept]
   812   C0162867:Media [Tissue]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C1254021:Media [Tissue]
   812   C2242979:Culture [Laboratory Procedure]
   779 E C0439536:Medium [Quantitative Concept]
   779 E C1705217:Medium [Substance]
   779 E C3244283:medium [Intellectual Product]

Phrase: "(DMEM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0009458:Medium [Intellectual Product]
   812   C0325564:Eagles [Bird]
   812   C0392747:Modified [Functional Concept]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]
   779 E C1551720:Eagle [Population Group]

Phrase: ")"

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an enzymatic spectrophotometric assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C2717977:Enzymatic Assay [Laboratory Procedure]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "(HK-50"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019907:HK [Geographic Area]
   861   C2681927:HK [Gene or Genome]
   861   C2987742:HK [Fish]

Phrase: "; Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.87: Glucose consumption of cultured VSMCs was calculated by subtracting the glucose concentration in the collected media from the initial glucose concentration in the media (5.5 mmol/l). 

Phrase: "Glucose consumption of cultured VSMCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0009830:Consumption [Activity]
   744   C1947907:Consumption [Physiologic Function]

Phrase: "was"

Phrase: "calculated by subtracting"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]
   756   C1719767:Subtract [Intellectual Product]
   756   C2348589:Subtract [Phenomenon or Process]

Phrase: "the glucose concentration in the collected media"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0427743:Glucose concentration [Laboratory Procedure]
   778   C1287281:Glucose concentration [Laboratory or Test Result]
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "from the initial glucose concentration"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C2827826:Initial Concentration [Quantitative Concept]
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "(5.5 mmol/"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439190:MMOLE [Quantitative Concept]
   734   C0450380:5/5 [Quantitative Concept]

Phrase: "l)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.88: ATP content. 

Phrase: "ATP content."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.89: Cellular ATP content was measured using a luciferase-based enzymatic assay from Boehringer Mannheim (Indianapolis, IN) according to the manufacturers directions. 

Phrase: "Cellular ATP content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a luciferase-based enzymatic assay from Boehringer Mannheim"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C2717977:Enzymatic Assay [Laboratory Procedure]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0243073:assay [Qualitative Concept]
   744   C1510438:Assay [Laboratory Procedure]

Phrase: "(Indianapolis,"

Phrase: "IN) according to the manufacturers directions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:In [Quantitative Concept]
   753   C0332285:In [Spatial Concept]
Processing 00000000.tx.90: NMR. 

Phrase: "NMR."
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
  1000   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
  1000   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0521447:Nuclear [Spatial Concept]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]
Processing 00000000.tx.91: 13C-NMR spectroscopy was used to characterize alterations in glucose metabolism as a result of stable upregulation of GLUT1 in VSMCs. 

Phrase: "13C-NMR spectroscopy"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   937   C0877853:Spectroscopy, Nuclear Magnetic Resonance [Diagnostic Procedure]
   884   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   884   C0024487:Magnetic Resonance Spectroscopy [Diagnostic Procedure]
   884   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   884   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   840   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   840   C1551403:Magnetic resonance [Laboratory Procedure]
   804   C0024488:Magnetic [Occupation or Discipline]
   804   C0037812:spectroscopy [Laboratory Procedure]
   804   C0231881:Resonance [Finding]
   804   C0459800:resonance [Natural Phenomenon or Process]
   804   C0521447:Nuclear [Spatial Concept]
   804   C0563532:magnetic [Natural Phenomenon or Process]
   804   C0684213:Resonance [Qualitative Concept]
   804   C2713504:Spectroscopy [Occupation or Discipline]
   804   C2984732:SPECTROSCOPY [Functional Concept]
   733 E C0024483:Magnet [Manufactured Object]
   733 E C0577554:Resonant [Qualitative Concept]
   733 E C0885556:magnets [Pharmacologic Substance]
   733 E C1706318:Magnet [Manufactured Object]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "alterations in glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   991   C0744434:Alteration in glucose metabolism [Finding]
   870   C1382395:Glucose Metabolism Alteration [Organ or Tissue Function]
   737   C1515926:Alteration [Idea or Concept]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of stable upregulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041904:Up-Regulation [Cell Function,Molecular Function]
   861   C0162493:Up-Regulation [Genetic Function]

Phrase: "of GLUT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in VSMCs."
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]
Processing 00000000.tx.92: The normal concentrations of glucose and pyruvate in DMEM media were replaced with 5.5 mmol/l uniformly labeled 13C-glucose ([U-13C]glucose) and 1 mmol/l [3-13C]pyruvate. 

Phrase: "The normal concentrations of glucose"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   797   C0427743:concentrations glucose [Laboratory Procedure]
   797   C1287281:concentrations glucose [Laboratory or Test Result]
   790   C1277200:Normal concentration [Finding]
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "pyruvate in DMEM media"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0034354:pyruvate [Organic Chemical]
   748   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "were"

Phrase: "replaced with 5.5 mmol/l uniformly labeled 13C-glucose ([U-13C]glucose)"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C1532563:mmol/L [Quantitative Concept]
   739   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   739   C0439190:MMOLE [Quantitative Concept]
   739   C0559956:Replaced [Functional Concept]
   739   C1299987:replaced [Functional Concept]
   739   C1708632:Labeled [Qualitative Concept]
   706 E C0181496:Label [Manufactured Object]
   706 E C1554078:Replace [Idea or Concept]
   706 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "1 mmol/l [3-13C"

Phrase: "]pyruvate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034354:pyruvate [Organic Chemical]
  1000   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
Processing 00000000.tx.93: Metabolism of [U-13C]glucose and [3-13C]pyruvate results in the formation of [1,2-13C]acetyl-CoA and [2-13C]acetyl-CoA, respectively. 

Phrase: "Metabolism of [U-13C"

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and ["

Phrase: "3-13C"

Phrase: "]pyruvate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034354:pyruvate [Organic Chemical]
  1000   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "results in the formation of [1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1274040:Result [Functional Concept]
   753   C1522492:Formation [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "2-13C"

Phrase: "]acetyl-CoA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and ["

Phrase: "2-13C"

Phrase: "]acetyl-CoA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "respectively."
Processing 00000000.tx.94: From acetyl-CoA, the 13C-label is transferred to the various tricarboxylic acid (TCA) cycle intermediates. 

Phrase: "From acetyl-CoA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "the 13C-label"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0181496:Label [Manufactured Object]
   861   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "is"

Phrase: "transferred to the various tricarboxylic acid (TCA) cycle intermediates."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   800   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   770   C0040887:tricarboxylic acid [Organic Chemical]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0348011:transferred [Functional Concept]
   744   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   744   C1511572:Cycle [Temporal Concept]
   711 E C0040671:Transfer [Mental Process]
   711   C0205103:Intermediate [Spatial Concept]
   711   C1550465:intermediate [Idea or Concept]
   711 E C1705822:Transfer [Activity]
   711   C2827755:INTERMEDIATE [Laboratory or Test Result]
Processing 00000000.tx.95: The concentrations of the TCA cycle intermediates are below the level of detection by 13C-NMR spectroscopy. 

Phrase: "The concentrations of the TCA cycle intermediates"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0086045:Concentrations [Mental Process]
   711 E C1446561:Concentration [Quantitative Concept]

Phrase: "are below the level of detection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1511790:Detection [Therapeutic or Preventive Procedure]
   753   C1547707:Level [Geographic Area]
   753   C1551058:Are [Quantitative Concept]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "by 13C-NMR spectroscopy."
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   937   C0877853:Spectroscopy, Nuclear Magnetic Resonance [Diagnostic Procedure]
   884   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   884   C0024487:Magnetic Resonance Spectroscopy [Diagnostic Procedure]
   884   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   884   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   840   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   840   C1551403:Magnetic resonance [Laboratory Procedure]
   804   C0024488:Magnetic [Occupation or Discipline]
   804   C0037812:spectroscopy [Laboratory Procedure]
   804   C0231881:Resonance [Finding]
   804   C0459800:resonance [Natural Phenomenon or Process]
   804   C0521447:Nuclear [Spatial Concept]
   804   C0563532:magnetic [Natural Phenomenon or Process]
   804   C0684213:Resonance [Qualitative Concept]
   804   C2713504:Spectroscopy [Occupation or Discipline]
   804   C2984732:SPECTROSCOPY [Functional Concept]
   733 E C0024483:Magnet [Manufactured Object]
   733 E C0577554:Resonant [Qualitative Concept]
   733 E C0885556:magnets [Pharmacologic Substance]
   733 E C1706318:Magnet [Manufactured Object]
Processing 00000000.tx.96: However, the concentration of glutamate is high enough to be observed and is in exchange with the TCA cycle via -ketoglutarate and aspartate aminotransferase. 

Phrase: "However,"

Phrase: "the concentration of glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "is"

Phrase: "high enough to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "is in exchange"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0678640:exchange [Social Behavior]

Phrase: "with the TCA cycle via -ketoglutarate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0008858:Tricarboxylic Acid Cycle [Molecular Function]

Phrase: "and"

Phrase: "aspartate aminotransferase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0004002:Aspartate Aminotransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0002594:Aminotransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.97: Thus, measurement of the 13C-label incorporation into glutamate can be used as an index of entry of 13C-labeled acetyl-CoA into the TCA cycle. 

Phrase: "Thus,"

Phrase: "measurement of the 13C-label incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0242485:Measurement [Functional Concept]

Phrase: "into glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "used as an index of entry of 13C-labeled acetyl-CoA"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   756   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0918012:Index [Intellectual Product]
   738   C1273517:used [Finding]
   738   C1552854:index [Idea or Concept]
   738   C1637833:% index [Quantitative Concept]
   738   C1705654:Entry [Intellectual Product]
   738   C1708632:Labeled [Qualitative Concept]
   737   C1524063:Use of [Functional Concept]
   704 E C0042153:use [Functional Concept]
   704 E C0181496:Label [Manufactured Object]
   704 E C0457083:Use [Functional Concept]
   704 E C1947944:Use [Intellectual Product]
   704 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "into the TCA cycle."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   901   C0040887:tricarboxylic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.98: Using the phenomenon of spin-spin coupling, it is possible to determine the relative contributions of different 13C-acetyl-CoA molecules to the overall TCA cycle flux, as described in detail by Malloy et al. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the phenomenon of spin-spin coupling,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "it"

Phrase: "is"

Phrase: "possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "determine"

Phrase: "the relative contributions of different 13C-acetyl-CoA molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1880177:Contribution [Activity]

Phrase: "to the overall TCA cycle flux,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C2348693:Flux [Natural Phenomenon or Process]
   717   C0008858:Tricarboxylic Acid Cycle [Molecular Function]

Phrase: "as"

Phrase: "described in detail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1522508:Detail [Qualitative Concept]
   790   C1552738:described [Idea or Concept]
   790   C1561567:detail [Functional Concept]

Phrase: "by Malloy et al."
Processing 00000000.tx.99: (28). 

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.100: These techniques have been used to study metabolism in intact tissues and organs as well as cells in culture (293031). 

Phrase: "These techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025664:techniques [Intellectual Product]
  1000   C0449851:Techniques [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "metabolism in intact tissues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "organs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178784:organs [Body Part, Organ, or Organ Component]

Phrase: "as well as"

Phrase: "cells in culture"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C0007585:cells culture [Laboratory Procedure]
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "(293031"

Phrase: ")."
Processing 00000000.tx.101: In addition to incorporation into acetyl-CoA, both glucose and pyruvate can be converted to lactate. 

Phrase: "In addition to incorporation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243126:incorporation [Functional Concept]

Phrase: "into acetyl-CoA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "both glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "pyruvate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034354:pyruvate [Organic Chemical]
  1000   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "can"

Phrase: "be"

Phrase: "converted to lactate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022924:lactate [Organic Chemical]
   790   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.102: [U-13C]glucose leads to the formation of [U-13C]lactate, and [3-13C]pyruvate to [3-13C]lactate. 

Phrase: "[U-13C"

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "leads to the formation of [U-13C"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0181586:leads [Medical Device]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522492:Formation [Functional Concept]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "]lactate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022924:lactate [Organic Chemical]
  1000   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "and ["

Phrase: "3-13C"

Phrase: "]pyruvate to [3-13C"

Phrase: "]lactate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022924:lactate [Organic Chemical]
  1000   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.103: Thus, 13C-NMR spectroscopy also allows determination of the relative contributions of exogenous glucose and pyruvate to lactate formation. 

Phrase: "Thus,"

Phrase: "13C-NMR spectroscopy also"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   901   C0877853:Spectroscopy, Nuclear Magnetic Resonance [Diagnostic Procedure]
   861   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   861   C0024487:Magnetic Resonance Spectroscopy [Diagnostic Procedure]
   861   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   861   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   827   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   827   C1551403:Magnetic resonance [Laboratory Procedure]
   799   C0024488:Magnetic [Occupation or Discipline]
   799   C0037812:spectroscopy [Laboratory Procedure]
   799   C0231881:Resonance [Finding]
   799   C0459800:resonance [Natural Phenomenon or Process]
   799   C0521447:Nuclear [Spatial Concept]
   799   C0563532:magnetic [Natural Phenomenon or Process]
   799   C0684213:Resonance [Qualitative Concept]
   799   C2713504:Spectroscopy [Occupation or Discipline]
   799   C2984732:SPECTROSCOPY [Functional Concept]
   727 E C0024483:Magnet [Manufactured Object]
   727 E C0577554:Resonant [Qualitative Concept]
   727 E C0885556:magnets [Pharmacologic Substance]
   727 E C1706318:Magnet [Manufactured Object]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "determination of the relative contributions of exogenous glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1148554:determination [Laboratory Procedure]

Phrase: "and"

Phrase: "pyruvate to lactate formation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0369581:Lactate/Pyruvate [Laboratory Procedure]
   819   C1327316:pyruvate formation [Molecular Function]
   770   C0034354:pyruvate [Organic Chemical]
   770   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
Processing 00000000.tx.104: 13C-NMR resonances of glycogen are distinct from glucose; 

Phrase: "13C-NMR resonances of glycogen"

Phrase: "are"

Phrase: "distinct from glucose"

Phrase: ";"
Processing 00000000.tx.105: therefore, conversion of [U-13C]glucose into glycogen can also be determined. 

Phrase: "therefore,"

Phrase: "conversion of [U-13C"

Phrase: "]glucose into glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.106: VSMCs with stable upregulation of GLUT1 or GFP were incubated in the labeled media for 24 h under serum-free conditions. 

Phrase: "VSMCs with stable upregulation of GLUT1"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   775   C0026844:Muscle, Smooth, Vascular [Tissue]
   775   C1135918:Smooth Muscle Cells [Cell]
   756   C0596981:Muscle Cells [Cell]
   756   C1267092:Muscle, Smooth [Tissue]
   738   C0005847:vascular [Body Part, Organ, or Organ Component]
   738   C0007634:Cells [Cell]
   738   C0026845:Muscle [Tissue]
   738   C0205357:Smooth [Qualitative Concept]
   738   C1558950:VASCULAR [Finding]
   738   C1801960:Vascular [Qualitative Concept]
   738   C3282337:Cells [Cell]
   704   C0005773:Blood Cells [Cell]
   704   C0005802:Blood Glucose [Carbohydrate]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "incubated in the labeled media"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C2827499:Label [Governmental or Regulatory Activity]
   726 E C3244283:medium [Intellectual Product]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "under serum-free conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.107: Media were harvested and deproteinized and stored at -80C before analysis. 

Phrase: "Media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "deproteinized"

Phrase: "and"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -80C before analysis."
Processing 00000000.tx.108: Cells were extracted in 6% perchloric acid (PCA) and centrifuged at 4,000g, and the protein-free supernatant was neutralized with KOH. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "extracted in 6% perchloric acid (PCA)"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0030981:Perchloric acid [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   760   C0001128:Acid [Chemical]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C0202406:Acid [Laboratory Procedure]
   760   C3541890:EXTRACTED [Finding]
   726 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "centrifuged at 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g,"

Phrase: "and"

Phrase: "the protein-free supernatant"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332296:free [Functional Concept]
   827   C1550101:Supernatant [Body Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]

Phrase: "was"

Phrase: "neutralized with KOH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0071767:KOH [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.109: The neutralized extract was stored at -80C before analysis. 

Phrase: "The neutralized extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -80C before analysis."
Processing 00000000.tx.110: Frozen superfusates were freeze-dried and resuspended in deuterium oxide, and the pH was adjusted to 7.0. 

Phrase: "Frozen superfusates"

Phrase: "were"

Phrase: "freeze-dried"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0016698:freeze-dried [Laboratory Procedure]
   861   C0016701:Freeze [Natural Phenomenon or Process]
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]
   827 E C0011682:Dry [Natural Phenomenon or Process]
   827 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "resuspended in deuterium oxide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0011745:Deuterium Oxide [Inorganic Chemical]
   770   C0011744:Deuterium [Element, Ion, or Isotope]
   770   C0030015:oxide [Inorganic Chemical]
   770   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "and"

Phrase: "the pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "was"

Phrase: "adjusted to 7.0."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456081:Adjusted [Functional Concept]
Processing 00000000.tx.111: Spectra of extracts were collected on a Bruker MSL 500-WB spectrometer (Billerica, MA) equipped with an 11.85-T magnet using a 10-mm broad-band probe as described previously (30). 

Phrase: "Spectra of extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1883073:Spectrum [Quantitative Concept]
   756   C2827424:Spectrum [Conceptual Entity]

Phrase: "were"

Phrase: "collected on a Bruker MSL 500-WB spectrometer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0023804:MSL [Disease or Syndrome]
   744   C0183395:Spectrometer [Medical Device]
   744   C0582525:Wb [Quantitative Concept]
   744   C1516695:Collected [Idea or Concept]
   744   C1516698:Collected [Functional Concept]
   744   C1549982:MSL [Intellectual Product]
   744   C1710143:Spectrometer [Manufactured Object]

Phrase: "(Billerica,"

Phrase: "MA)"

Phrase: "equipped with an 11.85-T magnet"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0024483:Magnet [Manufactured Object]
   748   C1706318:Magnet [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 10-mm broad-band probe"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0182400:Probe [Medical Device]
   799   C1704681:Probe [Gene or Genome]
   799   C2347609:Probe [Chemical Viewed Functionally]
   799   C3536729:Probe [Manufactured Object]
   709   C0230715:A band [Cell Component]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.112: The relative contributions of glucose and pyruvate to acetyl-CoA entry into the TCA cycle were determined from the analysis of glutamate isotopomer distribution (30) using software developed and provided by Dr. 

Phrase: "The relative contributions of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "pyruvate to acetyl-CoA entry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0034354:pyruvate [Organic Chemical]
   760   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "into the TCA cycle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   901   C0040887:tricarboxylic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1511572:Cycle [Temporal Concept]

Phrase: "were"

Phrase: "determined from the analysis of glutamate isotopomer distribution"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   744   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0520511:distribution [Idea or Concept]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: "(30"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "developed"

Phrase: "and"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.113: Mark Jeffrey (TCAcalc; University of Texas Southwestern Medical Center, Dallas, TX). 

Phrase: "Mark Jeffrey"

Phrase: "(TCAcalc"

Phrase: "; University of Texas Southwestern Medical Center,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   904   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   827   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   799   C0039711:Texas [Geographic Area]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0205099:Center [Spatial Concept]
   799   C0205476:Medical [Functional Concept]
   799   C1710136:Southwestern [Spatial Concept]

Phrase: "Dallas,"

Phrase: "TX"

Phrase: ")."
Processing 00000000.tx.114: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.115: Comparisons between two groups were analyzed via a Students t test (P < 0.05), and comparisons between three or more groups were analyzed via analysis of variance with a Student-Newman-Keuls post-hoc test (P < 0.05). 

Phrase: "Comparisons between two groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "analyzed via a Students t test"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0022885:Test [Laboratory Procedure]
   753   C0038492:Students [Professional or Occupational Group]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C0936012:Analyzed [Research Activity]
   719 E C1551041:student [Idea or Concept]
   719 E C1552573:student [Intellectual Product]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "comparisons between three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1707455:Comparison [Activity]

Phrase: "or"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "analyzed via analysis of variance"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
           Analyzed
   760   C1524024:analysis [Functional Concept]
   760   C1711260:Variance [Qualitative Concept]
   760   C2348152:Variance [Quantitative Concept]

Phrase: "with a Student-Newman-Keuls post-hoc test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0022885:Test [Laboratory Procedure]
   799   C0039593:Test [Functional Concept]
   799   C0392366:test [Intellectual Product]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.116: Data are presented as means  SE.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as means  SE."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0449450:Presented [Idea or Concept]
   770   C1704970:Means [Conceptual Entity]
   737 E C0150312:Present [Quantitative Concept]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.117: RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Upregulation of GLUT and glucose utilization in neointimal tissue. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Upregulation of GLUT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0041904:Up-Regulation [Cell Function,Molecular Function]
   790   C0162493:Up-Regulation [Genetic Function]

Phrase: "and"

Phrase: "glucose utilization in neointimal tissue."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0042153:utilization [Functional Concept]
Processing 00000000.tx.118: GLUT1 protein content was significantly increased in isolated neointimal tissue compared with specimens of media tissue harvested from a balloon-injured carotid artery of a rat (Fig. 1A). 

Phrase: "GLUT1 protein content"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   853   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0423896:Content [Mental Process]
   804   C0456205:Content [Conceptual Entity]
   717   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]

Phrase: "was"

Phrase: "significantly"

Phrase: "increased in isolated neointimal tissue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0040300:Tissue [Tissue]
   760   C0205217:Increased [Quantitative Concept]
   760   C0205409:Isolated [Functional Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1547928:Tissue [Intellectual Product]
   760   C1548221:Isolated [Idea or Concept]

Phrase: "compared with specimens of media tissue"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   767   C1292533:Tissue specimen [Tissue]
   753   C0009458:Media [Intellectual Product]
   753   C0040300:Tissue [Tissue]
   753   C0162867:Media [Tissue]
   753   C0370003:specimens [Substance]
   753   C1254021:Media [Tissue]
   753   C1547928:Tissue [Intellectual Product]
   753   C1707455:Compared [Activity]
   719 E C0439536:Medium [Quantitative Concept]
   719 E C1705217:Medium [Substance]
   719 E C2347026:Specimen [Conceptual Entity]
   719 E C3244283:medium [Intellectual Product]

Phrase: "harvested from a balloon-injured carotid artery of a rat"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0007272:Carotid artery [Body Part, Organ, or Organ Component]
   760   C0162859:Carotid artery [Body Part, Organ, or Organ Component]
   739   C0003842:Artery [Body Part, Organ, or Organ Component]
   739   C0034693:Rat, NOS [Mammal]
   739   C0034721:Rat [Mammal]
   739   C0226004:artery [Body System]
   739   C0332664:Injured [Functional Concept]
   739   C0336867:Balloon [Manufactured Object]
   739   C0441144:balloon [Medical Device]
   739   C0741968:Carotid [Body Part, Organ, or Organ Component]
   706   C1512335:Harvest [Health Care Activity]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.119: We performed identical balloon injuries in the rabbit and detected similar increases in GLUT1 protein expression (Fig. 1B). 

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "identical balloon injuries in the rabbit"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C1510467:injuries [Injury or Poisoning]
   753   C3263723:Injuries [Injury or Poisoning]
   719 E C3263722:Injury [Injury or Poisoning]

Phrase: "and"

Phrase: "detected similar increases in GLUT1 protein expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:increases [Functional Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.120: Imaging analysis confirmed the significant upregulation of GLUT1 (normal uninjured vessel 638  61 mean arbitrary units vs. neointima 3,546  615 mean arbitrary units, n = 4, P < 0.04). 

Phrase: "Imaging analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0200765:Image analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the significant upregulation of GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0041904:Up-Regulation [Cell Function,Molecular Function]
   748   C0162493:Up-Regulation [Genetic Function]

Phrase: "(normal uninjured vessel 638  61 mean arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   793   C0439148:Units [Quantitative Concept]
   793   C1264693:*Arbitrary [Quantitative Concept]
   793   C1519795:Units [Quantitative Concept]
   779   C0439183:Arbitrary unit [Quantitative Concept]
   760 E C1704753:Unit [Manufactured Object]
   760 E C1880519:Unit [Quantitative Concept]

Phrase: "vs. neointima 3,546  615 mean arbitrary units,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   795   C0439148:Units [Quantitative Concept]
   795   C1264693:*Arbitrary [Quantitative Concept]
   795   C1519795:Units [Quantitative Concept]
   785   C0439183:Arbitrary unit [Quantitative Concept]
   762 E C1704753:Unit [Manufactured Object]
   762 E C1880519:Unit [Quantitative Concept]

Phrase: "n = 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.121: In addition, GLUT4 protein expression was also significantly elevated in the rabbit neointima (Fig. 1C) (control uninjured vessel 1,260  101 mean arbitrary units vs. neointima 5,370  720 mean arbitrary units, n = 4, P < 0.03). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "GLUT4 protein expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1171362:protein expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0166441:GLUT-4 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "also significantly"

Phrase: "elevated in the rabbit neointima"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034493:Rabbit [Mammal]
   760   C0205250:Elevated [Qualitative Concept]
   760   C2936380:Neointima [Acquired Abnormality]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "(Fig. 1C"

Phrase: ")"

Phrase: "(control uninjured vessel 1,260  101 mean arbitrary units"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   791   C0439148:Units [Quantitative Concept]
   791   C1264693:*Arbitrary [Quantitative Concept]
   791   C1519795:Units [Quantitative Concept]
   774   C0439183:Arbitrary unit [Quantitative Concept]
   758 E C1704753:Unit [Manufactured Object]
   758 E C1880519:Unit [Quantitative Concept]

Phrase: "vs. neointima 5,370  720 mean arbitrary units,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   795   C0439148:Units [Quantitative Concept]
   795   C1264693:*Arbitrary [Quantitative Concept]
   795   C1519795:Units [Quantitative Concept]
   785   C0439183:Arbitrary unit [Quantitative Concept]
   762 E C1704753:Unit [Manufactured Object]
   762 E C1880519:Unit [Quantitative Concept]

Phrase: "n = 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.122: The increase in GLUT1 and GLUT4 protein expression was accompanied by a significant elevation in total tissue glucose in neointimal tissue specimens compared with the media tissue specimens (media 0.017  0.003 mol glucose/mg protein vs. neointima 0.035  0.007 mol glucose/mg protein, n = 12, P < 0.01) (Fig. 1D). 

Phrase: "The increase in GLUT1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "GLUT4 protein expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1171362:protein expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0166441:GLUT-4 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "accompanied by a significant elevation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0237881:significant [Quantitative Concept]
   760   C0439775:Elevation [Therapeutic or Preventive Procedure]
   760   C0702240:Elevation [Spatial Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]

Phrase: "in total tissue glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   734   C2983684:Total Tissue [Body Substance]

Phrase: "in neointimal tissue specimens"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1292533:Tissue specimen [Tissue]
   827   C0370003:specimens [Substance]
   793 E C2347026:Specimen [Conceptual Entity]

Phrase: "compared with the media tissue specimens"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   773   C1292533:Tissue specimen [Tissue]
   753   C0009458:Media [Intellectual Product]
   753   C0040300:Tissue [Tissue]
   753   C0162867:Media [Tissue]
   753   C0370003:specimens [Substance]
   753   C1254021:Media [Tissue]
   753   C1547928:Tissue [Intellectual Product]
   753   C1707455:Compared [Activity]
   719 E C0439536:Medium [Quantitative Concept]
   719 E C1705217:Medium [Substance]
   719 E C2347026:Specimen [Conceptual Entity]
   719 E C3244283:medium [Intellectual Product]

Phrase: "(media 0.017  0.003 mol glucose/mg protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   817   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "vs. neointima 0.035  0.007 mol glucose/mg protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   817   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 12,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.123: Considering the well-defined role of GLUT1 in basal-mediated glucose uptake in VSMC, we focused on the role of GLUT1 in mediating adaptive changes in VSMC remodeling. 

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "the well-defined role of GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in basal-mediated glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1159527:glucose uptake [Cell Function]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0243144:Uptake [Physiologic Function]
   812   C0347980:% uptake [Quantitative Concept]

Phrase: "in VSMC,"
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth muscle cell [Cell]
   861   C0596981:Muscle cell [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   861   C2328697:Hemal cell [Cell]
   852 E C0005773:Blood cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cell [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1269647:Cell [Cell]
   812   C1558950:VASCULAR [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1801960:Vascular [Qualitative Concept]
   812   C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "we"

Phrase: "focused on the role of GLUT1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   770   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0035820:Role [Social Behavior]
   744   C0205234:Focused [Spatial Concept]
   744   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1285542:focused [Functional Concept]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in"

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "adaptive changes in VSMC remodeling."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0231193:Adaptive [Functional Concept]
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.124: View larger version (39K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.125: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.126: GLUT1 and GLUT4 protein expression, as well as total tissue glucose content, are upregulated in isolated neointimal tissue. 

Phrase: "GLUT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "GLUT4 protein expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1171362:protein expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0166441:GLUT-4 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as well as"

Phrase: "total tissue glucose content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]

Phrase: "are"

Phrase: "upregulated in isolated neointimal tissue."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0040300:Tissue [Tissue]
   760   C0205409:Isolated [Functional Concept]
   760   C1547928:Tissue [Intellectual Product]
   760   C1548221:Isolated [Idea or Concept]
Processing 00000000.tx.127: A: Representative Western blot for GLUT1 protein in rat carotid artery tissue specimens. 

Phrase: "A"

Phrase: ":"

Phrase: "Representative Western blot for GLUT1 protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0949466:Western Blot [Laboratory Procedure]
   744   C1705493:Western [Spatial Concept]

Phrase: "in rat carotid artery tissue specimens."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   823   C1292533:Tissue specimen [Tissue]
   804   C0370003:specimens [Substance]
   771 E C2347026:Specimen [Conceptual Entity]
Processing 00000000.tx.128: Vessels were harvested 4 weeks after balloon injury, and the neointimal tissue was dissected away from the vessel. 

Phrase: "Vessels"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005847:Vessels [Body Part, Organ, or Organ Component]
   966 E C1511228:Vessel [Tissue]
   928 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "4 weeks after balloon injury,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1442465:4 Weeks [Temporal Concept]
   760   C0439230:weeks [Temporal Concept]
   726 E C0332174:/week [Temporal Concept]

Phrase: "and"

Phrase: "the neointimal tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "dissected away from the vessel."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0005847:Vessel [Body Part, Organ, or Organ Component]
   760   C0205239:dissected [Functional Concept]
   760   C1511228:Vessel [Tissue]
   704 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.129: Representative Western blot for medial tissue was collected from an uninjured, contralateral vessel. 

Phrase: "Representative Western blot for medial tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0949466:Western Blot [Laboratory Procedure]
   753   C1705493:Western [Spatial Concept]

Phrase: "was"

Phrase: "collected from an uninjured, contralateral vessel."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0005847:Vessel [Body Part, Organ, or Organ Component]
   753   C0441988:Contralateral [Spatial Concept]
   753   C1511228:Vessel [Tissue]
   753   C1516695:Collected [Idea or Concept]
   753   C1516698:Collected [Functional Concept]
Processing 00000000.tx.130: B: GLUT1 protein in rabbit carotid artery tissue specimens 4 weeks after injury. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "GLUT1 protein in rabbit carotid artery tissue specimens 4 weeks"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   766   C0138793:protein 4.1 [Amino Acid, Peptide, or Protein,Receptor]
   751   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "after injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.131: C: GLUT4 protein in rabbit carotid artery tissue specimens 4 weeks after injury. 

Phrase: "C"

Phrase: ":"

Phrase: "GLUT4 protein in rabbit carotid artery tissue specimens 4 weeks"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0166441:GLUT-4 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "after injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3263722:Injury [Injury or Poisoning]
  1000   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.132: D: Tissue glucose content is significantly increased in isolated neointima versus media tissue specimens. 

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "Tissue glucose content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "is"

Phrase: "significantly"

Phrase: "increased in isolated neointima"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205217:Increased [Quantitative Concept]
   770   C0205409:Isolated [Functional Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C2936380:Neointima [Acquired Abnormality]

Phrase: "versus"

Phrase: "media tissue specimens."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1292533:Tissue specimen [Tissue]
   827   C0370003:specimens [Substance]
   793 E C2347026:Specimen [Conceptual Entity]
Processing 00000000.tx.133: (media, 0.017  0.003 mol glucose/mg protein versus neointima, 0.035  0.007 mol glucose/mg protein, n = 12, P < 0.01).  

Phrase: "(media,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "0.017  0.003 mol glucose/mg protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   822   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "versus"

Phrase: "neointima,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2936380:Neointima [Acquired Abnormality]

Phrase: "0.035  0.007 mol glucose/mg protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   822   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 12,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.134: GLUT1 upregulation significantly increases glucose uptake. 

Phrase: "GLUT1 upregulation significantly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0041904:Up-Regulation [Cell Function,Molecular Function]
   804   C0162493:Up-Regulation [Genetic Function]
   717   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "glucose uptake."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159527:glucose uptake [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.135: We established several rat A7r5 VSMC isolates with constitutively upregulated GLUT1 expression using a retroviral expression strategy (Fig. 2A). 

Phrase: "We"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "several rat A7r5 VSMC"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   845   C0026844:Muscle, Smooth, Vascular [Tissue]
   845   C1135918:Smooth muscle cell [Cell]
   818   C0596981:Muscle cell [Cell]
   818   C1267092:Muscle, Smooth [Tissue]
   804   C2328697:Hemal cell [Cell]
   795 E C0005773:Blood cell [Cell]
   795   C0005847:vascular [Body Part, Organ, or Organ Component]
   795   C0007634:Cell [Cell]
   795   C0026845:Muscle [Tissue]
   795   C0205357:Smooth [Qualitative Concept]
   795   C1269647:Cell [Cell]
   795   C1558950:VASCULAR [Finding]
   795   C1704653:Cell [Medical Device]
   795   C1801960:Vascular [Qualitative Concept]
   795   C1948049:Cell [Spatial Concept]
   740 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   740 E C1511228:VESSEL, BLOOD [Tissue]
   724 E C0442025:Muscular [Spatial Concept]

Phrase: "isolates with constitutively upregulated GLUT1 expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   770   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0370215:Isolate [Substance]
   744   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a retroviral expression strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0679199:strategy [Mental Process]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.136: In parallel, the reporter gene, GFP, was used to establish several control isolates. 

Phrase: "In parallel,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C2348042:Parallel [Qualitative Concept]
   861   C2826345:PARALLEL [Research Activity]

Phrase: "the reporter gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206414:Reporter Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "GFP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "several control isolates."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0370215:isolates [Substance]
   793 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.137: GLUT4 was unaltered in response to constitutive upregulation of GLUT1. 

Phrase: "GLUT4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]

Phrase: "was"

Phrase: "unaltered in response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709843:Unaltered [Qualitative Concept]

Phrase: "to constitutive upregulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041904:Up-Regulation [Cell Function,Molecular Function]
   861   C0162493:Up-Regulation [Genetic Function]

Phrase: "of GLUT1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.138: Glucose uptake was determined with the radiolabeled glucose analog, 2-[3H]-deoxy-D-glucose. 

Phrase: "Glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159527:glucose uptake [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "determined with the radiolabeled glucose analog,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0596619:glucose analog [Carbohydrate]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0243071:Analog [Chemical Viewed Structurally]
   753   C1527121:Radiolabeled [Qualitative Concept]
   719 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]-deoxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "D-"

Phrase: "glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.139: Experiments were performed in the absence and presence of the fungal metabolite cytochalasin B, which inhibits facilitated glucose transport. 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed in the absence"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "presence of the fungal metabolite cytochalasin B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "facilitated glucose transport."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2244328:Facilitated Transport [Molecular Function]
   901   C0178666:glucose transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]
Processing 00000000.tx.140: As expected, upregulation of GLUT1 resulted in a threefold increase in facilitated glucose uptake (GFP 7,015  555 cpm  min-1  mg protein-1 vs. GLUT1 19,844  495 cpm  min-1  mg protein-1, n = 6, P < 0.0001) (Fig. 2B). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "upregulation of GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041904:Up-Regulation [Cell Function,Molecular Function]
   760   C0162493:Up-Regulation [Genetic Function]

Phrase: "resulted in a threefold increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0442805:Increase [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in facilitated glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1159527:glucose uptake [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "(GFP 7,015  555 cpm  min-1  mg protein-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "vs. GLUT1 19,844  495 cpm  min-1  mg protein-1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   881   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   871   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.141: Glucose uptake in control transfected cells in the presence of cytochalasin B was 585  123 cpm  min-1  mg protein-1 for control transfected cells and 2,501  400 cpm  min-1  mg protein1 for GLUT1-transfected cells, thus clearly demonstrating a specific significant increase in facilitated glucose uptake into VSMCs after GLUT1 upregulation. 

Phrase: "Glucose uptake in control transfected cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1159527:glucose uptake [Cell Function]
   783   C0726398:GLUCOSE CONTROL [Indicator, Reagent, or Diagnostic Aid]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of cytochalasin B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010737:Cytochalasin B [Biologically Active Substance,Pharmacologic Substance]
   861   C0010739:Cytochalasin [Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "585  123 cpm  min-1  mg protein-1 for control transfected cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "2,501  400 cpm  min-1  mg protein1"

Phrase: "for GLUT1-transfected cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]

Phrase: "thus clearly"

Phrase: "demonstrating"

Phrase: "a specific significant increase in facilitated glucose uptake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "into VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "after GLUT1 upregulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0041904:Up-Regulation [Cell Function,Molecular Function]
   812   C0162493:Up-Regulation [Genetic Function]
   756   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
Processing 00000000.tx.142: View larger version (27K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.143: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.144: GLUT1 protein expression and glucose uptake measurements in A7r5 VSMCs with constitutively upregulated GLUT1 expression. 

Phrase: "GLUT1 protein expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C1171362:protein expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   708   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]

Phrase: "and"

Phrase: "glucose uptake measurements in A7r5 VSMCs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0337438:glucose measurements [Laboratory Procedure]
   762   C0429854:Vascular measurements [Laboratory or Test Result]
   748   C0392201:blood glucose measurements [Laboratory Procedure]
   742   C0242485:measurements [Functional Concept]
   731   C0201807:Uptake measurement [Laboratory Procedure]

Phrase: "with constitutively upregulated GLUT1 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.145: A: GLUT1 protein is significantly enhanced after stable transfection with a GLUT1 expression vector in several VSMC isolates. 

Phrase: "A"

Phrase: ":"

Phrase: "GLUT1 protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   875   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]

Phrase: "is"

Phrase: "significantly"

Phrase: "enhanced after stable transfection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   770   C0205360:Stable [Qualitative Concept]
   770   C1547311:Stable [Intellectual Product]
   770   C2349975:Enhanced [Activity]

Phrase: "with a GLUT1 expression vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]
   717   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]

Phrase: "in several VSMC isolates."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0370215:isolates [Substance]
   766 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.146: B: Glucose uptake, as measured with the radiolabeled glucose analog, 2-[3H]-deoxy-D-glucose, is significantly elevated after constitutive upregulation of GLUT1 in cultured rat VSMCs (GFP, 7,015  555 cpm  min-1  mg protein-1 versus GLUT1, 19,844  495 cpm  min-1  mg protein-1, n = 6, P < 0.0001). 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Glucose uptake,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159527:glucose uptake [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "as"

Phrase: "measured with the radiolabeled glucose analog,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0596619:glucose analog [Carbohydrate]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0243071:Analog [Chemical Viewed Structurally]
   753   C0444706:Measured [Qualitative Concept]
   753   C1527121:Radiolabeled [Qualitative Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
   719 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]-deoxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "D-"

Phrase: "glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "is"

Phrase: "significantly"

Phrase: "elevated after constitutive upregulation of GLUT1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   770   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0041904:Up-Regulation [Cell Function,Molecular Function]
   744   C0162493:Up-Regulation [Genetic Function]
   744   C0205250:Elevated [Qualitative Concept]
   744   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C3163633:Elevated [Qualitative Concept]

Phrase: "in cultured rat VSMCs"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
   895   C0007600:cultured cells [Cell]
   895   C0007635:Cultured Cells [Cell]
   895   C3282338:Cells, Cultured [Cell]
   861   C0026844:Muscle, Smooth, Vascular [Tissue]
   861   C1135918:Smooth Muscle Cells [Cell]
   827   C0596981:Muscle Cells [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   808   C0005773:Blood Cells [Cell]
   799   C0005847:vascular [Body Part, Organ, or Organ Component]
   799   C0007634:Cells [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C1558950:VASCULAR [Finding]
   799   C1801960:Vascular [Qualitative Concept]
   799 E C2328697:Hemal cell [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C0442025:Muscular [Spatial Concept]

Phrase: "(GFP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "7,015  555 cpm  min-1  mg protein-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   807   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   807   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "versus"

Phrase: "GLUT1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "19,844  495 cpm  min-1  mg protein-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   807   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   807   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.147: Data are expressed as means  SE.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as means  SE."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.148: We also assessed cellular glucose consumption in VSMCs with upregulated GLUT1 or GFP expression by assessing the loss of glucose in the media. 

Phrase: "We also"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "cellular glucose consumption in VSMCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0009830:Consumption [Activity]
   744   C1947907:Consumption [Physiologic Function]

Phrase: "with upregulated GLUT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   861   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "GFP expression by assessing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the loss of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "in the media."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.149: Indeed, glucose consumption was significantly elevated in VSMCs with upregulated GLUT1 expression after 48 h (GFP 92.5  3.2 mol/l glucose  h1  mg1 protein vs. GLUT1 115.8  2.1 mol/l glucose  h1  mg1 protein, n = 6, P < 0.001). 

Phrase: "Indeed,"

Phrase: "glucose consumption"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009830:Consumption [Activity]
   861   C1947907:Consumption [Physiologic Function]

Phrase: "was"

Phrase: "significantly"

Phrase: "elevated in VSMCs"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   833   C0026844:Muscle, Smooth, Vascular [Tissue]
   833   C1135918:Smooth Muscle Cells [Cell]
   790   C0596981:Muscle Cells [Cell]
   790   C1267092:Muscle, Smooth [Tissue]
   753   C0005847:vascular [Body Part, Organ, or Organ Component]
   753   C0007634:Cells [Cell]
   753   C0026845:Muscle [Tissue]
   753   C0205250:Elevated [Qualitative Concept]
   753   C0205357:Smooth [Qualitative Concept]
   753   C1558950:VASCULAR [Finding]
   753   C1801960:Vascular [Qualitative Concept]
   753   C3163633:Elevated [Qualitative Concept]
   753   C3282337:Cells [Cell]
   733   C0005773:Blood Cells [Cell]
   725 E C2328697:Hemal cell [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "with upregulated GLUT1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]

Phrase: "after 48 h (GFP 92.5  3.2 mol/l glucose  h1  mg1 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   813   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   786   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "vs. GLUT1 115.8  2.1 mol/l glucose  h1  mg1 protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   890   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   881   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   786   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.150: Thus, constitutive upregulation of GLUT1 in cultured VSMCs resulted in increases in intracellular glucose similar to that of neointimal tissue. 

Phrase: "Thus,"

Phrase: "constitutive upregulation of GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "in cultured VSMCs"
Meta Candidates (Total=26; Excluded=11; Pruned=0; Remaining=15)
   897   C0007600:cultured cells [Cell]
   897   C0007635:Cultured Cells [Cell]
   897   C3282338:Cells, Cultured [Cell]
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "resulted in increases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0442805:increases [Functional Concept]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "in intracellular glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "similar to that of neointimal tissue."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.151: Metabolic profile of VSMC with upregulated GLUT1 expression 13C-NMR spectroscopy. 

Phrase: "Metabolic profile of VSMC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C2350400:Metabolic Profile [Natural Phenomenon or Process]
   748   C1979963:Profile [Laboratory Procedure]
   748   C2003903:Profile [Functional Concept]

Phrase: "with upregulated GLUT1 expression 13C-NMR spectroscopy."
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   840   C0877853:Spectroscopy, Nuclear Magnetic Resonance [Diagnostic Procedure]
   821   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   821   C0024487:Magnetic Resonance Spectroscopy [Diagnostic Procedure]
   821   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   821   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   804   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   804   C1551403:Magnetic resonance [Laboratory Procedure]
   790   C0024488:Magnetic [Occupation or Discipline]
   790   C0037812:spectroscopy [Laboratory Procedure]
   790   C0231881:Resonance [Finding]
   790   C0459800:resonance [Natural Phenomenon or Process]
   790   C0521447:Nuclear [Spatial Concept]
   790   C0563532:magnetic [Natural Phenomenon or Process]
   790   C0684213:Resonance [Qualitative Concept]
   790   C2713504:Spectroscopy [Occupation or Discipline]
   790   C2984732:SPECTROSCOPY [Functional Concept]
   718 E C0024483:Magnet [Manufactured Object]
   718 E C0577554:Resonant [Qualitative Concept]
   718 E C0885556:magnets [Pharmacologic Substance]
   718 E C1706318:Magnet [Manufactured Object]
Processing 00000000.tx.152: After glucose has entered the cell, it may enter several pathways, including glycogen synthesis, glycolysis, and the TCA cycle. 

Phrase: "After glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "has"

Phrase: "entered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521975:Entered [Qualitative Concept]
   966 E C1522196:ENTER [Functional Concept]

Phrase: "the cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "it"

Phrase: "may"

Phrase: "enter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "several pathways,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "glycogen synthesis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1157202:glycogen synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "glycolysis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017952:Glycolysis [Molecular Function]

Phrase: "and"

Phrase: "the TCA cycle."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   901   C0040887:tricarboxylic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.153: Figure 3A shows a typical 13C-NMR spectrum of a VSMC extract after incubation with [U-13C]glucose and [3-13C]pyruvate for 24 h. 

Phrase: "Figure 3A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a typical 13C-NMR spectrum"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   861   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   861   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   861   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   827   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   827   C1551403:Magnetic resonance [Laboratory Procedure]
   799   C0024488:Magnetic [Occupation or Discipline]
   799   C0231881:Resonance [Finding]
   799   C0459800:resonance [Natural Phenomenon or Process]
   799   C0521447:Nuclear [Spatial Concept]
   799   C0563532:magnetic [Natural Phenomenon or Process]
   799   C0684213:Resonance [Qualitative Concept]
   799   C1883073:Spectrum [Quantitative Concept]
   799   C2827424:Spectrum [Conceptual Entity]
   727 E C0024483:Magnet [Manufactured Object]
   727 E C0577554:Resonant [Qualitative Concept]
   727 E C0885556:magnets [Pharmacologic Substance]
   727 E C1706318:Magnet [Manufactured Object]

Phrase: "of a VSMC extract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C2828366:Extract [Substance]
   717   C0026844:Muscle, Smooth, Vascular [Tissue]
   717   C1135918:Smooth muscle cell [Cell]

Phrase: "after incubation"

Phrase: "with"

Phrase: "[U-13C"

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and ["

Phrase: "3-13C"

Phrase: "]pyruvate for 24 h."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034354:pyruvate [Organic Chemical]
   770   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
Processing 00000000.tx.154: Resonances from glucose, glutamate, aspartate, lactate, and alanine are all clearly evident. 

Phrase: "Resonances from glucose,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0231881:Resonance [Finding]
   756   C0459800:resonance [Natural Phenomenon or Process]
   756   C0684213:Resonance [Qualitative Concept]
   706 E C0577554:Resonant [Qualitative Concept]

Phrase: "glutamate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "aspartate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "lactate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022924:lactate [Organic Chemical]
  1000   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "alanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "all clearly evident."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.155: Incorporation of 13C-label into glutamate and aspartate from transamination of the TCA cycle intermediates -ketoglutarate and oxaloacetate, respectively, indicates the metabolism of 13C-labeled glucose and pyruvate into the TCA cycle. 

Phrase: "Incorporation of 13C-label"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243126:incorporation [Functional Concept]

Phrase: "into glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "aspartate from transamination of the TCA cycle intermediates -ketoglutarate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "oxaloacetate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0029989:oxaloacetate [Organic Chemical]
  1000   C0220889:oxaloacetate [Organic Chemical]

Phrase: "respectively,"

Phrase: "indicates"

Phrase: "the metabolism of 13C-labeled glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596620:glucose metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "pyruvate into the TCA cycle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0034354:pyruvate [Organic Chemical]
   753   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
Processing 00000000.tx.156: In all of the samples, resonances from 13C-glycogen were below the limit of detection. 

Phrase: "In all"

Phrase: "of the samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "resonances from 13C-glycogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0231881:Resonance [Finding]
   737   C0459800:resonance [Natural Phenomenon or Process]
   737   C0684213:Resonance [Qualitative Concept]

Phrase: "were below the limit of detection."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C2718050:Limit of Detection [Quantitative Concept]
           Detection Limit
   753   C0439801:limit [Functional Concept]
   753   C1511790:Detection [Therapeutic or Preventive Procedure]
   753   C1549649:Limit [Idea or Concept]
   753   C2349209:Limit [Conceptual Entity]
Processing 00000000.tx.157: This suggests that, under the conditions of these experiments, VSMCs convert very little, if any, glucose to glycogen. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "under the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "of these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "convert"

Phrase: "very little,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   861   C0700321:Little [Quantitative Concept]
   861   C2700395:Little [Quantitative Concept]

Phrase: "if"

Phrase: "any,"

Phrase: "glucose to glycogen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.158: View larger version (19K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.159: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.160: A: High-resolution 13C-NMR spectrum of a control cell extract prepared as described in RESEARCH DESIGN AND METHODS. 

Phrase: "A"

Phrase: ":"

Phrase: "High-resolution 13C-NMR spectrum of a control cell extract"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   770   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   770   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   753   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   753   C1551403:Magnetic resonance [Laboratory Procedure]
   751   C1518434:Nuclear Extract [Biomedical or Dental Material]
   736   C0024488:Magnetic [Occupation or Discipline]
   736   C0231881:Resonance [Finding]
   736   C0459800:resonance [Natural Phenomenon or Process]
   736   C0521447:Nuclear [Spatial Concept]
   736   C0563532:magnetic [Natural Phenomenon or Process]
   736   C0684213:Resonance [Qualitative Concept]
   736   C1883073:Spectrum [Quantitative Concept]
   736   C2827424:Spectrum [Conceptual Entity]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described in RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0035171:Research Design [Research Activity]
   770   C0035168:research [Research Activity]
   770   C0242481:Research [Research Activity]
   770   C1552738:described [Idea or Concept]
   770   C1707689:Design [Activity]
   770   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.161: The resonances are identified as follows: 1 = C1-glucose  , -anomers; 

Phrase: "The resonances"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0231881:Resonance [Finding]
   966   C0459800:resonance [Natural Phenomenon or Process]
   966   C0684213:Resonance [Qualitative Concept]
   916 E C0577554:Resonant [Qualitative Concept]

Phrase: "are"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "= C1-glucose  , -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "anomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0596105:anomer [Chemical Viewed Structurally]

Phrase: ";"
Processing 00000000.tx.162: 2 = C2, C3, C4, C5-glucose; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "= C2,"

Phrase: "C3,"

Phrase: "C4,"

Phrase: "C5-glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.163: 3 = C6-glucose; 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "= C6-glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.164: 4 = C2-glutamate; 

Phrase: "4"

Phrase: "= C2-glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.165: 5 = C2-glutamine; 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "= C2-glutamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.166: 6 = C2-aspartate; 

Phrase: "6"

Phrase: "= C2-aspartate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.167: 7 = C3-aspartate; 

Phrase: "7"

Phrase: "= C3-aspartate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.168: 8 = C4-glutamate; 

Phrase: "8"

Phrase: "= C4-glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.169: 9 = C3-glutamate; 

Phrase: "9"

Phrase: "= C3-glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   861   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.170: 10 = C3-lactate; 

Phrase: "10"

Phrase: "= C3-lactate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022924:lactate [Organic Chemical]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.171: 11 = C3-alanine. 

Phrase: "11"

Phrase: "= C3-alanine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.172: B: Region 8, the C4-glutamate resonances, has been expanded to demonstrate the isotopomer splitting pattern; 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Region 8,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "the C4-glutamate resonances,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0231881:Resonance [Finding]
   793   C0459800:resonance [Natural Phenomenon or Process]
   793   C0684213:Resonance [Qualitative Concept]
   743 E C0577554:Resonant [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "expanded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:expanded [Spatial Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "the isotopomer splitting pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Pattern [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.173: the resonances are identified using the nomenclature as defined by Malloy et al. 

Phrase: "the resonances"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0231881:Resonance [Finding]
   966   C0459800:resonance [Natural Phenomenon or Process]
   966   C0684213:Resonance [Qualitative Concept]
   916 E C0577554:Resonant [Qualitative Concept]

Phrase: "are"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the nomenclature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600281:Nomenclature [Intellectual Product]
  1000   C1524067:Nomenclature [Intellectual Product]

Phrase: "as"

Phrase: "defined by Malloy et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.174: (28). 

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.175: The C4Q and C4D45 result from the metabolism of [U-13C]glucose, whereas the C4D34 and C4S are from the metabolism of [3-13C]pyruvate.  

Phrase: "The C4Q"

Phrase: "and"

Phrase: "C4D45 result from the metabolism of [U-13C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "]glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "whereas"

Phrase: "the C4D34"

Phrase: "and"

Phrase: "C4S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412999:C4S [Gene or Genome]

Phrase: "are from the metabolism of [3-13C"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]
   748   C1551058:Are [Quantitative Concept]

Phrase: "]pyruvate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034354:pyruvate [Organic Chemical]
  1000   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
Processing 00000000.tx.176: In Fig. 

Phrase: "In Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.177: 3B, the C4-glutamate resonance has been expanded to show the multiplet structure. 

Phrase: "3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450365:3b [Intellectual Product]
  1000   C1706097:3B [Research Activity]

Phrase: "the C4-glutamate resonance"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   755 E C0577554:Resonant [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "expanded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:expanded [Spatial Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the multiplet structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.178: The resonances identified as C4D45 and C4Q arise from the metabolism of [U-13C]glucose and the C4D34 and C4S from metabolism of [3-13C]pyruvate. 

Phrase: "The resonances"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   966   C0231881:Resonance [Finding]
   966   C0459800:resonance [Natural Phenomenon or Process]
   966   C0684213:Resonance [Qualitative Concept]
   916 E C0577554:Resonant [Qualitative Concept]

Phrase: "identified as C4D45"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "C4Q"

Phrase: "arise from the metabolism of [U-13C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "the C4D34"

Phrase: "and"

Phrase: "C4S from metabolism of [3-13C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1412999:C4S [Gene or Genome]

Phrase: "]pyruvate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034354:pyruvate [Organic Chemical]
  1000   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
Processing 00000000.tx.179: Analysis of this multiplet structure, in combination with that from the C2- and C3-glutamate resonances, yields the relative contributions of glucose and pyruvate to the TCA cycle via acetyl-CoA (30). 

Phrase: "Analysis of this multiplet structure,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0204514:Structural analysis [Therapeutic or Preventive Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205195:Combination [Qualitative Concept]
  1000   C1947911:Combination [Physical Object]

Phrase: "with that"

Phrase: "from the C2-"

Phrase: "and"

Phrase: "C3-glutamate resonances,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0231881:Resonance [Finding]
   793   C0459800:resonance [Natural Phenomenon or Process]
   793   C0684213:Resonance [Qualitative Concept]
   743 E C0577554:Resonant [Qualitative Concept]

Phrase: "yields"

Phrase: "the relative contributions of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "pyruvate to the TCA cycle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0034354:pyruvate [Organic Chemical]
   753   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "via acetyl-CoA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.180: Results from the NMR analysis are listed in Table 1. 

Phrase: "Results from the NMR analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "are"

Phrase: "listed in Table 1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C0745732:List [Conceptual Entity]
   737   C3272378:LIST [Intellectual Product]
Processing 00000000.tx.181: In the control transfected cells (GFP), glucose contributed 56.0  1.7% acetyl-CoA entering the TCA cycle and 28.3  1.7% pyruvate. 

Phrase: "In the control transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: ")"

Phrase: ","

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "56.0  1.7% acetyl-CoA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "entering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1522196:ENTER [Functional Concept]

Phrase: "the TCA cycle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   901   C0040887:tricarboxylic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "28.3  1.7% pyruvate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0034354:pyruvate [Organic Chemical]
   804   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
Processing 00000000.tx.182: Approximately 15.7  2.6% acetyl-CoA originated from unlabeled substrates, presumably as a result of oxidation of amino acids present in the cell culture medium. 

Phrase: "Approximately 15.7  2.6% acetyl-CoA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   818   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "originated from unlabeled substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1710236:Substrate [Manufactured Object]

Phrase: "presumably as a result of oxidation of amino acids"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   764   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0001128:Acids [Chemical]
   742   C0030011:Oxidation [Molecular Function]
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C2825142:Result [Finding]
   731 E C2917660:Amino Acid [Pharmacologic Substance]
   708 E C0202406:Acid [Laboratory Procedure]

Phrase: "present in the cell culture medium."
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   790   C0007585:Cell Culture [Laboratory Procedure]
   790   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0007634:Cell [Cell]
   753   C0009458:Medium [Intellectual Product]
   753   C0010453:Culture [Idea or Concept]
   753   C0150312:Present [Quantitative Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0439536:Medium [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1705217:Medium [Substance]
   753   C1948049:Cell [Spatial Concept]
   753   C2242979:Culture [Laboratory Procedure]
   753   C3244283:medium [Intellectual Product]
Processing 00000000.tx.183: In the GLUT1 transfected cells, there was a small but significant increase in the contribution of [U-13C]glucose to acetyl-CoA entry into the TCA cycle (60.9  1.0%). 

Phrase: "In the GLUT1 transfected cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   717   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]

Phrase: "there"

Phrase: "was"

Phrase: "a small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "but"

Phrase: "significant increase in the contribution of [U-13C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "]glucose to acetyl-CoA entry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "into the TCA cycle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   901   C0040887:tricarboxylic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1511572:Cycle [Temporal Concept]

Phrase: "(60.9  1.0%"

Phrase: ")."
Processing 00000000.tx.184: This was matched by a decrease in the contributions of both [3-13C]pyruvate and unlabeled substrates. 

Phrase: "This"

Phrase: "was"

Phrase: "matched by a decrease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0150103:matched [Research Activity]
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   770   C1708943:Matched [Qualitative Concept]

Phrase: "in the contributions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribution [Activity]

Phrase: "of both"

Phrase: "[3-13C"

Phrase: "]pyruvate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034354:pyruvate [Organic Chemical]
  1000   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "and"

Phrase: "unlabeled substrates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.185: View this table: [in this window] [in a new window]  TABLE 1 Percent contributions of glucose, pyruvate, and unlabeled substrates to acetyl-CoA entry into the TCA cycle  From our NMR analysis, we were also able to calculate the proportion of lactate originating from glucose. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Percent contributions of glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1880177:Contribution [Activity]

Phrase: "pyruvate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034354:pyruvate [Organic Chemical]
  1000   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "and"

Phrase: "unlabeled substrates to acetyl-CoA entry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1710236:Substrate [Manufactured Object]

Phrase: "into the TCA cycle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   901   C0040887:tricarboxylic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1511572:Cycle [Temporal Concept]

Phrase: "From our NMR analysis,"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   923   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   923   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   923   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   861   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   861   C1551403:Magnetic resonance [Laboratory Procedure]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0024488:Magnetic [Occupation or Discipline]
   812   C0231881:Resonance [Finding]
   812   C0459800:resonance [Natural Phenomenon or Process]
   812   C0521447:Nuclear [Spatial Concept]
   812   C0563532:magnetic [Natural Phenomenon or Process]
   812   C0684213:Resonance [Qualitative Concept]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   741 E C0024483:Magnet [Manufactured Object]
   741 E C0577554:Resonant [Qualitative Concept]
   741 E C0885556:magnets [Pharmacologic Substance]
   741 E C1706318:Magnet [Manufactured Object]

Phrase: "we"

Phrase: "were"

Phrase: "also able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "the proportion of lactate originating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709707:Proportion [Quantitative Concept]

Phrase: "from glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.186: There were no differences in the fraction of lactate originating from glucose in the control and GLUT1 stable transfectants (63.9  1.1 vs. 65.4  2.0%). 

Phrase: "There"

Phrase: "were"

Phrase: "no differences in the fraction of lactate originating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "from glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "in the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "GLUT1 stable transfectants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]

Phrase: "(63.9  1.1"

Phrase: "vs. 65.4  2.0%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450385:65 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.187: However, at the end of the incubation, the ratio of [U-13C]glucose to [U-13C]lactate in the culture medium was significantly decreased in VSMCs with upregulated GLUT1 (GFP 6.5  0.1 vs. GLUT1 5.5  0.2, P < 0.005). 

Phrase: "However,"

Phrase: "at the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the incubation,"

Phrase: "the ratio of [U-13C"

Phrase: "]glucose to [U-13C"

Phrase: "]lactate in the culture medium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0022924:lactate [Organic Chemical]
   760   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "significantly"

Phrase: "decreased in VSMCs"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
   833   C0026844:Muscle, Smooth, Vascular [Tissue]
   833   C1135918:Smooth Muscle Cells [Cell]
   790   C0596981:Muscle Cells [Cell]
   790   C1267092:Muscle, Smooth [Tissue]
   753   C0005847:vascular [Body Part, Organ, or Organ Component]
   753   C0007634:Cells [Cell]
   753   C0026845:Muscle [Tissue]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0205357:Smooth [Qualitative Concept]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C1558950:VASCULAR [Finding]
   753   C1801960:Vascular [Qualitative Concept]
   753   C3282337:Cells [Cell]
   733   C0005773:Blood Cells [Cell]
   725 E C2328697:Hemal cell [Cell]
   719 E C0547047:Decrease [Quantitative Concept]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "with upregulated GLUT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   861   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(GFP 6.5  0.1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "vs. GLUT1 5.5  0.2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   900   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   852   C1420176:GLUCOSE TRANSPORTER 5 [Gene or Genome]
   845   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   818   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   795   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "P < 0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.188: A decrease in this ratio is consistent with an increase in glucose consumption and/or an increase in lactate production. 

Phrase: "A decrease in this ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "is"

Phrase: "consistent with an increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in glucose consumption"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009830:Consumption [Activity]
   861   C1947907:Consumption [Physiologic Function]

Phrase: "and/or"

Phrase: "an increase in lactate production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]
Processing 00000000.tx.189: These results are consistent with the increased glucose consumption we demonstrated in the VSMCs with increased GLUT1 expression. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with the increased glucose consumption"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "we"

Phrase: "demonstrated in the VSMCs"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   814   C0026844:Muscle, Smooth, Vascular [Tissue]
   814   C1135918:Smooth Muscle Cells [Cell]
   778   C0596981:Muscle Cells [Cell]
   778   C1267092:Muscle, Smooth [Tissue]
   748   C0005847:vascular [Body Part, Organ, or Organ Component]
   748   C0007634:Cells [Cell]
   748   C0026845:Muscle [Tissue]
   748   C0205357:Smooth [Qualitative Concept]
   748   C1558950:VASCULAR [Finding]
   748   C1801960:Vascular [Qualitative Concept]
   748   C3282337:Cells [Cell]
   724   C0005773:Blood Cells [Cell]
   716 E C2328697:Hemal cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "with increased GLUT1 expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   717   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
Processing 00000000.tx.190: The total protein contents of the cell extracts for the NMR studies were not significantly different between the GLUT1 and control (GFP) groups (3.7  0.3 vs. 4.1  0.3 mg, respectively). 

Phrase: "The total protein contents of the cell"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0456205:Contents [Conceptual Entity]
   748   C1552853:contents [Idea or Concept]
   714 E C0423896:Content [Mental Process]

Phrase: "extracts for the NMR studies"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   814   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
           Magnetic resonance study
   814   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   814   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   778   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   778   C1551403:Magnetic resonance [Laboratory Procedure]
   774   C0024488:magnetic studies [Occupation or Discipline]
           Magnetic
   774   C1518434:Nuclear Extract [Biomedical or Dental Material]
   748   C0231881:Resonance [Finding]
   748   C0459800:resonance [Natural Phenomenon or Process]
   748   C0521447:Nuclear [Spatial Concept]
   748   C0563532:magnetic [Natural Phenomenon or Process]
   748   C0684213:Resonance [Qualitative Concept]
   748   C0947630:studies [Laboratory Procedure]
   748   C2828366:Extract [Substance]
   714 E C0557651:Study [Manufactured Object]
   714 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "not significantly different between the GLUT1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(GFP) groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "(3.7  0.3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0439086:<3 [Quantitative Concept]
   812   C2827736:3+ [Quantitative Concept]
   812   C2981702:3+ [Classification]

Phrase: "vs. 4.1  0.3 mg,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0439269:mg% [Quantitative Concept]
   804   C1960952:mg % [Quantitative Concept]
   804   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.191: Therefore, the differences in the contribution of glucose to the TCA cycle and the ratio of [U-13C]glucose to [U-13C]lactate cannot be accounted for by differences in cell number. 

Phrase: "Therefore,"

Phrase: "the differences in the contribution of glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "to the TCA cycle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   901   C0040887:tricarboxylic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "the ratio of [U-13C"

Phrase: "]glucose to [U-13C"

Phrase: "]lactate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022924:lactate [Organic Chemical]
  1000   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "cannot"

Phrase: "be"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by differences in cell number."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007584:Cell Number [Laboratory Procedure]
   812   C0237753:*Number [Quantitative Concept]
   812   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.192: ATP. 

Phrase: "ATP."
Processing 00000000.tx.193: To determine whether an upregulation in GLUT1 content affected cellular ATP content, we used a luciferase-based ATP assay to compare ATP content in VSMCs. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "an upregulation in GLUT1 content affected cellular ATP content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0041904:Up-Regulation [Cell Function,Molecular Function]
   738   C0162493:Up-Regulation [Genetic Function]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a luciferase-based ATP"

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "ATP content in VSMCs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.194: Cells were exposed to growth media for 48 h followed by 24 h in serum-free media to recapitulate identical conditions for the NMR and apoptosis experiments listed above. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to growth media"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   833   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0009458:Media [Intellectual Product]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0162867:Media [Tissue]
   770   C0220844:growth [Physiologic Function]
   770   C1254021:Media [Tissue]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "for 48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "followed by 24 h"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "in serum-free media to"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   923   C0085414:Serum-Free Media [Indicator, Reagent, or Diagnostic Aid]
   812   C0009458:Media [Intellectual Product]
   812   C0162867:Media [Tissue]
   812   C0229671:Serum [Body Substance]
   812   C0332296:free [Functional Concept]
   812   C1254021:Media [Tissue]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   779 E C0439536:Medium [Quantitative Concept]
   779 E C1705217:Medium [Substance]
   779 E C3244283:medium [Intellectual Product]

Phrase: "recapitulate"

Phrase: "identical conditions for the NMR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0012634:condition [Disease or Syndrome]
   714   C0348080:Condition [Qualitative Concept]
   714   C1705253:Condition [Conceptual Entity]

Phrase: "and"

Phrase: "apoptosis experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "listed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0745732:List [Conceptual Entity]
   966   C3272378:LIST [Intellectual Product]

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.195: No significant differences in cellular ATP content were found (GFP 13.8  0.6 nmol/mg protein vs. GLUT1 14.0  0.3 nmol/mg protein, n = 5, NS). 

Phrase: "No significant differences in cellular ATP content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "(GFP 13.8  0.6 nmol/mg protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   835   C1881965:nmol/mg{protein} [Quantitative Concept]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "vs. GLUT1 14.0  0.3 nmol/mg protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   891   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   880   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   821   C1881965:nmol/mg{protein} [Quantitative Concept]
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "NS)."
Processing 00000000.tx.196: Exposure of VSMCs to growth media for 72 h also had no significant effect on ATP content (GFP 13.1  0.4 nmol/mg protein vs. GLUT1 12.9  0.7 nmol/mg protein, n = 5, NS). 

Phrase: "Exposure of VSMCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]

Phrase: "to growth media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0010454:growth media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0162867:Media [Tissue]
   861   C0220844:growth [Physiologic Function]
   861   C1254021:Media [Tissue]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "for 72 h also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "had"

Phrase: "no significant effect on ATP content"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "(GFP 13.1  0.4 nmol/mg protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   835   C1881965:nmol/mg{protein} [Quantitative Concept]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "vs. GLUT1 12.9  0.7 nmol/mg protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   891   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   880   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   821   C1881965:nmol/mg{protein} [Quantitative Concept]
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "NS)."
Processing 00000000.tx.197: Enhanced glucose uptake and metabolism inhibits apoptosis and promotes growth. 

Phrase: "Enhanced glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1159527:glucose uptake [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "growth."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]
Processing 00000000.tx.198: We were intrigued by the observation that intimal VSMCs exhibit a constitutive upregulation of GLUT1 expression in association with a resistance to apoptosis in vivo (5,6). 

Phrase: "We"

Phrase: "were"

Phrase: "intrigued by the observation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]

Phrase: "that intimal VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a constitutive upregulation of GLUT1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0041904:Up-Regulation [Cell Function,Molecular Function]
   744   C0162493:Up-Regulation [Genetic Function]

Phrase: "in association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with a resistance"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0237834:Resistance [Mental Process]
  1000   C1514892:Resistance [Physiologic Function]
   928 E C0332325:Resistant [Functional Concept]
   928 E C1550464:resistent [Idea or Concept]
   928 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "to apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.199: We hypothesized that enhanced glucose uptake and metabolism are sufficient for increasing the resistance of VSMCs to apoptosis. 

Phrase: "We"

Phrase: "hypothesized"

Phrase: "that enhanced glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1159527:glucose uptake [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "are"

Phrase: "sufficient for increasing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205410:Sufficient [Qualitative Concept]

Phrase: "the resistance of VSMCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0042380:Vascular resistance [Physiologic Function]
   748   C0237834:Resistance [Mental Process]
   748   C1514892:Resistance [Physiologic Function]

Phrase: "to apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.200: As an initial test of this postulate, VSMCs with upregulated GLUT1 or the control transgene (GFP) were exposed to serum-free media for a period of 20 h. 

Phrase: "As an initial test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "of this"

Phrase: "postulate"

Phrase: ","

Phrase: "VSMCs with upregulated GLUT1"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   790   C0026844:Muscle, Smooth, Vascular [Tissue]
   790   C1135918:Smooth Muscle Cells [Cell]
   764   C0596981:Muscle Cells [Cell]
   764   C1267092:Muscle, Smooth [Tissue]
   742   C0005847:vascular [Body Part, Organ, or Organ Component]
   742   C0007634:Cells [Cell]
   742   C0026845:Muscle [Tissue]
   742   C0205357:Smooth [Qualitative Concept]
   742   C1558950:VASCULAR [Finding]
   742   C1801960:Vascular [Qualitative Concept]
   742   C3282337:Cells [Cell]
   712   C0005773:Blood Cells [Cell]
   712   C0005802:Blood Glucose [Carbohydrate]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
   703 E C2328697:Hemal cell [Cell]

Phrase: "or"

Phrase: "the control transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282641:Transgene [Gene or Genome]

Phrase: "(GFP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "exposed to serum-free media"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   862   C0085414:Serum-Free Media [Indicator, Reagent, or Diagnostic Aid]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C0229671:Serum [Body Substance]
   760   C0332296:free [Functional Concept]
   760   C1254021:Media [Tissue]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "for a period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0439531:/period [Temporal Concept]
  1000   C1948053:Period [Temporal Concept]
   928 E C0332182:Periodic [Temporal Concept]
   928 E C1706381:PERIODIC [Intellectual Product]
   900 E C0031084:Periodicities [Temporal Concept]

Phrase: "of 20 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.201: Constitutive upregulation of GLUT1 inhibited the percentage of VSMCs undergoing apoptosis in response to serum withdrawal (control transfected 20  1% vs. GLUT1 11  1%, n = 6, P < 0.0005) (Fig. 4). 

Phrase: "Constitutive upregulation of GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the percentage of VSMCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "undergoing"

Phrase: "apoptosis in response"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "to serum withdrawal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2349954:Withdrawal [Activity]
   861   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "transfected"

Phrase: "20  1%"

Phrase: "vs. GLUT1 11  1%,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   888   C1422501:GLUCOSE TRANSPORTER 11 [Gene or Genome]
   884   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   840   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.0005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.202: This antiapoptotic effect of upregulated GLUT1 expression was also demonstrated in two additional GLUT1 transfected VSMC isolates. 

Phrase: "This antiapoptotic effect of upregulated GLUT1 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1158774:glucose effect [Genetic Function]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "demonstrated in two additional GLUT1 transfected VSMC isolates."
Meta Candidates (Total=22; Excluded=1; Pruned=0; Remaining=21)
   766   C0026844:Muscle, Smooth, Vascular [Tissue]
   766   C1135918:Smooth muscle cell [Cell]
   766   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   750   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C0596981:Muscle cell [Cell]
   750   C1267092:Muscle, Smooth [Tissue]
   735   C0005847:vascular [Body Part, Organ, or Organ Component]
   735   C0007634:Cell [Cell]
   735   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   735   C0026845:Muscle [Tissue]
   735   C0205357:Smooth [Qualitative Concept]
   735   C0205448:Two [Quantitative Concept]
   735   C0370215:isolates [Substance]
   735   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C1269647:Cell [Cell]
   735   C1524062:Additional [Functional Concept]
   735   C1558950:VASCULAR [Finding]
   735   C1704653:Cell [Medical Device]
   735   C1801960:Vascular [Qualitative Concept]
   735   C1948049:Cell [Spatial Concept]
   707   C2328697:Hemal cell [Cell]
   702 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.203: As a further test of our hypothesis, we transiently upregulated GLUT1 and found a similar inhibition of apoptosis in response to serum withdrawal (control transfected 41  3% vs. GLUT1 28  2%, n = 8, P < 0.002). 

Phrase: "As a further test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "of our hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we transiently upregulated GLUT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   840   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "a similar inhibition of apoptosis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C1512772:Inhibition of Apoptosis [Cell Function]
           Apoptosis Inhibition
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to serum withdrawal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2349954:Withdrawal [Activity]
   861   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "transfected"

Phrase: "41  3%"

Phrase: "vs. GLUT1 28  2%,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   911   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   884   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   840   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 8,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.002"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.204: View larger version (9K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.205: 4. 

Phrase: "4."
Processing 00000000.tx.206: Upregulation of GLUT1 significantly inhibits apoptosis induced by serum withdrawal (control transfected [GFP] 20  1% vs. GLUT1 11  1%, n = 6, P < 0.0005). 

Phrase: "Upregulation of GLUT1 significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induced by serum withdrawal"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205263:Induced [Functional Concept]
   770   C0229671:Serum [Body Substance]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]
   770   C2349954:Withdrawal [Activity]
   770   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "transfected"

Phrase: "[GFP] 20  1%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "vs. GLUT1 11  1%,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   888   C1422501:GLUCOSE TRANSPORTER 11 [Gene or Genome]
   884   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   840   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.0005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.207: The percentage of apoptotic nuclei was assessed 20 h after serum withdrawal by staining with H33342. 

Phrase: "The percentage of apoptotic nuclei"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "20 h after serum withdrawal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "by staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "with H33342."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0062907:H33342 [Pharmacologic Substance]
Processing 00000000.tx.208: Data are expressed as means  SE.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as means  SE."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.209: Considering the local expression of the proapoptotic mediator, Fas, within neointimal lesions (323334), we also tested whether the constitutive upregulation of GLUT1 was protective against this proapoptotic stimulus. 

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "the local expression of the proapoptotic mediator,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Fas,"

Phrase: "within neointimal lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0221198:lesions [Finding]
   827 E C1546698:Lesion [Intellectual Product]

Phrase: "(323334"

Phrase: ")"

Phrase: ","

Phrase: "we also"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "whether"

Phrase: "the constitutive upregulation of GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0041904:Up-Regulation [Cell Function,Molecular Function]
   748   C0162493:Up-Regulation [Genetic Function]

Phrase: "was"

Phrase: "protective against this proapoptotic stimulus."
Processing 00000000.tx.210: VSMCs were assessed for apoptosis 20 h after treatment with Fas-ligand (100 ng/ml) in low serum in the presence of a Fas-ligand enhancer protein (mouse IgG). 

Phrase: "VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "were"

Phrase: "assessed for apoptosis 20 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0162638:Apoptosis [Cell Function]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C1516048:Assessed [Activity]

Phrase: "after treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with Fas-ligand"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0253023:Fas Ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1515370:Fas Ligand [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0023688:Ligand [Chemical]

Phrase: "(100 ng/ml) in low serum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439275:ng/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of a Fas-ligand enhancer protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0253023:Fas Ligand Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(mouse IgG"

Phrase: ")."
Processing 00000000.tx.211: Consistent with the serum-withdrawal data, constitutive upregulation of GLUT1 also inhibited apoptosis in response to Fas-ligand (control [GFP] + Fas-ligand 12  1% vs. GLUT1 + Fas-ligand 6  1.0%, n = 8, P < 0.0005) (Fig. 5). 

Phrase: "Consistent with the serum-withdrawal data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "constitutive upregulation of GLUT1 also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0041904:Up-Regulation [Cell Function,Molecular Function]
   748   C0162493:Up-Regulation [Genetic Function]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "apoptosis in response"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "to Fas-ligand"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0253023:Fas Ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1515370:Fas Ligand [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0023688:Ligand [Chemical]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "[GFP] + Fas-ligand 12  1%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0253023:Fas Ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1515370:Fas Ligand [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0023688:Ligand [Chemical]
   804   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "vs. GLUT1 + Fas-ligand 6  1.0%,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   835   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   812   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0253023:Fas Ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1515370:Fas Ligand [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   793   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   793   C0023688:Ligand [Chemical]
   793   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 8,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.0005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.212: These data suggest that upregulated glucose transport and metabolism protects VSMCs from apoptosis, thereby potentiating lesion formation. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that upregulated glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0178666:glucose transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "protects"

Phrase: "VSMCs from apoptosis,"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   847   C2612492:smooth muscle cell apoptosis [Cell Function]
   833   C0026844:Muscle, Smooth, Vascular [Tissue]
   833   C1135918:Smooth Muscle Cells [Cell]
   804   C2611952:muscle cell apoptosis [Cell Function]
   790   C0596981:Muscle Cells [Cell]
   790   C1267092:Muscle, Smooth [Tissue]
   753   C0005847:vascular [Body Part, Organ, or Organ Component]
   753   C0007634:Cells [Cell]
   753   C0026845:Muscle [Tissue]
   753   C0205357:Smooth [Qualitative Concept]
   753   C1558950:VASCULAR [Finding]
   753   C1801960:Vascular [Qualitative Concept]
   753   C3282337:Cells [Cell]
   733   C0005773:Blood Cells [Cell]
   725 E C2328697:Hemal cell [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "thereby"

Phrase: "potentiating"

Phrase: "lesion formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.213: View larger version (9K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.214: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.215: Upregulation of GLUT1 significantly inhibits apoptosis induced by Fas-ligand (control transfected [GFP] + Fas-ligand, 12  1% vs. GLUT1 + Fas-ligand 6  1.0%, n = 8, P < 0.0005). 

Phrase: "Upregulation of GLUT1 significantly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induced by Fas-ligand"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0253023:Fas Ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1515370:Fas Ligand [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0023688:Ligand [Chemical]
   770   C0205263:Induced [Functional Concept]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "transfected"

Phrase: "[GFP] + Fas-ligand,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0253023:Fas Ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1515370:Fas Ligand [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0023688:Ligand [Chemical]

Phrase: "12  1%"

Phrase: "vs. GLUT1 + Fas-ligand 6  1.0%,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   835   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   812   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0253023:Fas Ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1515370:Fas Ligand [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   793   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   793   C0023688:Ligand [Chemical]
   793   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 8,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.0005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.216: The percentage of apoptotic nuclei was assessed 20 h after treatment by staining with H33342. 

Phrase: "The percentage of apoptotic nuclei"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "20 h after treatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "by staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "with H33342."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0062907:H33342 [Pharmacologic Substance]
Processing 00000000.tx.217: Data are expressed as means  SE.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as means  SE."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.218: To address the role of GLUT1 upregulation on VSMC growth, we performed cell-cycle analysis. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the role of GLUT1 upregulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "on VSMC growth,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0007595:Cell Growth [Cell Function]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2911660:Growth [Activity]
   717   C0026844:Muscle, Smooth, Vascular [Tissue]
   717   C1135918:Smooth muscle cell [Cell]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "cell-cycle analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]
Processing 00000000.tx.219: Indeed, upregulation of GLUT1 resulted in a significant increase in the percentage of cells in S, G2, and M phases of the cell cycle (GLUT1 43  6% vs. control [GFP] 22  1%, n = 3, P < 0.022) (Fig. 6). 

Phrase: "Indeed,"

Phrase: "upregulation of GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041904:Up-Regulation [Cell Function,Molecular Function]
   760   C0162493:Up-Regulation [Genetic Function]

Phrase: "resulted in a significant increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0237881:significant [Quantitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in the percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439165:Percentage [Quantitative Concept]
  1000   C1549488:Percentage [Idea or Concept]
  1000   C1561533:Percentage [Idea or Concept]

Phrase: "of cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "in S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "G2,"

Phrase: "and"

Phrase: "M phases of the cell cycle"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   804   C1516337:Cell Cycle Phase [Cell Function]
   790   C0007591:Phases, M [Cell Function]
   783   C0599757:M-cell [Cell]
   767   C2963400:Cell phase [Temporal Concept]
   756 E C0026255:M Phase [Cell Function]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0585064:Phases [Temporal Concept]
   753   C1067936:Phasis [Eukaryote]
   719 E C0205390:Phase [Temporal Concept]

Phrase: "(GLUT1 43  6%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   840   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "vs. control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "[GFP] 22  1%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "n = 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.022"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0450305:0.022" [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.220: View larger version (10K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.221: 6. 

Phrase: "6."
Processing 00000000.tx.222: Upregulation of GLUT1 results in a significant increase in entry into the cell cycle. 

Phrase: "Upregulation of GLUT1 results"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "in a significant increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in entry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705654:Entry [Intellectual Product]

Phrase: "into the cell cycle."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007586:Cell Cycle [Cell Function]
  1000   C1155839:Cell Cycle [Cell Function]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1511572:Cycle [Temporal Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.223: VSMCs transiently upregulated with GLUT1 or a control vector (GFP) were exposed to low serumcontaining media for 24 h, followed by stimulation with 10% FBS for 24 h. 

Phrase: "VSMCs transiently"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "upregulated with GLUT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   806   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "a control vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031249:control vector [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "(GFP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "exposed to low serumcontaining media"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C0205251:low [Qualitative Concept]
   760   C1254021:Media [Tissue]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "for 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "followed by stimulation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1948023:Stimulation [Natural Phenomenon or Process]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with 10% FBS"

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.224: GLUT1 upregulation resulted in a significant increase in the percentage of cells in the S, G2, and M phases of the cell cycle. 

Phrase: "GLUT1 upregulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0041904:Up-Regulation [Cell Function,Molecular Function]
   812   C0162493:Up-Regulation [Genetic Function]
   756   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]

Phrase: "resulted in a significant increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0237881:significant [Quantitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in the percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439165:Percentage [Quantitative Concept]
  1000   C1549488:Percentage [Idea or Concept]
  1000   C1561533:Percentage [Idea or Concept]

Phrase: "of cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "in the S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "G2,"

Phrase: "and"

Phrase: "M phases of the cell cycle."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   804   C1516337:Cell Cycle Phase [Cell Function]
   790   C0007591:Phases, M [Cell Function]
   783   C0599757:M-cell [Cell]
   767   C2963400:Cell phase [Temporal Concept]
   756 E C0026255:M Phase [Cell Function]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0585064:Phases [Temporal Concept]
   753   C1067936:Phasis [Eukaryote]
   719 E C0205390:Phase [Temporal Concept]
Processing 00000000.tx.225: Data are presented as means  SE.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as means  SE."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0449450:Presented [Idea or Concept]
   770   C1704970:Means [Conceptual Entity]
   737 E C0150312:Present [Quantitative Concept]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.226: Differential regulation of GSK3. 

Phrase: "Differential regulation of GSK3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.227: Catalytically active GSK3 phosphorylates glycogen synthase and inhibits glycogen storage (18). 

Phrase: "Catalytically active GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphorylates"

Phrase: "glycogen synthase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   861   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "glycogen storage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337174:Storage [Spatial Concept]
   861   C1698986:Storage [Functional Concept]
   861   C1753314:storage [Cell Component]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.228: Recent work has also demonstrated that catalytically active GSK3 induces apoptosis (21). 

Phrase: "Recent work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "has"

Phrase: "also"

Phrase: "demonstrated"

Phrase: "that catalytically active GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.229: Considering the dual function of this enzyme, we hypothesized that it may be playing a role as a critical mediator linking a nutrient signal to the fate of VSMCs. 

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "the dual function of this enzyme,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "playing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:playing [Daily or Recreational Activity]
  1000   C0600138:playing [Finding]

Phrase: "a role as a critical mediator"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "a nutrient signal to the fate of VSMCs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1710082:Signal [Phenomenon or Process]
   737   C0037083:signal cell [Cell Function]
Processing 00000000.tx.230: To test this postulate, we compared total and phosphorylated (ser9) GSK3 protein expression in neointimal versus medial tissue specimens. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this"

Phrase: "postulate"

Phrase: ","

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "and"

Phrase: "phosphorylated"

Phrase: "(ser9"

Phrase: ")"

Phrase: "GSK3 protein expression in neointimal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1171362:protein expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "versus"

Phrase: "medial tissue specimens."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1292533:Tissue specimen [Tissue]
   827   C0370003:specimens [Substance]
   793 E C2347026:Specimen [Conceptual Entity]
Processing 00000000.tx.231: As seen in Fig. 

Phrase: "As"

Phrase: "seen in Fig."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.232: 7A, phosphorylation of GSK3 on ser9 was significantly enhanced in neointimal tissue, whereas total GSK3 expression was unchanged (Fig. 7B). 

Phrase: "7A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "phosphorylation of GSK3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "on ser9"

Phrase: "was"

Phrase: "significantly"

Phrase: "enhanced in neointimal tissue,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0040300:Tissue [Tissue]
   770   C1547928:Tissue [Intellectual Product]
   770   C2349975:Enhanced [Activity]

Phrase: "whereas"

Phrase: "total GSK3 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.233: View larger version (17K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.234: 7. 

Phrase: "7."
Processing 00000000.tx.235: A: Representative Western blot demonstrating enhanced phosphorylated (ser9) GSK3 protein expression in neointima (lanes 2, 4, and 6) versus isolated media (lanes 1, 3, and 5). 

Phrase: "A"

Phrase: ":"

Phrase: "Representative Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   901   C0949466:Western Blot [Laboratory Procedure]
   827   C1705493:Western [Spatial Concept]

Phrase: "demonstrating"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "phosphorylated"

Phrase: "(ser9"

Phrase: ")"

Phrase: "GSK3 protein expression in neointima"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1171362:protein expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(lanes 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "4,"

Phrase: "and"

Phrase: "6"

Phrase: ")"

Phrase: "versus"

Phrase: "isolated media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "(lanes 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.236: B: Total GSK3 protein expression was unchanged between neointima and media.  

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Total GSK3 protein expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C1171362:protein expression [Genetic Function]
   795   C0185117:Expression [Therapeutic or Preventive Procedure]
   710   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   710   C0555903:Total protein [Laboratory Procedure]
   710   C1261360:total protein [Laboratory or Test Result]

Phrase: "was"

Phrase: "unchanged between neointima"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442739:Unchanged [Finding]
   790   C2346711:Unchanged [Qualitative Concept]

Phrase: "and"

Phrase: "media."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.237: To determine whether the increased phosphorylation of GSK3 in the neointima was driven by alterations in the metabolic profile of these cells, we assessed GSK3 phosphorylation in our GLUT1 overexpressing VSMCs. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the increased phosphorylation of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "in the neointima"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2936380:Neointima [Acquired Abnormality]

Phrase: "was"

Phrase: "driven by alterations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0013126:Drive [Mental Process]
   756   C1515926:Alteration [Idea or Concept]

Phrase: "in the metabolic profile"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2350400:Metabolic Profile [Natural Phenomenon or Process]
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "of these cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "GSK3 phosphorylation in our GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0031715:Phosphorylation [Molecular Function]
   739   C1158886:Phosphorylation [Molecular Function]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "VSMCs."
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]
Processing 00000000.tx.238: Indeed, the phosphorylated form of GSK3 was significantly increased in GLUT1 overexpressing cells under fully supplemented conditions (Fig. 8A) as well as after 6 h of serum withdrawal (Fig. 8B). 

Phrase: "Indeed,"

Phrase: "the phosphorylated form of GSK3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "increased in GLUT1 overexpressing cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   814   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   778   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0860803:glucose increased [Finding]
   748   C0007634:Cells [Cell]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714   C1514559:overexpress [Genetic Function]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "under fully supplemented conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: ")"

Phrase: "as well as after 6 h of serum withdrawal"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   762   C0444953:H 6 [Intellectual Product]
   742   C0033727:H+ [Element, Ion, or Isotope]
   742   C0205170:Well [Qualitative Concept]
   742   C0229671:Serum [Body Substance]
   742   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441932:H+ [Classification]
   742   C0564385:/h [Quantitative Concept]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   742   C2349954:Withdrawal [Activity]
   742   C2825032:Withdrawal [Mental or Behavioral Dysfunction]
   742   C3146287:Well [Manufactured Object]

Phrase: "(Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.239: Total GSK3 protein expression was unchanged. 

Phrase: "Total GSK3 protein expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C1171362:protein expression [Genetic Function]
   795   C0185117:Expression [Therapeutic or Preventive Procedure]
   710   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   710   C0555903:Total protein [Laboratory Procedure]
   710   C1261360:total protein [Laboratory or Test Result]

Phrase: "was"

Phrase: "unchanged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.240: This suggested that the enhanced phosphorylation state of GSK3 in the neointima was, in part, a consequence of the enhanced glucose metabolism in these cells. 

Phrase: "This"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the enhanced phosphorylation state of GSK3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]
   742   C1301808:State [Geographic Area]
   742   C1442792:State [Functional Concept]
   742   C3148680:State [Geographic Area]

Phrase: "in the neointima"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2936380:Neointima [Acquired Abnormality]

Phrase: "was"

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "a consequence of the enhanced glucose metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "in these cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.241: These findings are consistent with the working hypothesis that enhanced glucose metabolism promotes VSMC viability by inactivating the proapoptotic kinase GSK3. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with the working hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that enhanced glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0596620:glucose metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "VSMC viability by inactivating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0007620:Cell Viability [Cell Function]
   748   C0443348:viability [Qualitative Concept]

Phrase: "the proapoptotic kinase GSK3."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.242: View larger version (16K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.243: 8. 

Phrase: "8."
Processing 00000000.tx.244: Representative Western blots demonstrating enhanced phosphorylated GSK3 protein expression in A7r5 VSMCs with constitutive upregulation of GLUT1 or the control transgene (GFP) under fully supplemented conditions (A) as well as after 6 h of serum withdrawal (B).  

Phrase: "Representative Western blots"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0949466:Western Blots [Laboratory Procedure]
   867 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1705493:Western [Spatial Concept]

Phrase: "demonstrating"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "phosphorylated GSK3 protein expression in A7r5 VSMCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1171362:protein expression [Genetic Function]
   735   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with constitutive upregulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041904:Up-Regulation [Cell Function,Molecular Function]
   861   C0162493:Up-Regulation [Genetic Function]

Phrase: "of GLUT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "the control transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282641:Transgene [Gene or Genome]

Phrase: "(GFP) under fully supplemented conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(A)"

Phrase: "as well as after 6 h of serum withdrawal"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   762   C0444953:H 6 [Intellectual Product]
   742   C0033727:H+ [Element, Ion, or Isotope]
   742   C0205170:Well [Qualitative Concept]
   742   C0229671:Serum [Body Substance]
   742   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441932:H+ [Classification]
   742   C0564385:/h [Quantitative Concept]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   742   C2349954:Withdrawal [Activity]
   742   C2825032:Withdrawal [Mental or Behavioral Dysfunction]
   742   C3146287:Well [Manufactured Object]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.245: To elucidate the regulation of GSK3 as a determinant of VSMC fate, we simulated GSK3 activation by transiently upregulating the catalytically active form of GSK3 and assessing the effect on VSMC apoptosis. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "elucidate"

Phrase: "the regulation of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "as a determinant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521761:Determinant [Functional Concept]

Phrase: "of VSMC fate,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   840   C1540661:cell fate [Cell Function]
   804   C1539479:FATE [Gene or Genome]
   733 E C1302234:Fatal [Qualitative Concept]
   733 E C1705232:Fatal [Finding]
   717   C0026844:Muscle, Smooth, Vascular [Tissue]
   717   C1135918:Smooth muscle cell [Cell]

Phrase: "we"

Phrase: "simulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0284447:simulated [Biomedical or Dental Material]

Phrase: "GSK3 activation by transiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "upregulating"

Phrase: "the catalytically active form of GSK3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "assessing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516048:Assess [Activity]

Phrase: "the effect on VSMC apoptosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.246: Indeed, upregulation of GSK3 was sufficient to induce apoptosis in VSMC (Fig. 9) (control 7  1% vs. GSK3 28  2%, n = 12, P < 0.0001). 

Phrase: "Indeed,"

Phrase: "upregulation of GSK3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in VSMC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   864   C2612492:smooth muscle cell apoptosis [Cell Function]
   820   C2611952:muscle cell apoptosis [Cell Function]
   753   C0162638:Apoptosis [Cell Function]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(control 7  1%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "vs. GSK3 28  2%,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   904   C1415378:GLYCOGEN SYNTHASE 2 [Gene or Genome]
   901   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "n = 12,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.247: To test our postulate that enhanced glucose transport and metabolism inhibited VSMC apoptosis through the inactivation of GSK3, we transiently cotransfected GSK3 along with GFP in control previously untransfected cells and cells with stable upregulation of GLUT1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "our"

Phrase: "postulate"

Phrase: "that enhanced glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0178666:glucose transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "VSMC apoptosis through the inactivation of GSK3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   784   C2612492:smooth muscle cell apoptosis [Cell Function]
   766   C2611952:muscle cell apoptosis [Cell Function]
   735   C0162638:Apoptosis [Cell Function]

Phrase: "we transiently cotransfected GSK3 along with GFP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   739   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in control previously untransfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cells with stable upregulation of GLUT1."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.248: In accord with our postulate, VSMCs with constitutively upregulated GLUT1 expression were less susceptible to GSK3-induced apoptosis compared with control VSMCs (control 29  3% vs. GLUT1 6  1%, n = 12, P < 0.001) (Fig. 10). 

Phrase: "In accord"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:accord [Social Behavior]

Phrase: "with our"

Phrase: "postulate"

Phrase: ","

Phrase: "VSMCs with constitutively upregulated GLUT1 expression"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   775   C0026844:Muscle, Smooth, Vascular [Tissue]
   775   C1135918:Smooth Muscle Cells [Cell]
   756   C0596981:Muscle Cells [Cell]
   756   C1267092:Muscle, Smooth [Tissue]
   738   C0005847:vascular [Body Part, Organ, or Organ Component]
   738   C0007634:Cells [Cell]
   738   C0026845:Muscle [Tissue]
   738   C0205357:Smooth [Qualitative Concept]
   738   C1558950:VASCULAR [Finding]
   738   C1801960:Vascular [Qualitative Concept]
   738   C3282337:Cells [Cell]
   704   C0005773:Blood Cells [Cell]
   704   C0005802:Blood Glucose [Carbohydrate]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "less susceptible to GSK3-induced apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0231204:Susceptible [Functional Concept]
   742   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "compared with control VSMCs"
Meta Candidates (Total=22; Excluded=4; Pruned=0; Remaining=18)
   814   C0026844:Muscle, Smooth, Vascular [Tissue]
   814   C1135918:Smooth Muscle Cells [Cell]
   778   C0596981:Muscle Cells [Cell]
   778   C1267092:Muscle, Smooth [Tissue]
   748   C0005847:vascular [Body Part, Organ, or Organ Component]
   748   C0007634:Cells [Cell]
   748   C0026845:Muscle [Tissue]
   748   C0205357:Smooth [Qualitative Concept]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1558950:VASCULAR [Finding]
   748   C1707455:Compared [Activity]
   748   C1801960:Vascular [Qualitative Concept]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   748   C3282337:Cells [Cell]
   724   C0005773:Blood Cells [Cell]
   716 E C2328697:Hemal cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(control 29  3%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "vs. GLUT1 6  1%,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   840   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 12,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "(Fig. 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.249: Moreover, GSK3-mediated apoptosis was also inhibited in VSMCs with transient upregulation of GLUT1 (GLUT1 6  2%, n = 6, P < 0.001). 

Phrase: "Moreover,"

Phrase: "GSK3-mediated apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0162638:Apoptosis [Cell Function]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   727 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "inhibited in VSMCs"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   833   C0026844:Muscle, Smooth, Vascular [Tissue]
   833   C1135918:Smooth Muscle Cells [Cell]
   790   C0596981:Muscle Cells [Cell]
   790   C1267092:Muscle, Smooth [Tissue]
   753   C0005847:vascular [Body Part, Organ, or Organ Component]
   753   C0007634:Cells [Cell]
   753   C0026845:Muscle [Tissue]
   753   C0205357:Smooth [Qualitative Concept]
   753   C0311403:Inhibited [Qualitative Concept]
   753   C1558950:VASCULAR [Finding]
   753   C1801960:Vascular [Qualitative Concept]
   753   C3282337:Cells [Cell]
   733   C0005773:Blood Cells [Cell]
   725 E C2328697:Hemal cell [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "with transient upregulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041904:Up-Regulation [Cell Function,Molecular Function]
   861   C0162493:Up-Regulation [Genetic Function]

Phrase: "of GLUT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(GLUT1 6  2%,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   911   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   884   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   840   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.250: Taken together, these experiments indicate that enhanced glucose transport stimulates the phosphorylation and inactivation of the proapoptotic mediator GSK3, in association with enhanced VSMC survival. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "indicate"

Phrase: "that enhanced glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0178666:glucose transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "stimulates"

Phrase: "the phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "and"

Phrase: "inactivation of the proapoptotic mediator GSK3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "in association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with enhanced VSMC survival."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0007620:Cell Survival [Cell Function]
   799   C0038952:Survival [Activity]
   799   C0220921:survival [Functional Concept]
Processing 00000000.tx.251: View larger version (10K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.252: 9. 

Phrase: "9."
Processing 00000000.tx.253: Transient upregulation of catalytically active GSK3 induces apoptosis in A7r5 VSMCs. 

Phrase: "Transient upregulation of catalytically active GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0041904:Up-Regulation [Cell Function,Molecular Function]
   742   C0162493:Up-Regulation [Genetic Function]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in A7r5 VSMCs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   823   C2612492:smooth muscle cell apoptosis [Cell Function]
   788   C2611952:muscle cell apoptosis [Cell Function]
   748   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.254: The percentage of apoptotic nuclei was assessed 20 h after serum withdrawal by staining with H33342 (control transfected 7  1% vs. catalytically active GSK3 28  2%, n = 12, P < 0.0001). 

Phrase: "The percentage of apoptotic nuclei"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "20 h after serum withdrawal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "by staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "with H33342"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0062907:H33342 [Pharmacologic Substance]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "transfected"

Phrase: "7  1%"

Phrase: "vs. catalytically active GSK3 28  2%,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   869   C1415378:GLYCOGEN SYNTHASE 2 [Gene or Genome]
   861   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   835   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   793   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0205177:Active [Functional Concept]

Phrase: "n = 12,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.255: Data are expressed as means  SE.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as means  SE."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.256: View larger version (10K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.257: 10. 

Phrase: "10."
Processing 00000000.tx.258: Constitutive upregulation of GLUT1 inhibits GSK3-induced VSMC death. 

Phrase: "Constitutive upregulation of GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "GSK3-induced VSMC death."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0007587:Cell Death [Cell Function]
   790   C0011065:Death [Organism Function]
   790   C1306577:Death, NOS [Finding]
Processing 00000000.tx.259: The percentage of apoptotic nuclei was assessed 24 h after transient transfection of catalytically active GSK3 by staining with H33342 and determining the percentage of apoptotic nuclei in the transfected subset (GFP-positive). 

Phrase: "The percentage of apoptotic nuclei"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "24 h after transient transfection of catalytically active GSK3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   751   C0041119:h 3 [Element, Ion, or Isotope]
   736   C0033727:H+ [Element, Ion, or Isotope]
   736   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   736   C0441932:H+ [Classification]
   736   C0564385:/h [Quantitative Concept]

Phrase: "by staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "with H33342"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0062907:H33342 [Pharmacologic Substance]

Phrase: "and"

Phrase: "determining"

Phrase: "the percentage of apoptotic nuclei"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "in the transfected subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1515021:Subset [Classification]

Phrase: "(GFP-positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.260: Controls were A7r5 VSMC transiently cotransfected with a control vector + GSK3 (control 29  3% vs. GLUT1 6  2%, n = 6, P < 0.001). 

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "A7r5 VSMC transiently"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   861   C0026844:Muscle, Smooth, Vascular [Tissue]
   861   C1135918:Smooth muscle cell [Cell]
   827   C0596981:Muscle cell [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   816   C2328697:Hemal cell [Cell]
   808 E C0005773:Blood cell [Cell]
   799   C0005847:vascular [Body Part, Organ, or Organ Component]
   799   C0007634:Cell [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C1269647:Cell [Cell]
   799   C1558950:VASCULAR [Finding]
   799   C1704653:Cell [Medical Device]
   799   C1801960:Vascular [Qualitative Concept]
   799   C1948049:Cell [Spatial Concept]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C0442025:Muscular [Spatial Concept]

Phrase: "cotransfected with a control vector + GSK3"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   818   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033640:Glycogen synthase a kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1417673:glycogen synthase A kinase [Gene or Genome]
   804   C3537353:Glycogen Synthase A Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0031249:control vector [Occupational Activity]
   742   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   742   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0243148:control [Qualitative Concept]
   742   C0442335:Vector [Spatial Concept]
   742   C1550141:Control [Substance]
   742   C1705099:Vector [Idea or Concept]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]

Phrase: "(control 29  3%"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "vs. GLUT1 6  2%,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   911   C1420172:GLUCOSE TRANSPORTER 2 [Gene or Genome]
   884   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   840   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "n = 6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.261: Data are expressed as means  SE.   

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as means  SE."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C1704970:Means [Conceptual Entity]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.262: DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  We have demonstrated that GLUT1 protein and intracellular glucose are differentially elevated in neointimal VSMCs compared with medial VSMCs after balloon injury. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0035171:Research Design [Research Activity]
   799   C0035168:research [Research Activity]
   799   C0242481:Research [Research Activity]
   799   C1707689:Design [Activity]
   799   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that GLUT1 protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C2599779:Glucose & Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Carbohydrate]
   875   C0007292:Transporter Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]

Phrase: "and"

Phrase: "intracellular glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "are"

Phrase: "differentially"

Phrase: "elevated in neointimal VSMCs"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   814   C0026844:Muscle, Smooth, Vascular [Tissue]
   814   C1135918:Smooth Muscle Cells [Cell]
   778   C0596981:Muscle Cells [Cell]
   778   C1267092:Muscle, Smooth [Tissue]
   748   C0005847:vascular [Body Part, Organ, or Organ Component]
   748   C0007634:Cells [Cell]
   748   C0026845:Muscle [Tissue]
   748   C0205250:Elevated [Qualitative Concept]
   748   C0205357:Smooth [Qualitative Concept]
   748   C1558950:VASCULAR [Finding]
   748   C1801960:Vascular [Qualitative Concept]
   748   C3163633:Elevated [Qualitative Concept]
   748   C3282337:Cells [Cell]
   724   C0005773:Blood Cells [Cell]
   716 E C2328697:Hemal cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "compared with medial VSMCs"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   814   C0026844:Muscle, Smooth, Vascular [Tissue]
   814   C1135918:Smooth Muscle Cells [Cell]
   778   C0596981:Muscle Cells [Cell]
   778   C1267092:Muscle, Smooth [Tissue]
   748   C0005847:vascular [Body Part, Organ, or Organ Component]
   748   C0007634:Cells [Cell]
   748   C0026845:Muscle [Tissue]
   748   C0205098:Medial [Spatial Concept]
   748   C0205357:Smooth [Qualitative Concept]
   748   C1558950:VASCULAR [Finding]
   748   C1707455:Compared [Activity]
   748   C1801960:Vascular [Qualitative Concept]
   748   C3282337:Cells [Cell]
   724   C0005773:Blood Cells [Cell]
   716 E C2328697:Hemal cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "after balloon injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.263: To understand the link between metabolic signaling and lesion formation, we created cultured VSMCs with constitutive upregulation of GLUT1. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the link between metabolic signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "lesion formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "we"

Phrase: "created"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706214:Created [Activity]
   966 E C3244320:create [Functional Concept]

Phrase: "cultured VSMCs with constitutive upregulation of GLUT1."
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   770   C0026844:Muscle, Smooth, Vascular [Tissue]
   770   C1135918:Smooth Muscle Cells [Cell]
   753   C0596981:Muscle Cells [Cell]
   753   C1267092:Muscle, Smooth [Tissue]
   751   C0007600:cultured cells [Cell]
   751   C0007635:Cultured Cells [Cell]
   751   C3282338:Cells, Cultured [Cell]
   736   C0005847:vascular [Body Part, Organ, or Organ Component]
   736   C0007634:Cells [Cell]
   736   C0026845:Muscle [Tissue]
   736   C0205357:Smooth [Qualitative Concept]
   736   C1558950:VASCULAR [Finding]
   736   C1801960:Vascular [Qualitative Concept]
   736   C3282337:Cells [Cell]
   703 E C1269647:Cell [Cell]
   703 E C1704653:Cell [Medical Device]
   703 E C1948049:Cell [Spatial Concept]
   701   C0005773:Blood Cells [Cell]
   701   C0005802:Blood Glucose [Carbohydrate]
Processing 00000000.tx.264: Upregulation of GLUT1 resulted in increases in both nonoxidative and oxidative glucose metabolism, as assessed by 13C-NMR spectroscopy. 

Phrase: "Upregulation of GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041904:Up-Regulation [Cell Function,Molecular Function]
   760   C0162493:Up-Regulation [Genetic Function]

Phrase: "resulted in increases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0442805:increases [Functional Concept]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "in both nonoxidative"

Phrase: "and"

Phrase: "oxidative glucose metabolism,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0282636:oxidative metabolism [Cell Function]
   901   C0596620:glucose metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "as"

Phrase: "assessed by 13C-NMR spectroscopy."
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   853   C0877853:Spectroscopy, Nuclear Magnetic Resonance [Diagnostic Procedure]
   814   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   814   C0024487:Magnetic Resonance Spectroscopy [Diagnostic Procedure]
   814   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   814   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   778   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   778   C1551403:Magnetic resonance [Laboratory Procedure]
   748   C0024488:Magnetic [Occupation or Discipline]
   748   C0037812:spectroscopy [Laboratory Procedure]
   748   C0231881:Resonance [Finding]
   748   C0459800:resonance [Natural Phenomenon or Process]
   748   C0521447:Nuclear [Spatial Concept]
   748   C0563532:magnetic [Natural Phenomenon or Process]
   748   C0684213:Resonance [Qualitative Concept]
   748   C1516048:Assessed [Activity]
   748   C2713504:Spectroscopy [Occupation or Discipline]
   748   C2984732:SPECTROSCOPY [Functional Concept]
Processing 00000000.tx.265: This enhanced glucose transport and utilization was sufficient to inhibit apoptosis induced by serum withdrawal as well as Fas-ligand. 

Phrase: "This enhanced glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0178666:glucose transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042153:utilization [Functional Concept]

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induced by serum withdrawal"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205263:Induced [Functional Concept]
   770   C0229671:Serum [Body Substance]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]
   770   C2349954:Withdrawal [Activity]
   770   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "as well as"

Phrase: "Fas-ligand."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0253023:Fas Ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1515370:Fas Ligand [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0023688:Ligand [Chemical]
Processing 00000000.tx.266: The inhibition of apoptosis in response to two mechanistically distinct proapoptotic stimuli suggests a fundamental effect on the final common pathways regulating cell death. 

Phrase: "The inhibition of apoptosis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   909   C1512772:Inhibition of Apoptosis [Cell Function]
           Apoptosis Inhibition
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to two mechanistically distinct proapoptotic stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0234402:Stimuli [Phenomenon or Process]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a fundamental effect on the final common pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "regulating"

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.267: The coordinate increase in cell proliferation and decrease in VSMC apoptosis provides a mechanism by which enhanced glucose transport and metabolism may promote vascular lesion formation. 

Phrase: "The coordinate increase in cell proliferation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0596290:Cell Proliferation [Cell Function]
   804   C0334094:Proliferation [Pathologic Function]
   804   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "decrease in VSMC apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a mechanism by which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "may"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "vascular lesion formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.268: Coincident with the upregulation in GLUT1 expression in neointimal tissue and cultured VSMC was a significant increase in the phosphorylation state and, hence, inactivation of the proapoptotic mediator GSK3. 

Phrase: "Coincident with the upregulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205420:Coincident [Temporal Concept]

Phrase: "in GLUT1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]

Phrase: "in neointimal tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "cultured VSMC"
Meta Candidates (Total=23; Excluded=8; Pruned=0; Remaining=15)
   897   C0007635:cultured cell [Cell]
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth muscle cell [Cell]
   840   C0596981:Muscle cell [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   833   C2328697:Hemal cell [Cell]
   825 E C0005773:Blood cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cell [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1269647:Cell [Cell]
   804   C1558950:VASCULAR [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1801960:Vascular [Qualitative Concept]
   804   C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "was"

Phrase: "a significant increase in the phosphorylation state"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: ","

Phrase: "hence,"

Phrase: "inactivation of the proapoptotic mediator GSK3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0544461:Inactivation [Cell or Molecular Dysfunction]
Processing 00000000.tx.269: Transient expression of active GSK3 was sufficient to induce apoptosis in VSMCs. 

Phrase: "Transient expression of active GSK3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in VSMCs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   847   C2612492:smooth muscle cell apoptosis [Cell Function]
   804   C2611952:muscle cell apoptosis [Cell Function]
   753   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.270: However, GSK3-induced apoptosis was significantly attenuated by upregulation of GLUT1. 

Phrase: "However,"

Phrase: "GSK3-induced apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0162638:Apoptosis [Cell Function]
   734   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   727 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "attenuated by upregulation of GLUT1."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   778   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0041904:Up-Regulation [Cell Function,Molecular Function]
   748   C0162493:Up-Regulation [Genetic Function]
   748   C0332161:Attenuated [Qualitative Concept]
   748   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0599946:Attenuated [Activity]
Processing 00000000.tx.271: Thus, our data suggest that an elevation in GLUT1 concordant with increased glucose uptake and metabolism activates an antiapoptotic signaling pathway that seems to be linked to the phosphorylation and inactivation of GSK3 in the vasculature. 

Phrase: "Thus,"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "an elevation in GLUT1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439775:Elevation [Therapeutic or Preventive Procedure]
   753   C0702240:Elevation [Spatial Concept]

Phrase: "concordant with increased glucose uptake"

Phrase: "and"

Phrase: "metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "an antiapoptotic signaling pathway"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0037083:signaling pathway [Cell Function]
   901   C0086982:Signaling Pathway [Molecular Function]
   884 E C0037080:Signal Pathway [Molecular Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "that"

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "linked to the phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "inactivation of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0544461:Inactivation [Cell or Molecular Dysfunction]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the vasculature."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005839:vasculature [Body Part, Organ, or Organ Component]
Processing 00000000.tx.272: This is the first study to demonstrate differential regulation of metabolic gene expression in neointimal VSMCs versus medial VSMCs after balloon injury. 

Phrase: "This"

Phrase: "is"

Phrase: "the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "differential regulation of metabolic gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0017263:Regulation of Gene Expression [Genetic Function]
           Gene Expression Regulation
           Gene Regulation
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "in neointimal VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "versus"

Phrase: "medial VSMCs after balloon injury."
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   800   C0026844:Muscle, Smooth, Vascular [Tissue]
   800   C1135918:Smooth Muscle Cells [Cell]
   770   C0596981:Muscle Cells [Cell]
   770   C1267092:Muscle, Smooth [Tissue]
   767   C0178324:Vascular injury [Injury or Poisoning]
   767   C0410256:muscle injury [Injury or Poisoning]
   767   C1998242:Muscle injury [Injury or Poisoning]
   750   C0599732:cell injury [Cell or Molecular Dysfunction]
   744   C0005847:vascular [Body Part, Organ, or Organ Component]
   744   C0007634:Cells [Cell]
   744   C0026845:Muscle [Tissue]
   744   C0205357:Smooth [Qualitative Concept]
   744   C1558950:VASCULAR [Finding]
   744   C1801960:Vascular [Qualitative Concept]
   744   C3282337:Cells [Cell]
   717   C0005773:Blood Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
   709 E C2328697:Hemal cell [Cell]
Processing 00000000.tx.273: After vascular injury, a subset of medial VSMCs migrates into the lumen and is phenotypically modified from a contractile, differentiated state to a synthetic, "de-differentiated" phenotype (353637). 

Phrase: "After vascular injury,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178324:Vascular injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]

Phrase: "a subset of medial VSMCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1515021:Subset [Classification]

Phrase: "migrates into the lumen"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0232902:migrate [Functional Concept]
   770   C0524461:Lumen [Body Space or Junction]
   770   C1282864:Lumen [Body Space or Junction]
   770   C1301906:Lumen [Qualitative Concept]
   770   C1551056:Lumen [Quantitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "phenotypically"

Phrase: "modified from a contractile, differentiated state"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0007589:Differentiated [Cell Function]
   753   C0026820:Contractile [Physiologic Function]
   753   C0205615:Differentiated [Qualitative Concept]
   753   C0392747:Modified [Functional Concept]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C3148680:State [Geographic Area]

Phrase: "to a synthetic, """
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:synthetic [Activity]

Phrase: "de-differentiated"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0007589:Differentiated [Cell Function]
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C0205615:Differentiated [Qualitative Concept]
   861   C3541240:DE [Idea or Concept]
   789 E C1511938:Differentiation [Clinical Attribute]
   789 E C2945687:Differentiation [Functional Concept]

Phrase: """ phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(353637"

Phrase: ")."
Processing 00000000.tx.274: Considering that the risk of restenosis and atherosclerosis after balloon angioplasty is significantly elevated in diabetic individuals (123), we postulated that a component of the phenotypic modulation involved altered metabolic signaling pathways. 

Phrase: "Considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "that"

Phrase: "the risk of restenosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "atherosclerosis after balloon angioplasty"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0004153:Atherosclerosis [Disease or Syndrome]

Phrase: "is"

Phrase: "significantly"

Phrase: "elevated in diabetic individuals"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205250:Elevated [Qualitative Concept]
   770   C0241863:DIABETIC [Finding]
   770   C3163633:Elevated [Qualitative Concept]
   737   C0027361:Individual [Population Group]
   737   C0237401:Individual [Human]

Phrase: "(123"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "postulated"

Phrase: "that"

Phrase: "a component of the phenotypic modulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "altered metabolic signaling pathways."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C1291081:Metabolic Pathways [Functional Concept]
   844   C0037080:Signal Pathways [Molecular Function]
   844   C0037083:signaling pathway [Cell Function]
   844   C0086982:Signaling Pathway [Molecular Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.275: Indeed, we found an upregulation in glucose transport, resulting in significant increases in intracellular glucose in the neointimal population. 

Phrase: "Indeed,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "an upregulation in glucose transport,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041904:Up-Regulation [Cell Function,Molecular Function]
   760   C0162493:Up-Regulation [Genetic Function]

Phrase: "resulting in significant increases"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0332294:Resulting in [Functional Concept]
   770   C0237881:significant [Quantitative Concept]
   770   C0442805:increases [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "in intracellular glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "in the neointimal population."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]
Processing 00000000.tx.276: It is noteworthy that neoplastic transformation is often associated with a similar upregulation of glucose transporters (38). 

Phrase: "It"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that neoplastic transformation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0007621:neoplastic transformation [Neoplastic Process]
   861   C0040682:Transformation [Cell Function]
   861   C1510411:Transformation [Pathologic Function]
   861   C1705163:Transformation [Research Activity]
   861   C1709160:Neoplastic [Qualitative Concept]
   789 E C0027651:Neoplasia [Neoplastic Process]

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "associated with a similar upregulation of glucose transporters"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0041904:Up-Regulation [Cell Function,Molecular Function]
   744   C0162493:Up-Regulation [Genetic Function]
   744   C0596902:transporters [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C2348205:Similar [Qualitative Concept]
   737   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.277: We demonstrated a threefold increase in VSMC glucose uptake as a result of upregulating GLUT1. 

Phrase: "We"

Phrase: "demonstrated"

Phrase: "a threefold increase in VSMC glucose uptake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "as a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "of upregulating GLUT1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   861   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.278: This significant upregulation of glucose transport is similar to findings in other cell systems in which GLUT1 has been upregulated, including proximal tubule-like cells, skeletal muscle, and the heart (394041). 

Phrase: "This significant upregulation of glucose transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C1523075:up-regulation of transport [Cell Function]
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "is"

Phrase: "similar to findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "in other cell systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "in which GLUT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "upregulated"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "proximal tubule-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022677:proximal tubule [Body Part, Organ, or Organ Component]
   861   C0205107:Proximal [Spatial Concept]

Phrase: "like cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "skeletal muscle,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "the heart"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018787:Heart [Body Part, Organ, or Organ Component]
  1000   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "(394041"

Phrase: ")."
Processing 00000000.tx.279: To characterize the flux of glucose in VSMCs with upregulated GLUT1 content, we used 13C-NMR spectroscopy. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "the flux of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "in VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "with upregulated GLUT1 content,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0423896:Content [Mental Process]
   804   C0456205:Content [Conceptual Entity]
   717   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "13C-NMR spectroscopy."
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   937   C0877853:Spectroscopy, Nuclear Magnetic Resonance [Diagnostic Procedure]
   884   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
   884   C0024487:Magnetic Resonance Spectroscopy [Diagnostic Procedure]
   884   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   884   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   840   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   840   C1551403:Magnetic resonance [Laboratory Procedure]
   804   C0024488:Magnetic [Occupation or Discipline]
   804   C0037812:spectroscopy [Laboratory Procedure]
   804   C0231881:Resonance [Finding]
   804   C0459800:resonance [Natural Phenomenon or Process]
   804   C0521447:Nuclear [Spatial Concept]
   804   C0563532:magnetic [Natural Phenomenon or Process]
   804   C0684213:Resonance [Qualitative Concept]
   804   C2713504:Spectroscopy [Occupation or Discipline]
   804   C2984732:SPECTROSCOPY [Functional Concept]
   733 E C0024483:Magnet [Manufactured Object]
   733 E C0577554:Resonant [Qualitative Concept]
   733 E C0885556:magnets [Pharmacologic Substance]
   733 E C1706318:Magnet [Manufactured Object]
Processing 00000000.tx.280: Upregulated glucose transport resulted in significant increases in the contribution of glucose to lactate (nonoxidative) and acetyl-CoA formation (oxidative). 

Phrase: "Upregulated glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0178666:glucose transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "resulted in significant increases"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0237881:significant [Quantitative Concept]
   770   C0442805:increases [Functional Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "in the contribution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribution [Activity]

Phrase: "of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "to lactate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022924:lactate [Organic Chemical]
  1000   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "(nonoxidative"

Phrase: ")"

Phrase: "and"

Phrase: "acetyl-CoA formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1157700:acetyl-CoA formation [Molecular Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(oxidative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0311404:Oxidative [Functional Concept]

Phrase: ")."
Processing 00000000.tx.281: In contrast, glucose incorporation to glycogen was unchanged. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "glucose incorporation to glycogen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243126:incorporation [Functional Concept]

Phrase: "was"

Phrase: "unchanged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.282: To our knowledge, this is the first study to examine the effect of increased glucose transport on flux through both nonoxidative and oxidative pathways in VSMCs. 

Phrase: "To our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "this"

Phrase: "is"

Phrase: "the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the effect of increased glucose transport"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0595938:EFFECT INCREASED [Pathologic Function]
   783   C1158774:glucose effect [Genetic Function]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on flux"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "through both nonoxidative"

Phrase: "and"

Phrase: "oxidative pathways in VSMCs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1704259:Pathways [Molecular Function]
   748   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.283: Studies from our laboratory and others have suggested that neointimal VSMCs are more resistant to apoptosis compared with medial VSMCs (456). 

Phrase: "Studies from our laboratory"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   819   C0681827:Laboratory studies [Laboratory Procedure]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that neointimal VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "are"

Phrase: "more resistant to apoptosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332325:Resistant to [Functional Concept]
           Resistant
   770   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "compared with medial VSMCs"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   814   C0026844:Muscle, Smooth, Vascular [Tissue]
   814   C1135918:Smooth Muscle Cells [Cell]
   778   C0596981:Muscle Cells [Cell]
   778   C1267092:Muscle, Smooth [Tissue]
   748   C0005847:vascular [Body Part, Organ, or Organ Component]
   748   C0007634:Cells [Cell]
   748   C0026845:Muscle [Tissue]
   748   C0205098:Medial [Spatial Concept]
   748   C0205357:Smooth [Qualitative Concept]
   748   C1558950:VASCULAR [Finding]
   748   C1707455:Compared [Activity]
   748   C1801960:Vascular [Qualitative Concept]
   748   C3282337:Cells [Cell]
   724   C0005773:Blood Cells [Cell]
   716 E C2328697:Hemal cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(456"

Phrase: ")."
Processing 00000000.tx.284: We hypothesized that the differential upregulation of glucose transport and metabolism in neointimal VSMCs was a sufficient driving force to enhance survival of this VSMC population. 

Phrase: "We"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "the differential upregulation of glucose transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C1523075:up-regulation of transport [Cell Function]
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "and"

Phrase: "metabolism in neointimal VSMCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0596984:metabolism muscle [Organ or Tissue Function]
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]

Phrase: "was"

Phrase: "a sufficient driving force to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0441722:Force [Phenomenon or Process]
   812   C0563538:Force [Phenomenon or Process]
   756 E C0729333:Dynamic [Functional Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "survival of this VSMC population."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007620:Cell Survival [Cell Function]
   744   C0038952:Survival [Activity]
   744   C0220921:survival [Functional Concept]
Processing 00000000.tx.285: Indeed, this study demonstrates that the upregulation of glucose transport significantly inhibits the percentage of VSMCs undergoing apoptosis in response to both serum withdrawal and Fas-ligand. 

Phrase: "Indeed,"

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "demonstrates"

Phrase: "that"

Phrase: "the upregulation of glucose transport significantly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C1523075:up-regulation of transport [Cell Function]
   753   C0041904:Up-Regulation [Cell Function,Molecular Function]
   753   C0162493:Up-Regulation [Genetic Function]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the percentage of VSMCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "undergoing"

Phrase: "apoptosis in response"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "to both serum withdrawal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2349954:Withdrawal [Activity]
   861   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "Fas-ligand."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0253023:Fas Ligand [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1515370:Fas Ligand [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0023688:Ligand [Chemical]
Processing 00000000.tx.286: Our findings support previous work from our laboratory and others in VSMCs, proximal tubule-like cells, and the myocardium, demonstrating that glucose metabolism is of critical importance for cell survival (10,414243). 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "previous work from our laboratory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0043227:Work [Occupational Activity]

Phrase: "and"

Phrase: "others in VSMCs,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1979779:Other cells [Cell]
   753   C1955473:Others [Finding]
   719 E C0205394:Other [Qualitative Concept]

Phrase: "proximal tubule-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022677:proximal tubule [Body Part, Organ, or Organ Component]
   861   C0205107:Proximal [Spatial Concept]

Phrase: "like cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the myocardium,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027061:Myocardium [Tissue]
   928 E C1522564:Myocardial [Spatial Concept]

Phrase: "demonstrating"

Phrase: "that glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "is of critical importance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]

Phrase: "for cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(10,"

Phrase: "414243"

Phrase: ")."
Processing 00000000.tx.287: To our knowledge, this is the first study to demonstrate a regulatory role for GSK3 as a critical mechanistic mediator linking nutrient signaling pathways and cell fate. 

Phrase: "To our knowledge,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376554:Knowledge [Intellectual Product]

Phrase: "this"

Phrase: "is"

Phrase: "the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "a regulatory role for GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "as a critical mechanistic mediator linking nutrient signaling pathways"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   893   C0282655:Critical Pathways [Intellectual Product]
   801   C0037080:Signal Pathways [Molecular Function]
   801   C0037083:signaling pathway [Cell Function]
   801   C0086982:Signaling Pathway [Molecular Function]
   795   C1704259:Pathways [Molecular Function]
   795   C1705987:Pathways [Conceptual Entity]

Phrase: "and"

Phrase: "cell fate."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1540661:cell fate [Cell Function]
   861   C1539479:FATE [Gene or Genome]
   789 E C1302234:Fatal [Qualitative Concept]
   789 E C1705232:Fatal [Finding]
Processing 00000000.tx.288: Moreover, the description of alterations in GSK3 phosphorylation in the vasculature has not been described previously. 

Phrase: "Moreover,"

Phrase: "the description of alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678257:Description [Idea or Concept]

Phrase: "in GSK3 phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0031715:Phosphorylation [Molecular Function]
   804   C1158886:Phosphorylation [Molecular Function]
   771   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the vasculature"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005839:vasculature [Body Part, Organ, or Organ Component]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously."
Processing 00000000.tx.289: The enhanced phosphorylation of GSK3 in the isolated neointima is intriguing. 

Phrase: "The enhanced phosphorylation of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]

Phrase: "in the isolated neointima"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2936380:Neointima [Acquired Abnormality]

Phrase: "is"

Phrase: "intriguing."
Processing 00000000.tx.290: Given the observation that GSK3 was also significantly enhanced in VSMCs stably transfected with GLUT1 suggests that the regulation of GSK3 in neointimal VSMCs may be mediated, in part, by the altered metabolic profile of these cells. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "also significantly"

Phrase: "enhanced in VSMCs stably"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   814   C0026844:Muscle, Smooth, Vascular [Tissue]
   814   C1135918:Smooth Muscle Cells [Cell]
   778   C0596981:Muscle Cells [Cell]
   778   C1267092:Muscle, Smooth [Tissue]
   748   C0005847:vascular [Body Part, Organ, or Organ Component]
   748   C0007634:Cells [Cell]
   748   C0026845:Muscle [Tissue]
   748   C0205357:Smooth [Qualitative Concept]
   748   C1558950:VASCULAR [Finding]
   748   C1801960:Vascular [Qualitative Concept]
   748   C2349975:Enhanced [Activity]
   748   C3282337:Cells [Cell]
   724   C0005773:Blood Cells [Cell]
   716 E C2328697:Hemal cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with GLUT1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   806   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the regulation of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "in neointimal VSMCs"
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]

Phrase: "may"

Phrase: "be"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "by the altered metabolic profile"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2350400:Metabolic Profile [Natural Phenomenon or Process]
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]

Phrase: "of these cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.291: A recent finding demonstrating inactivation of GSK3 by elevated glucose concentrations in rat hepatocytes lends support to our findings (16). 

Phrase: "A recent finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "demonstrating"

Phrase: "inactivation of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0544461:Inactivation [Cell or Molecular Dysfunction]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "by elevated glucose concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   884   C0427743:Glucose concentration [Laboratory Procedure]
   884   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in rat hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "lends"

Phrase: "support to our findings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0183683:Support [Medical Device]
   770   C1521721:Support [Conceptual Entity]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.292: Clearly, growth factors such as insulin, IGF-I, fibroblast growth factor, and epidermal growth factor may also be involved in the regulation. 

Phrase: "Clearly,"

Phrase: "growth factors such as insulin,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "IGF-I,"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "fibroblast growth factor,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0016026:Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0016030:Fibroblast [Cell]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "epidermal growth factor"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "involved in the regulation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1314939:Involved [Functional Concept]
   770   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.293: The mechanism linking increases in glucose metabolism with the inactivation of GSK3 is currently unknown. 

Phrase: "The mechanism linking increases in glucose metabolism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:increases [Functional Concept]

Phrase: "with the inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "of GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "currently unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.294: Future lines of investigation will be needed to define the regulation of GSK3 activity by glucose metabolism and the role of GSK3 as a determinant of fate in VSMCs. 

Phrase: "Future lines of investigation"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "will"

Phrase: "be"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the regulation of GSK3 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   815   C1625162:regulation of kinase activity [Molecular Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1327622:Regulation [Biologic Function]
   703   C1150570:glycogen synthase kinase 3 activity [Molecular Function]

Phrase: "by glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "the role of GSK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "as a determinant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521761:Determinant [Functional Concept]

Phrase: "of fate"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1539479:FATE [Gene or Genome]
   928 E C1302234:Fatal [Qualitative Concept]
   928 E C1705232:Fatal [Finding]

Phrase: "in VSMCs."
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]
Processing 00000000.tx.295: It is noteworthy that the significant alterations in the regulation of GSK3 activity were not associated with detectable alterations in either glycogen content in isolated neointimal versus medial samples or cultured VSMCs. 

Phrase: "It"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that"

Phrase: "the significant alterations in the regulation of GSK3 activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0184517:Activity alteration [Finding]
   703   C1515926:Alteration [Idea or Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with detectable alterations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   737 E C0750490:Associate [Idea or Concept]
   737   C1515926:Alteration [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in either glycogen content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "in isolated neointimal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C2936380:Neointima [Acquired Abnormality]

Phrase: "versus"

Phrase: "medial samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "or"

Phrase: "cultured VSMCs."
Meta Candidates (Total=26; Excluded=11; Pruned=0; Remaining=15)
   897   C0007600:cultured cells [Cell]
   897   C0007635:Cultured Cells [Cell]
   897   C3282338:Cells, Cultured [Cell]
   884   C0026844:Muscle, Smooth, Vascular [Tissue]
   884   C1135918:Smooth Muscle Cells [Cell]
   840   C0596981:Muscle Cells [Cell]
   840   C1267092:Muscle, Smooth [Tissue]
   825   C0005773:Blood Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   804   C0005847:vascular [Body Part, Organ, or Organ Component]
   804   C0007634:Cells [Cell]
   804   C0026845:Muscle [Tissue]
   804   C0205357:Smooth [Qualitative Concept]
   804   C1558950:VASCULAR [Finding]
   804   C1801960:Vascular [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   748 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   748 E C1511228:VESSEL, BLOOD [Tissue]
   733 E C0442025:Muscular [Spatial Concept]
   704 E C0005767:Blood [Tissue]
   704 E C0005768:blood [Body Substance]
   704 E C0229664:Blood [Body Substance]
   704 E C0392895:Bloods [Population Group]
Processing 00000000.tx.296: This is not surprising, considering the complex enzymatic signaling cascade involved in glycogen regulation. 

Phrase: "This"

Phrase: "is"

Phrase: "not surprising,"

Phrase: "considering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considering [Idea or Concept]

Phrase: "the complex enzymatic signaling cascade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2611812:signaling cascade [Cell Function]
   812   C1707310:Cascade [Manufactured Object]

Phrase: "involved in glycogen regulation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1314939:Involved [Functional Concept]
   770   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.297: The role of vascular glycogen stores and its regulation remains a poorly characterized area of vascular biology. 

Phrase: "The role of vascular glycogen stores"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "its regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "remains"

Phrase: "a poorly characterized area of vascular biology."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017446:Area [Geographic Area]
   748   C0205146:Area [Spatial Concept]
Processing 00000000.tx.298: Our findings that GSK3 induces apoptosis supports and extends earlier work in nonvascular cells (21), demonstrating that the proapoptotic influence of GSK3 is contextual and determined by growth factors and glucose metabolism. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "that GSK3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "and"

Phrase: "extends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "work in nonvascular cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0043227:Work [Occupational Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "demonstrating"

Phrase: "that"

Phrase: "the proapoptotic influence of GSK3"

Phrase: "is"

Phrase: "contextual"

Phrase: "and"

Phrase: "determined by growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "glucose metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.299: In summary, we have found that glucose transport and metabolism are differentially upregulated in the process of intimal lesion formation. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that glucose transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178666:glucose transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "are"

Phrase: "differentially"

Phrase: "upregulated in the process of intimal lesion formation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0220781:formation [Biologic Function]
   744   C0221198:Lesion [Finding]
   744   C0439634:formation [Spatial Concept]
   744   C1184743:Process [Body Part, Organ, or Organ Component]
   744   C1522240:Process [Phenomenon or Process]
   744   C1522492:Formation [Functional Concept]
   744   C1546698:Lesion [Intellectual Product]
Processing 00000000.tx.300: Moreover, we have provided evidence to support a role for GSK3 regulation as a novel mechanistic link between upregulated glucose metabolism and an antiapoptotic cellular signaling pathway in VSMCs. 

Phrase: "Moreover,"

Phrase: "we"

Phrase: "have"

Phrase: "provided evidence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:Evidence [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a role for GSK3 regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "as a novel mechanistic link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "between upregulated glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0596620:glucose metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "an antiapoptotic cellular signaling pathway in VSMCs."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0037083:signaling pathway [Cell Function]
   760   C0086982:Signaling Pathway [Molecular Function]
   757 E C0037080:pathway signaling [Molecular Function]
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.301: These findings may have important implications for understanding the contributing role of metabolism in the process of occlusive macrovascular disease and may begin to help us understand the mechanisms underlying the elevated risk of restenosis and atherosclerosis in the diabetic population.  

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "may"

Phrase: "have"

Phrase: "important implications for understanding"

Phrase: "the contributing role of metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "of occlusive macrovascular disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "may"

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "us"

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlying"

Phrase: "the elevated risk of restenosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035647:Risk [Qualitative Concept]

Phrase: "and"

Phrase: "atherosclerosis in the diabetic population."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0004153:Atherosclerosis [Disease or Syndrome]
Processing 00000000.tx.302: ACKNOWLEDGMENTS  This study was supported by grants from the National Institutes of Health (J.L.H., G.H.G., J.C.C.), the American Heart Association (J.L.H., G.H.G.), and the PEW Foundation (G.H.G.). 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the National Institutes of Health"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "(J.L.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "G.H.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1319635:g/g [Quantitative Concept]
   734   C0560020:g h [Quantitative Concept]

Phrase: "J."

Phrase: "C.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the American Heart Association"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0002458:American Heart Association [Health Care Related Organization]
   827   C0004083:Association [Mental Process]
   827   C0018787:Heart [Body Part, Organ, or Organ Component]
   827   C0439849:Association [Qualitative Concept]
   827   C0596070:American [Population Group]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   827   C1281570:Heart [Body Part, Organ, or Organ Component]

Phrase: "(J.L.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "G.H.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1319635:g/g [Quantitative Concept]
   734   C0560020:g h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the PEW Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "(G.H.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1319635:g/g [Quantitative Concept]
   734   C0560020:g h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.303: We thank Drs. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs."
Processing 00000000.tx.304: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.305: Birnbaum and M. 

Phrase: "Birnbaum"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.306: Mueckler for the GLUT1 expression constructs, Dr. 

Phrase: "Mueckler for the GLUT1 expression constructs,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.307: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.308: Goodyear for the GLUT1 antibody, John Daley for his help and expertise with the fluorescence-activated cell sorter analysis, and Dr. 

Phrase: "Goodyear for the GLUT1 antibody,"

Phrase: "John Daley for his"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "and"

Phrase: "expertise with the fluorescence-activated cell sorter analysis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0870520:expertise [Qualitative Concept]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.309: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.310: Kahn for her insightful discussions.  

Phrase: "Kahn for her insightful discussions."
Processing 00000000.tx.311: FOOTNOTES  Address correspondence and reprint requests to Gary H. 

Phrase: "FOOTNOTES  Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Gary H."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0458974:gary [Food]
   770   C0564385:/h [Quantitative Concept]
   770   C0686900:request [Functional Concept]
   770   C1272683:Request [Functional Concept]
   770   C1522634:Request [Intellectual Product]
Processing 00000000.tx.312: Gibbons, Cardiovascular Research Institute, Morehouse School of Medicine, 720 Westview Dr. 

Phrase: "Gibbons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020410:Gibbons [Mammal]

Phrase: "Cardiovascular Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0035172:Research Institute [Organization]
   827   C0021622:institute [Organization]
   827   C0035168:research [Research Activity]
   827   C0242481:Research [Research Activity]
   827   C1272753:Institute [Idea or Concept]

Phrase: "Morehouse School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036375:School [Manufactured Object,Organization]

Phrase: "720 Westview Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0031831:DR [Professional or Occupational Group]
   827   C1707664:DR [Biomedical or Dental Material]
   827   C2348314:Dr. [Conceptual Entity]
   827   C3540849:DR [Idea or Concept]
Processing 00000000.tx.313: SW, Atlanta, GA 30310-1495. 

Phrase: "SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420193:SW [Gene or Genome]
  1000   C1832169:SW [Body System]
  1000   C3538902:SW [Gene or Genome]

Phrase: "Atlanta,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2993063:Atlanta [Eukaryote]

Phrase: "GA 30310-1495."
Processing 00000000.tx.314: E-mail: ggibbons{at}msm.edu . Received for publication 8 May 2000 and accepted in revised form 11 January 2001. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "ggibbons{at}msm.edu ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "Received for publication 8 May 2000"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0034036:Publication [Intellectual Product,Manufactured Object]
   753   C0034037:Publication [Occupational Activity]
   753   C1514756:Received [Qualitative Concept]
   753   C1704324:Publication [Intellectual Product]

Phrase: "and"

Phrase: "accepted in revised form 11 January 2001."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1527075:Revised [Therapeutic or Preventive Procedure]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.315: DMEM, Dulbeccos modified Eagles medium; 

Phrase: "DMEM,"

Phrase: "Dulbeccos modified Eagles medium"

Phrase: ";"
Processing 00000000.tx.316: FBS, fetal bovine serum; 

Phrase: "FBS,"

Phrase: "fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0007452:Bovine [Mammal]
   827   C0015965:Fetal [Embryonic Structure]
   827   C0229671:Serum [Body Substance]
   827   C0521457:Fetal [Functional Concept]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.317: GFP, green fluorescent protein; 

Phrase: "GFP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "green fluorescent protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.318: GSK3, glycogen synthase kinase 3; 

Phrase: "GSK3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glycogen synthase kinase 3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.319: NMR, nuclear magnetic resonance; 

Phrase: "NMR,"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
  1000   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
  1000   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0521447:Nuclear [Spatial Concept]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]

Phrase: "nuclear magnetic resonance"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
  1000   C0024485:nuclear magnetic resonance [Diagnostic Procedure]
  1000   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
  1000   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   901   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   901   C1551403:Magnetic resonance [Laboratory Procedure]
   827   C0024488:Magnetic [Occupation or Discipline]
   827   C0231881:Resonance [Finding]
   827   C0459800:resonance [Natural Phenomenon or Process]
   827   C0521447:Nuclear [Spatial Concept]
   827   C0563532:magnetic [Natural Phenomenon or Process]
   827   C0684213:Resonance [Qualitative Concept]
   755 E C0024483:Magnet [Manufactured Object]
   755 E C0577554:Resonant [Qualitative Concept]
   755 E C0885556:magnets [Pharmacologic Substance]
   755 E C1706318:Magnet [Manufactured Object]

Phrase: ";"
Processing 00000000.tx.320: PBS, phosphate-buffered solution; 

Phrase: "PBS,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "phosphate-buffered solution"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.321: TCA, tricarboxylic acid; 

Phrase: "TCA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040887:tricarboxylic acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "tricarboxylic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040887:tricarboxylic acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.322: VSMC, vascular smooth muscle cell.  

Phrase: "VSMC,"
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth muscle cell [Cell]
   861   C0596981:Muscle cell [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   861   C2328697:Hemal cell [Cell]
   852 E C0005773:Blood cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cell [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1269647:Cell [Cell]
   812   C1558950:VASCULAR [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1801960:Vascular [Qualitative Concept]
   812   C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]

Phrase: "vascular smooth muscle cell."
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth muscle cell [Cell]
   861   C0596981:Muscle cell [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   861   C2328697:Hemal cell [Cell]
   852 E C0005773:Blood cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cell [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1269647:Cell [Cell]
   812   C1558950:VASCULAR [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1801960:Vascular [Qualitative Concept]
   812   C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]
Processing 00000000.tx.323: REFERENCES TOP ABSTRACT INTRODUCTION RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Brand FN, Abbott RD, Kannel WB: Diabetes, intermittent claudication, and risk of cardiovascular events: the Framingham Study. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Brand FN,"

Phrase: "Abbott RD,"

Phrase: "Kannel WB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582525:Wb [Quantitative Concept]

Phrase: ":"

Phrase: "Diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "intermittent claudication,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021775:Intermittent Claudication [Disease or Syndrome]
   861   C0205267:Intermittent [Temporal Concept]
   861   C0311395:claudication [Finding]
   861   C1456822:Claudication [Disease or Syndrome]
   789 E C0745348:intermittency [Finding]

Phrase: "and"

Phrase: "risk of cardiovascular events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   865   C1273410:Cardiovascular event risk [Finding]
   770   C0035647:Risk [Qualitative Concept]

Phrase: ":"

Phrase: "the Framingham Study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.324: Diabetes 38:504509, 1989[Abstract] Aronson D, Rayfield EJ, Chesebro JH: Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. 

Phrase: "Diabetes 38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "504509,"

Phrase: "1989"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Aronson D,"

Phrase: "Rayfield EJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]

Phrase: "Chesebro JH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: ":"

Phrase: "Mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "determining"

Phrase: "course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "and"

Phrase: "outcome of diabetic patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C1547647:Patient Outcome [Idea or Concept]
   770   C1274040:Outcome [Functional Concept]

Phrase: "who"

Phrase: "have"

Phrase: "had"

Phrase: "acute myocardial infarction."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0155626:Acute myocardial infarction [Disease or Syndrome]
  1000   C3541950:ACUTE MYOCARDIAL INFARCTION [Finding]
   901   C0027051:Myocardial Infarction [Disease or Syndrome]
   901   C0428953:MYOCARDIAL INFARCTION [Finding]
   901   C2926063:Myocardial infarction [Clinical Attribute]
   863   C0333548:Acute infarct [Pathologic Function]
   827   C0021308:Infarction [Pathologic Function]
   827   C0027061:Myocardial [Tissue]
   827   C0205178:acute [Temporal Concept]
   827   C1522564:Myocardial [Spatial Concept]
   755 E C0333541:Infarcted [Functional Concept]
Processing 00000000.tx.325: Ann Intern Med 126:296306, 1997[Abstract/Free FullText] Kornowski R, Mintz GS, Kent KM, Richard AD, Satler LF, Bucher TA, Hong MK, Popma JJ, Leon MB: Increased restenosis in diabetes mellitus after coronary interventions is due to an exaggerated intimal hyperplasia: a serial intravascular ultrasound study. 

Phrase: "Ann Intern Med 126"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1144859:INTERN [Professional or Occupational Group]

Phrase: ":"

Phrase: "296306,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kornowski R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Mintz GS,"

Phrase: "Kent KM,"

Phrase: "Richard AD,"

Phrase: "Satler LF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416933:LF [Gene or Genome]
   861   C2986618:LF [Gene or Genome]

Phrase: "Bucher TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Hong MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Popma JJ,"

Phrase: "Leon MB"

Phrase: ":"

Phrase: "Increased restenosis in diabetes mellitus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333186:Restenosis [Acquired Abnormality]

Phrase: "after coronary interventions"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0886296:interventions [Health Care Activity]
   861   C1273869:Interventions [Health Care Activity]
   861   C2979881:Interventions [Clinical Attribute]
   861   C3542921:Interventions [Classification]
   827 E C1948041:Intervention [Therapeutic or Preventive Procedure]
   777 E C3274035:INTERVENTIONAL [Research Activity]

Phrase: "is due to an exaggerated intimal hyperplasia"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0020507:Hyperplasia [Pathologic Function]
   748   C0442801:Exaggerated [Qualitative Concept]
   748   C3146286:Due [Idea or Concept]

Phrase: ":"

Phrase: "a serial intravascular ultrasound study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0557651:Study [Manufactured Object]
   812   C2603343:Study [Research Activity]
Processing 00000000.tx.326: Circulation 95:13661369, 1997[Abstract/Free FullText] Bauriedel G, Shluckebier S, Hutter R, Kankdolf R, Luderitz B, Prescot MF: Apoptosis in restenosis versus stable angina atherosclerosis. 

Phrase: "Circulation 95"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "13661369,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bauriedel G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Shluckebier S,"

Phrase: "Hutter R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Kankdolf R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Luderitz B,"

Phrase: "Prescot MF"

Phrase: ":"

Phrase: "Apoptosis in restenosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "versus"

Phrase: "stable angina atherosclerosis."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0004153:Atherosclerosis [Disease or Syndrome]
   755 E C0333482:Atherosclerotic [Functional Concept]
   734   C0340288:Stable angina [Disease or Syndrome]
   734   C0699826:Angina, Stable [Disease or Syndrome]
Processing 00000000.tx.327: Arterioscler Thromb Vasc Biol 18:11321139, 1998[Abstract/Free FullText] Pollman MJ, Hall JL, Gibbons GH: Determinants of vascular smooth muscle apoptosis after balloon angioplasty: influence of redox state and cell phenotype. 

Phrase: "Arterioscler Thromb Vasc Biol 18"

Phrase: ":"

Phrase: "11321139,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pollman MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Hall JL,"

Phrase: "Gibbons GH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033993:GH [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539616:GH [Gene or Genome]

Phrase: ":"

Phrase: "Determinants of vascular smooth muscle apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1521761:Determinant [Functional Concept]

Phrase: "after balloon angioplasty"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0002996:Angioplasty, Balloon [Therapeutic or Preventive Procedure]
  1000   C0002997:balloon angioplasty [Therapeutic or Preventive Procedure]
   861   C0162577:Angioplasty [Therapeutic or Preventive Procedure]
   861   C0336867:Balloon [Manufactured Object]
   861   C0441144:balloon [Medical Device]
   861   C1548817:Angioplasty [Health Care Activity]

Phrase: ":"

Phrase: "influence of redox state"

Phrase: "and"

Phrase: "cell phenotype."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0427385:Cell phenotype [Laboratory Procedure]
  1000   C1318444:Cell phenotype [Organism Attribute]
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.328: Circ Res 84:113121, 1999[Abstract/Free FullText] Pollman MJ, Hall JH, Mann MJ, Zhang L, Gibbons GH: Inhibition of neointimal cell Bcl-x expression induces apoptosis and regression of vascular disease. 

Phrase: "Circ Res 84"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "113121,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Pollman MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Hall JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Mann MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Zhang L,"

Phrase: "Gibbons GH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033993:GH [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539616:GH [Gene or Genome]

Phrase: ":"

Phrase: "Inhibition of neointimal cell Bcl-x expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "regression of vascular disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0684320:Disease regression [Pathologic Function]
           Regression
   819   C2826596:Vascular Regression [Finding]
   770   C0684321:Regression [Mental Process]
Processing 00000000.tx.329: Nature Med 4:222227, 1998[Medline] Campbell JD, Paul RJ: The nature of fuel provision for the Na+-K+-ATPase in vascular smooth muscle. 

Phrase: "Nature Med 4"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0349590:Nature [Idea or Concept]
   827   C1262865:Nature [Functional Concept]
   755 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "222227,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Campbell JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Paul RJ"

Phrase: ":"

Phrase: "The nature of fuel provision"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0349590:Nature [Idea or Concept]
   760   C1262865:Nature [Functional Concept]

Phrase: "for the Na+-K+-ATPase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001479:NA K ATPASE [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0525416:Na ATPase [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in vascular smooth muscle."
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
  1000   C0026844:Muscle, Smooth, Vascular [Tissue]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0005847:vascular [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C1558950:VASCULAR [Finding]
   827   C1801960:Vascular [Qualitative Concept]
   771 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   771 E C1511228:VESSEL, BLOOD [Tissue]
   755 E C0442025:Muscular [Spatial Concept]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   711 E C0333275:Bloody [Qualitative Concept]
Processing 00000000.tx.330: J Physiol (Lond) 447:6782, 1992[Abstract] Hardin CD, Raeymaekers L, Paul RJ: Comparison of endogenous and exogenous sources of ATP in fueling Ca2+ uptake in smooth muscle plasma membrane vesicles. 

Phrase: "J Physiol"

Phrase: "(Lond) 447"

Phrase: ":"

Phrase: "6782,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hardin CD,"

Phrase: "Raeymaekers L,"

Phrase: "Paul RJ"

Phrase: ":"

Phrase: "Comparison of endogenous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "exogenous sources of ATP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0449416:sources [Finding]
   737 E C1705919:Source [Idea or Concept]

Phrase: "in fueling Ca2+ uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "in smooth muscle plasma membrane vesicles."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0333262:VESICLES [Acquired Abnormality]
   771 E C1622418:vesicle [Cell Component]
   721 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.331: J Gen Physiol 99:2140, 1992[Abstract] Lund DD, Faraci FM, Miller FJ Jr, Heistad DD: Gene transfer of endothelial nitric oxide synthase improves relaxation of carotid arteries from diabetic rats. 

Phrase: "J Gen Physiol 99"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704351:GEN [Quantitative Concept]
   812   C2239486:Gen [Gene or Genome]

Phrase: ":"

Phrase: "2140,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lund DD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538867:DD [Gene or Genome]

Phrase: "Faraci FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Miller FJ Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Heistad DD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538867:DD [Gene or Genome]

Phrase: ":"

Phrase: "Gene transfer of endothelial nitric oxide synthase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1517499:Gene Transfer [Molecular Biology Research Technique]
   748   C0017337:Gene [Gene or Genome]
   748   C0040671:Transfer [Mental Process]
   748   C1705822:Transfer [Activity]

Phrase: "improves"

Phrase: "relaxation of carotid arteries"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0035028:Relaxation [Activity]

Phrase: "from diabetic rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]
Processing 00000000.tx.332: Circulation 101:10271033, 2000[Abstract/Free FullText] Hall JL, Matter C, Pollman MJ, Bai HZ, Inishi Y, Gibbons GH: Hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway. 

Phrase: "Circulation 101"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "10271033,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hall JL,"

Phrase: "Matter C,"

Phrase: "Pollman MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Bai HZ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439482:Hz [Quantitative Concept]

Phrase: "Inishi Y,"

Phrase: "Gibbons GH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033993:GH [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539616:GH [Gene or Genome]

Phrase: ":"

Phrase: "Hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2612492:smooth muscle cell apoptosis [Cell Function]
   770   C2611952:muscle cell apoptosis [Cell Function]
   751   C0162638:Apoptosis Pathway [Cell Function]
           Apoptosis
Processing 00000000.tx.333: Circulation 98:574580, 2000 Rumble JR, Cooper ME, Soulis T, Wu L, Yousself S, Gilbert RE: Vascular hypertrophy in experimental diabetes: role of advanced glycation end products. 

Phrase: "Circulation 98"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "574580,"

Phrase: "2000 Rumble JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Cooper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "ME,"

Phrase: "Soulis T,"

Phrase: "Wu L,"

Phrase: "Yousself S,"

Phrase: "Gilbert RE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: ":"

Phrase: "Vascular hypertrophy in experimental diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020564:Hypertrophy [Pathologic Function]

Phrase: ":"

Phrase: "role of advanced glycation end products."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
   716   C0162574:Glycation End Products, Advanced [Biologically Active Substance,Organic Chemical]
Processing 00000000.tx.334: J Clin Invest 99:10161027, 1997[Abstract/Free FullText] Klip A, Tsakiridis T, Marette A, Oritz P: Regulation of expression of glucose transporter by glucose: a review of studies in vivo and in cell culture. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "99"

Phrase: ":"

Phrase: "10161027,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Klip A,"

Phrase: "Tsakiridis T,"

Phrase: "Marette A,"

Phrase: "Oritz P"

Phrase: ":"

Phrase: "Regulation of expression of glucose transporter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ":"

Phrase: "a review of studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0282443:Review [Intellectual Product]
   770   C1552617:Review [Idea or Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in cell culture."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0007585:Cell Culture [Laboratory Procedure]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.335: FASEB J 8:4353, 1994[Abstract/Free FullText] Koya D, King GL: Protein kinase C activation and the development of diabetic complications. 

Phrase: "FASEB J 8"

Phrase: ":"

Phrase: "4353,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "] Koya D,"

Phrase: "King"

Phrase: "GL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018229:GL [Geographic Area]
  1000   C1423073:GL [Gene or Genome]
  1000   C1427674:GL [Gene or Genome]

Phrase: ":"

Phrase: "Protein kinase C activation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C3546691:protein kinase C activation [Molecular Function]
   923   C1819041:protein kinase activation [Cell Function]
   902   C0599177:protein activation [Genetic Function]
   812   C1879547:Activation [Activity]
   756   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   708   C1168438:Protein C [Laboratory Procedure]
   708   C1418943:PROTEIN C [Gene or Genome]
   708   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the development of diabetic complications."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
Processing 00000000.tx.336: Diabetes 47:859866, 1998[Abstract] Natarajan R, Bai W, Lanting L, Gonzales N, Nadler J: Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. 

Phrase: "Diabetes 47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "859866,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Natarajan R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Bai W,"

Phrase: "Lanting L,"

Phrase: "Gonzales N,"

Phrase: "Nadler J"

Phrase: ":"

Phrase: "Effects of high glucose"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C1158774:glucose effect [Genetic Function]
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on vascular endothelial growth factor expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C1522575:Vascular Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   717   C0079280:Endothelial Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C0078057:vascular factor [Amino Acid, Peptide, or Protein]

Phrase: "in vascular smooth muscle cells."
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]
Processing 00000000.tx.337: Am J Physiol Heart Circ Physiol 273:H2224H2231, 1997[Abstract/Free FullText] Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R: Hyperglycemia-induced activation of nuclear transcription factor B in vascular smooth muscle cells. 

Phrase: "Am"

Phrase: "J Physiol Heart Circ Physiol 273"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0018787:Heart [Body Part, Organ, or Organ Component]
   799   C0332520:Circ [Quantitative Concept]
   799   C1281570:Heart [Body Part, Organ, or Organ Component]
   799   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "H2224H2231,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yerneni KK,"

Phrase: "Bai W,"

Phrase: "Khan BV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511278:BV [Geographic Area]

Phrase: "Medford RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Natarajan R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Hyperglycemia-induced activation of nuclear transcription factor B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0162493:Transcription Activation [Genetic Function]
   744   C1879547:Activation [Activity]

Phrase: "in vascular smooth muscle cells."
Meta Candidates (Total=23; Excluded=11; Pruned=0; Remaining=12)
   923   C0026844:Muscle, Smooth, Vascular [Tissue]
   923   C1135918:Smooth Muscle Cells [Cell]
   861   C0596981:Muscle Cells [Cell]
   861   C1267092:Muscle, Smooth [Tissue]
   852   C0005773:Blood Cells [Cell]
   844 E C2328697:Hemal cell [Cell]
   812   C0005847:vascular [Body Part, Organ, or Organ Component]
   812   C0007634:Cells [Cell]
   812   C0026845:Muscle [Tissue]
   812   C0205357:Smooth [Qualitative Concept]
   812   C1558950:VASCULAR [Finding]
   812   C1801960:Vascular [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   756 E C1511228:VESSEL, BLOOD [Tissue]
   741 E C0442025:Muscular [Spatial Concept]
   712 E C0005767:Blood [Tissue]
   712 E C0005768:blood [Body Substance]
   712 E C0229664:Blood [Body Substance]
   712 E C0392895:Bloods [Population Group]
Processing 00000000.tx.338: Diabetes 48:855864, 1999[Abstract] Auer KL, Contessa J, Brenz-Verca S, Pirola L, Rusconi S, Cooper G, Abo A, Wymann MP, Davis RJ, Birrer M, Dent P: The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "855864,"

Phrase: "1999"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Auer KL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: "Contessa J,"

Phrase: "Brenz-Verca S,"

Phrase: "Pirola L,"

Phrase: "Rusconi S,"

Phrase: "Cooper G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Abo A,"

Phrase: "Wymann MP,"

Phrase: "Davis RJ,"

Phrase: "Birrer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Dent P"

Phrase: ":"

Phrase: "The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   836   C1155542:JNK cascade [Molecular Function]
   793   C1707310:Cascade [Manufactured Object]

Phrase: "is"

Phrase: "a key pathway by which agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "stimulate"

Phrase: "DNA synthesis in primary cultures of rat hepatocytes."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0598312:DNA Synthesis [Genetic Function]
   770   C1328870:DNA synthesis [Laboratory Procedure]
   770   C1817262:DNA synthesis [Genetic Function]
   744   C0220781:synthesis [Biologic Function]
   744   C1883254:Synthesis [Activity]
   731 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.339: Mol Biol Cell 9:561573, 1998[Abstract/Free FullText] Parker PJ, Caudwell FB, Cohen P: Glycogen synthase from rabbit skeletal muscle: effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo. 

Phrase: "Mol Biol Cell 9"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "561573,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Parker PJ,"

Phrase: "Caudwell FB,"

Phrase: "Cohen P"

Phrase: ":"

Phrase: "Glycogen synthase from rabbit skeletal muscle"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1415377:GLYCOGEN SYNTHASE, MUSCLE [Gene or Genome]
   790   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   753   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ":"

Phrase: "effect of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on the state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301808:State [Geographic Area]
  1000   C1442792:State [Functional Concept]
  1000   C3148680:State [Geographic Area]

Phrase: "of phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "of the seven phosphoserine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.340: Eur J Biochem 103:227234, 1983[Medline] Eldar-Finkelman H, Argast GM, Foord O, Fischer EH, Krebs EG: Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells. 

Phrase: "Eur J Biochem 103"

Phrase: ":"

Phrase: "227234,"

Phrase: "1983"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Eldar-Finkelman H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Argast GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Foord O,"

Phrase: "Fischer EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Krebs EG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013715:EG [Geographic Area]
   861   C1705651:EG [Idea or Concept]

Phrase: ":"

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "characterization of glycogen synthase kinase-3 mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "their effect on glycogen synthase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "in intact cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0682538:intact cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.341: Proc Natl Acad Sci U S A 93:1022810233, 1996[Abstract/Free FullText] Welsh GI, Proud CG: Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. 

Phrase: "Proc Natl Acad Sci U S A 93"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "1022810233,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] Welsh GI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539617:GI [Idea or Concept]

Phrase: "Proud CG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: ":"

Phrase: "Glycogen synthase kinase-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "inactivated in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "phosphorylates"

Phrase: "eukaryotic initiation factor eIF-2B."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   933   C0606869:Eukaryotic Initiation Factor-2B [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           EIF 2B
   804   C0450354:2b [Intellectual Product]
   804   C1706096:2B [Research Activity]
Processing 00000000.tx.342: Biochem J 294:625629, 1993[Medline] Siegfried E, Chou TB, Perrimon N: Wingless signaling acts through zeste-white 3, the Drosophila homolog of glycogen synthase kinase-3, to regulate engrailed and establish cell fate. 

Phrase: "Biochem J 294"

Phrase: ":"

Phrase: "625629,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Siegfried E,"

Phrase: "Chou TB,"

Phrase: "Perrimon N"

Phrase: ":"

Phrase: "Wingless signaling acts through zeste-white 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "the Drosophila homolog of glycogen synthase kinase-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1334043:Homolog [Gene or Genome]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "engrailed"

Phrase: "and"

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "cell fate."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1540661:cell fate [Cell Function]
   861   C1539479:FATE [Gene or Genome]
   789 E C1302234:Fatal [Qualitative Concept]
   789 E C1705232:Fatal [Finding]
Processing 00000000.tx.343: Cell 71:11671179, 1992[Medline] Pap M, Cooper GM: Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. 

Phrase: "Cell 71"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0007634:Cell [Cell]
   861   C0450389:71 [Intellectual Product]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "11671179,"

Phrase: "1992"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pap M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Cooper GM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: ":"

Phrase: "Role of glycogen synthase kinase-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the phosphatidylinositol 3-kinase/Akt cell survival pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1704259:Pathway [Molecular Function]
   795   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.344: J Biol Chem 273:1992919932, 1998[Abstract/Free FullText] He X, Saint-Jeannet JP, Woodgett JR, Varmus HE, Dawid IB: Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1992919932,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "He X,"

Phrase: "Saint-Jeannet JP,"

Phrase: "Woodgett JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Varmus"

Phrase: "HE,"

Phrase: "Dawid IB"

Phrase: ":"

Phrase: "Glycogen synthase kinase-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   923   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "dorsoventral patterning in Xenopus embryos."
Processing 00000000.tx.345: Nature l374:617622, 1995[Medline] Yost C, Farr GH, Pierce SB, Ferkey DM, Chen MM, Kimelman D: GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis. 

Phrase: "Nature l374"

Phrase: ":"

Phrase: "617622,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yost C,"

Phrase: "Farr GH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033993:GH [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539616:GH [Gene or Genome]

Phrase: "Pierce SB,"

Phrase: "Ferkey DM,"

Phrase: "Chen MM,"

Phrase: "Kimelman D"

Phrase: ":"

Phrase: "GBP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3538683:GBP [Gene or Genome]
  1000   C3538684:GBP [Gene or Genome]
  1000   C3539609:GBP [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "an inhibitor of GSK-3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "is"

Phrase: "implicated in Xenopus development"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0043342:Xenopus [Amphibian]
   770   C0043343:Xenopus [Amphibian]
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1504663:Xenopus [Amphibian]
   770   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "oncogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007621:Oncogenesis [Neoplastic Process]
  1000   C0596263:Oncogenesis [Neoplastic Process]
Processing 00000000.tx.346: Cell 93:10311041, 1998[Medline] Summers SA, Kao AW, Kohn AD, Backus GS, Roth RA, Pessin JE, Birnbaum MJ: The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism. 

Phrase: "Cell 93"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "10311041,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Summers SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Kao AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Kohn AD,"

Phrase: "Backus GS,"

Phrase: "Roth RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Pessin JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "Birnbaum MJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: ":"

Phrase: "The role of glycogen synthase kinase 3beta"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in insulin-stimulated glucose metabolism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C3547575:insulin metabolism [Molecular Function]
   861   C0596620:glucose metabolism [Molecular Function]
   812   C0025519:Metabolism [Organism Function]
   812   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.347: J Biol Chem 274:1793417940, 1999[Abstract/Free FullText] Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin is mediated by protein kinase B. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1793417940,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "Cross"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828360:Cross [Conceptual Entity]

Phrase: "DA,"

Phrase: "Alessi DR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]

Phrase: "Cohen P,"

Phrase: "Andjelkovich M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hemmings BA"

Phrase: ":"

Phrase: "Inhibition of glycogen synthase kinase-3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]
   716   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "by insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "mediated by protein kinase B."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0164786:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   862   C0285558:Protein Kinase B [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0377800:protein B [Amino Acid, Peptide, or Protein,Receptor]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.348: Nature 378:785789, 1995[Medline] Pollman MJ, Yamada T, Horiuchi M, Gibbons GH: Vasoactive substances regulate vascular smooth muscle cell apoptosis: countervailing influences of nitric oxide and angiotensin II. 

Phrase: "Nature 378"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "785789,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pollman MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Yamada T,"

Phrase: "Horiuchi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gibbons GH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033993:GH [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539616:GH [Gene or Genome]

Phrase: ":"

Phrase: "Vasoactive substances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439861:Substances [Substance]

Phrase: "regulate"

Phrase: "vascular smooth muscle cell apoptosis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   937   C2612492:smooth muscle cell apoptosis [Cell Function]
   884   C2611952:muscle cell apoptosis [Cell Function]
   804   C0162638:Apoptosis [Cell Function]
   733 E C1516044:Apoptotic [Qualitative Concept]
   717   C0026844:Muscle, Smooth, Vascular [Tissue]
   717   C1135918:Smooth muscle cell [Cell]

Phrase: ":"

Phrase: "countervailing influences of nitric oxide"

Phrase: "and"

Phrase: "angiotensin II."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003009:Angiotensin 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.349: Circ Res 79:748756, 1996[Abstract/Free FullText] Shepard PR, Gnudi L, Tozzo E, Yang H, Leach F, Kahn BB: Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4. 

Phrase: "Circ Res 79"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332520:Circ [Quantitative Concept]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "748756,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shepard PR,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0279759:PR+ [Laboratory or Test Result]
   861   C0279766:PR- [Laboratory or Test Result]
   861   C1418864:PR@ [Gene or Genome]
   861   C3538934:PR [Intellectual Product]
   861   C3538935:PR [Idea or Concept]

Phrase: "Gnudi L,"

Phrase: "Tozzo E,"

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Leach"

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Kahn BB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004739:BB [Geographic Area]
   861   C0332297:BB [Spatial Concept]

Phrase: ":"

Phrase: "Adipose cell hyperplasia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020507:Hyperplasia [Pathologic Function]
   734   C0206131:Adipose cell [Cell]

Phrase: "and"

Phrase: "enhanced glucose disposal in transgenic mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707797:Disposal [Activity]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "GLUT4."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0166441:GLUT-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420175:GLUT4 [Gene or Genome]
  1000   C2982484:GLUT4 [Gene or Genome]
Processing 00000000.tx.350: J Biol Chem 268:2224322246, 1993[Abstract/Free FullText] Malloy CR, Sherry AD, Jeffrey FMH: Analysis of tricarboxylic acid cycle of the heart using 13C isotope isomers. 

Phrase: "J Biol Chem 268"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2224322246,"

Phrase: "1993"

Phrase: "[Abstract/Free FullText"

Phrase: "] Malloy CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Sherry AD,"

Phrase: "Jeffrey FMH"

Phrase: ":"

Phrase: "Analysis of tricarboxylic acid cycle of the heart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "13C isotope isomers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022203:isomers [Natural Phenomenon or Process]
Processing 00000000.tx.351: Am J Physiol Endocrinol Metab 259:H987H995, 1990 Allen TM, Hardin CD: Pattern of substrate utilization in vascular smooth muscle using 13C isotopomer analysis of glutamate. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 259"

Phrase: ":"

Phrase: "H987H995,"

Phrase: "1990 Allen TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   827   C3540468:TM [Gene or Genome]

Phrase: "Hardin CD"

Phrase: ":"

Phrase: "Pattern of substrate utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0449774:Pattern [Spatial Concept]

Phrase: "in vascular smooth muscle"
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
  1000   C0026844:Muscle, Smooth, Vascular [Tissue]
   901   C1267092:Muscle, Smooth [Tissue]
   827   C0005847:vascular [Body Part, Organ, or Organ Component]
   827   C0026845:Muscle [Tissue]
   827   C0205357:Smooth [Qualitative Concept]
   827   C1558950:VASCULAR [Finding]
   827   C1801960:Vascular [Qualitative Concept]
   771 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   771 E C1511228:VESSEL, BLOOD [Tissue]
   755 E C0442025:Muscular [Spatial Concept]
   727 E C0005767:Blood [Tissue]
   727 E C0005768:blood [Body Substance]
   727 E C0229664:Blood [Body Substance]
   727 E C0392895:Bloods [Population Group]
   711 E C0333275:Bloody [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "13C isotopomer analysis of glutamate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.352: Am J Physiol Heart Circ Physiol 275:H2227H2235, 1998[Abstract/Free FullText] Chatham JC, Gao Z-P, Forder JR: The impact of 1 week of diabetes on the regulation of myocardial carbohydrate and fatty acid oxidation. 

Phrase: "Am"

Phrase: "J Physiol Heart Circ Physiol 275"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0018787:Heart [Body Part, Organ, or Organ Component]
   799   C0332520:Circ [Quantitative Concept]
   799   C1281570:Heart [Body Part, Organ, or Organ Component]
   799   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "H2227H2235,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chatham JC,"

Phrase: "Gao Z-P,"

Phrase: "Forder JR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: ":"

Phrase: "The impact of 1 week of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1825598:IMPACT [Gene or Genome]

Phrase: "on the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of myocardial carbohydrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007004:Carbohydrate [Carbohydrate]

Phrase: "and"

Phrase: "fatty acid oxidation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1158366:fatty acid oxidation [Molecular Function]
   901   C0015684:Fatty acid [Lipid]
   827   C0001128:Acid [Chemical]
   827   C0030011:Oxidation [Molecular Function]
   827   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.353: Am J Physiol Endocrinol Metab 277:E342E351, 1999[Abstract/Free FullText] Bouzier AK, Goodwin R, de Gannes FM, Valeins H, Voisin P, Canoni P, Merle M: Compartmentation of lactate and glucose metabolism in C6 glioma cells: a 13C and 1H NMR study. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 277"

Phrase: ":"

Phrase: "E342E351,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bouzier AK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]

Phrase: "Goodwin R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "de Gannes FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540627:FM [Gene or Genome]

Phrase: "Valeins H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Voisin P,"

Phrase: "Canoni P,"

Phrase: "Merle M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Compartmentation of lactate"

Phrase: "and"

Phrase: "glucose metabolism in C6 glioma cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0596620:glucose metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "a 13C"

Phrase: "and"

Phrase: "1H NMR study."
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   884   C0024485:Magnetic resonance study [Diagnostic Procedure]
           nuclear magnetic resonance
   884   C0028580:Nuclear Magnetic Resonance [Natural Phenomenon or Process]
           Magnetic Resonance
   884   C1547989:Nuclear Magnetic Resonance [Intellectual Product]
   853   C0024488:magnetic study [Occupation or Discipline]
           Magnetic
   840   C0917874:Magnetic Resonance [Natural Phenomenon or Process]
   840   C1551403:Magnetic resonance [Laboratory Procedure]
   804   C0231881:Resonance [Finding]
   804   C0459800:resonance [Natural Phenomenon or Process]
   804   C0521447:Nuclear [Spatial Concept]
   804   C0557651:Study [Manufactured Object]
   804   C0563532:magnetic [Natural Phenomenon or Process]
   804   C0684213:Resonance [Qualitative Concept]
   804   C2603343:Study [Research Activity]
   733 E C0024483:Magnet [Manufactured Object]
   733 E C0577554:Resonant [Qualitative Concept]
   733 E C0885556:magnets [Pharmacologic Substance]
   733 E C1706318:Magnet [Manufactured Object]
Processing 00000000.tx.354: J Biol Chem 273:2716227169, 1998[Abstract/Free FullText] Bennett M, Macdonald K, Chan S, Luzio JP, Simari R, Weissberg P: Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2716227169,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bennett M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Macdonald K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Chan S,"

Phrase: "Luzio JP,"

Phrase: "Simari R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Weissberg P"

Phrase: ":"

Phrase: "Cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "trafficking of Fas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0599896:trafficking [Cell Function]

Phrase: ":"

Phrase: "a rapid mechanism of p53-mediated apoptosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.355: Science 282:290293, 1998[Abstract/Free FullText] Fukuo K, Nakahashi T, Nomura S, Hata S, Suhara T, Shimizu M, Tamatani M, Morimoto S, Kitamura Y, Ogihara T: Possible participation of Fas-mediated apoptosis in the mechanism of atherosclerosis. 

Phrase: "Science 282"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "290293,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fukuo K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Nakahashi T,"

Phrase: "Nomura S,"

Phrase: "Hata S,"

Phrase: "Suhara T,"

Phrase: "Shimizu M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tamatani M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Morimoto S,"

Phrase: "Kitamura Y,"

Phrase: "Ogihara T"

Phrase: ":"

Phrase: "Possible participation of Fas-mediated apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679823:Participation [Functional Concept]

Phrase: "in the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "of atherosclerosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004153:Atherosclerosis [Disease or Syndrome]
   928 E C0333482:Atherosclerotic [Functional Concept]
Processing 00000000.tx.356: Gerontology 43 (Suppl. 1):3542, 1997 Geng YJ, Henderson LE, Levesque EB, Muszynski M, Libby P: Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. 

Phrase: "Gerontology 43"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017469:Gerontology [Biomedical Occupation or Discipline]
   861   C0205767:Gerontology [Occupation or Discipline]

Phrase: "(Suppl. 1"

Phrase: ")"

Phrase: ":"

Phrase: "3542,"

Phrase: "1997 Geng YJ,"

Phrase: "Henderson LE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439090:LE [Idea or Concept]
   861   C1423767:LE [Gene or Genome]

Phrase: "Levesque EB,"

Phrase: "Muszynski M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Libby P"

Phrase: ":"

Phrase: "Fas"

Phrase: "is"

Phrase: "expressed in human atherosclerotic intima"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086418:Human [Human]
   760   C0162864:Intima [Tissue]
   760   C0333482:Atherosclerotic [Functional Concept]
   760   C1256463:Intima [Tissue]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "apoptosis of cytokine-primed human vascular smooth muscle cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   832   C2612492:apoptosis of smooth muscle cells [Cell Function]
           smooth muscle cell apoptosis
   767   C2611952:muscle cell apoptosis [Cell Function]
   742   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.357: Arterioscler Thromb Vasc Biol 10:22002208, 1997 Thyberg J: Phenotypic modulation of smooth muscle cells during formation of neointimal thickenings following vascular injury. 

Phrase: "Arterioscler Thromb Vasc Biol 10"

Phrase: ":"

Phrase: "22002208,"

Phrase: "1997 Thyberg J"

Phrase: ":"

Phrase: "Phenotypic modulation of smooth muscle cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443264:Modulation [Spatial Concept]

Phrase: "during formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of neointimal thickenings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205400:thickenings [Finding]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "vascular injury."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178324:Vascular injury [Injury or Poisoning]
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.358: Histol Histopathol 13:8191, 1998[Medline] Aikawa M, Sakomura Y, Ueda M, Kimura K, Manabe I, Ishiwata S, Komiyama N, Yamagucki H, Yazaki Y, Nagai R: Redifferentiation of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression. 

Phrase: "Histol Histopathol 13"

Phrase: ":"

Phrase: "8191,"

Phrase: "1998"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Aikawa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sakomura Y,"

Phrase: "Ueda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kimura K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Manabe I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ishiwata S,"

Phrase: "Komiyama N,"

Phrase: "Yamagucki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Yazaki Y,"

Phrase: "Nagai R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Redifferentiation of smooth muscle cells"

Phrase: "after coronary angioplasty"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002997:coronary angioplasty [Therapeutic or Preventive Procedure]
  1000   C0190211:Coronary angioplasty [Therapeutic or Preventive Procedure]
   861   C0018787:coronary [Body Part, Organ, or Organ Component]
   861   C0162577:Angioplasty [Therapeutic or Preventive Procedure]
   861   C1548817:Angioplasty [Health Care Activity]

Phrase: "determined via myosin heavy chain expression."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0027100:Myosin Heavy Chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1420192:heavy chain [Gene or Genome]
   753   C0027096:Myosin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0337112:Chain [Manufactured Object]
   753   C0439539:Heavy [Qualitative Concept]
   753   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.359: Circulation 96:8290, 1997[Abstract/Free FullText] Majesky MW, Giachelli CM, Reidy MA, Schwartz SM: Rat carotid neointimal smooth muscle cells reexpress a developmentally regulated mRNA phenotype during repair of arterial injury. 

Phrase: "Circulation 96"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005775:Circulation [Physiologic Function]
   861   C1516559:Circulation [Organism Function]

Phrase: ":"

Phrase: "8290,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Majesky MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Giachelli CM,"

Phrase: "Reidy MA,"

Phrase: "Schwartz SM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: ":"

Phrase: "Rat carotid neointimal smooth muscle cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   861   C1135918:Smooth Muscle Cells [Cell]
   827   C0596981:Muscle Cells [Cell]
   827   C1267092:Muscle, Smooth [Tissue]
   799   C0007634:Cells [Cell]
   799   C0026845:Muscle [Tissue]
   799   C0205357:Smooth [Qualitative Concept]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   727 E C0442025:Muscular [Spatial Concept]

Phrase: "reexpress"

Phrase: "a developmentally regulated mRNA phenotype during repair of arterial injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0031437:Phenotype [Organism Attribute]
   739   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.360: Circ Res 71:759768, 1992[Abstract] Glick RP, Unterman TG, Lacson R: Identification of insulin-like growth factor (IGF) and glucose transporter-1 and 3 mRNA in CNS tumors. 

Phrase: "Circ Res 71"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332520:Circ [Quantitative Concept]
   827   C0450389:71 [Intellectual Product]
   827   C2347379:RES [Finding]
   827   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "759768,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Glick RP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1538326:RP [Gene or Genome]
   861   C3541325:RP [Idea or Concept]

Phrase: "Unterman TG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337445:TG [Laboratory Procedure]

Phrase: "Lacson R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ":"

Phrase: "Identification of insulin-like growth factor (IGF)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]
   716   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   716   C1753359:insulin-like growth factor [Molecular Function]

Phrase: "and"

Phrase: "glucose transporter-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "3 mRNA in CNS tumors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.361: Regul Pept 48:251256, 1993[Medline] Heilig CW, Concepcion L, Riser BL, Freytag SO, Zhu M, Cortes P: Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. 

Phrase: "Regul Pept 48"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0080384:PEPT [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "251256,"

Phrase: "1993"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Heilig CW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0454665:CW [Geographic Area]

Phrase: "Concepcion L,"

Phrase: "Riser BL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006413:BL [Neoplastic Process]
   861   C1552663:BL [Idea or Concept]
   861   C2827109:BL [Geographic Area]

Phrase: "Freytag SO,"

Phrase: "Zhu M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Cortes P"

Phrase: ":"

Phrase: "Overexpression of glucose transporters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in rat mesangial cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0227651:Mesangial Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755   C0017655:Mesangium [Body Part, Organ, or Organ Component]

Phrase: "cultured in a normal glucose milieu"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0860800:normal glucose [Finding]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C2347086:% Normal [Quantitative Concept]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "the diabetic phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.362: J Clin Invest 96:18021814, 1995[Medline] Gulve EA, Ren J, Marshall BA, Gao J, Hansen PA, Holloszy JO, Mueckler M: Glucose transport activity in skeletal muscles from transgenic mice overexpressing GLUT1. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "96"

Phrase: ":"

Phrase: "18021814,"

Phrase: "1995"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gulve EA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014963:EA [Organic Chemical,Pharmacologic Substance]
   861   C1457900:EA [Quantitative Concept]

Phrase: "Ren J,"

Phrase: "Marshall BA,"

Phrase: "Gao J,"

Phrase: "Hansen PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Holloszy JO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022418:JO [Geographic Area]

Phrase: "Mueckler M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: ":"

Phrase: "Glucose transport activity in skeletal muscles"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
   748   C0005529:Active Transport [Physiologic Function]
   742   C0231484:Muscular activity [Organ or Tissue Function]

Phrase: "from transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "GLUT1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1335837:GLUCOSE TRANSPORTER 1 [Gene or Genome]
   901   C0017742:Glucose Transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0596902:transporter [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.363: J Biol Chem 269:1836618370, 1994[Abstract/Free FullText] Malhotra R, Brosius FC 3rd: Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1836618370,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "] Malhotra R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Brosius FC 3rd"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205437:3rd [Quantitative Concept]
   827   C2983605:FC [Activity]

Phrase: ":"

Phrase: "Glucose uptake"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1159527:glucose uptake [Cell Function]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "and"

Phrase: "glycolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017952:Glycolysis [Molecular Function]

Phrase: "reduce"

Phrase: "hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.364: J Biol Chem 274:1256712575, 1999[Abstract/Free FullText] Dominguez JH, Song B, Liu-Chen S, Qulali M, Howard R, Lee C, McAteer J: Studies of renal injury II: activation of the glucose transporter 1 (GLUT1) gene and glycolysis in LLC-PK1 cells under calcium stress. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1256712575,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dominguez JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Song B,"

Phrase: "Liu-Chen S,"

Phrase: "Qulali M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Howard R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lee C,"

Phrase: "McAteer J"

Phrase: ":"

Phrase: "Studies of renal injury II"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   781   C0846101:renal study [Diagnostic Procedure]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "activation of the glucose transporter 1 (GLUT1) gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0017255:Gene Activation [Genetic Function]
   748   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "glycolysis in LLC-PK1 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0017952:Glycolysis [Molecular Function]

Phrase: "under calcium stress."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.365: J Clin Invest 98:395404, 1996[Abstract/Free FullText] Schaffer SW, Croft CB, Solodushko V: Cardioprotective effect of hyperglycemia: effect on hypoxia-induced apoptosis and necrosis. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "98"

Phrase: ":"

Phrase: "395404,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "] Schaffer SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420193:SW [Gene or Genome]
   861   C1832169:SW [Body System]
   861   C3538902:SW [Gene or Genome]

Phrase: "Croft CB,"

Phrase: "Solodushko V"

Phrase: ":"

Phrase: "Cardioprotective effect of hyperglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: ":"

Phrase: "effect on hypoxia-induced apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "necrosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027540:Necrosis [Organ or Tissue Function]
  1000   C1334928:Necrosis [Finding]
Processing 00000000.tx.366: Am J Physiol Heart Circ Physiol 278:H1948H1954, 2000[Abstract/Free FullText]

Phrase: "Am"

Phrase: "J Physiol Heart Circ Physiol 278"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0018787:Heart [Body Part, Organ, or Organ Component]
   799   C0332520:Circ [Quantitative Concept]
   799   C1281570:Heart [Body Part, Organ, or Organ Component]
   799   C2347774:circ [Quantitative Concept]

Phrase: ":"

Phrase: "H1948H1954,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

